Cinemark Usa 10-K 9 Mar 22 2021 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2021	Mar. 04, 2022
Document Information [Line Items]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	FY
Entity Registrant Name	CINEMARK USA INC /TX
Entity Central Index Key	0000885975
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Public Float	$ 0
Entity Shell Company	false
Entity Small Business	false
Entity Emerging Growth Company	false
Entity File Number	33-47040
Entity Tax Identification Number	75-2206284
Entity Address, Address Line One	3900 Dallas Parkway
Entity Address, City or Town	Plano
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	75093
City Area Code	972
Local Phone Number	665-1000
Entity Incorporation, State or Country Code	TX
Document Annual Report	true
Document Transition Report	false
ICFR Auditor Attestation Flag	false
Documents Incorporated by Reference	Certain portions of the definitive proxy statement of Cinemark Holdings, Inc. the registrant’s parent company, to be filed within 120 days of December 31, 2021 , are incorporated by reference into Part III, Items 10-14, of this annual report on Form 10-K.
Auditor Name	Deloitte & Touche LLP
Auditor Firm ID	34
Auditor Location	Dallas, Texas
Class A common stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		1,500
Class B common stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		182,648

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands		Dec. 31, 2021	Dec. 31, 2020
Current assets
Cash and cash equivalents		$ 442,677	$ 260,538
Inventories		15,451	12,593
Accounts receivable		68,835	25,257
Current income tax receivable		46,631	158,932
Prepaid expenses and other		36,209	34,400
Accounts receivable from parent		46,651	36,775
Total current assets		656,454	528,495
Theatre properties and equipment
Land		102,625	104,190
Buildings		536,984	535,780
Property under capital and finance leases		138,291	147,156
Theatre furniture and equipment		1,402,698	1,425,142
Leasehold interests and improvements		1,188,175	1,190,835
Total		3,368,773	3,403,103
Less: accumulated depreciation and amortization		1,985,927	1,788,041
Theatre properties and equipment, net		1,382,846	1,615,062
Operating lease right-of-use assets, net	[1]	1,230,790	1,278,191
Other assets
Goodwill	[2]	1,248,791	1,253,840
Intangible assets, net		310,843	314,195
Investments in affiliates		25,205	23,726
Deferred charges and other assets, net		22,259	33,199
Total other assets		1,742,542	1,776,922
Total assets		5,012,632	5,198,670
Current liabilities
Current portion of long-term debt		24,254	18,056
Current portion of operating lease obligations	[1]	217,092	208,593
Current portion of finance lease obligations	[1]	14,605	16,407
Current income tax payable		91	5,632
Accounts payable		75,989	70,635
Accrued interest		33,214	8,215
Accrued film rentals		86,105	10,668
Accrued payroll		54,912	23,388
Accrued property taxes		29,970	35,586
Accrued other current liabilities (see Note 10)		224,366	201,602
Total current liabilities		760,598	598,782
Long-term liabilities
Long-term debt, less current portion		2,028,692	2,024,956
Operating lease obligations, less current portion	[1]	1,078,260	1,138,142
Finance lease obligations, less current portion	[1]	102,571	124,609
Long-term deferred tax liability		57,768	89,961
Long-term liability for uncertain tax positions		45,942	19,225
Other long-term liabilities		37,929	73,746
Total long-term liabilities		3,697,188	3,814,894
Commitments and contingencies (see Note 18)
Cinemark USA, Inc.'s stockholder's equity:
Additional paid-in-capital		1,458,973	1,310,625
Retained earnings (deficit)		(543,950)	(163,284)
Accumulated other comprehensive loss		(397,051)	(398,653)
Total Cinemark USA, Inc.'s stockholder's equity		543,282	773,998
Noncontrolling interests		11,564	10,996
Total equity		554,846	784,994
Total liabilities and equity		5,012,632	5,198,670
NCM
Current assets
Accounts receivable		4,498	636
Other assets
Investment in NCM		135,444	151,962
Long-term liabilities
NCM screen advertising advances		346,026	344,255
Class A common stock
Cinemark USA, Inc.'s stockholder's equity:
Common stock		0	0
Class B common stock
Cinemark USA, Inc.'s stockholder's equity:
Common stock		49,543	49,543
Treasury stock, 57,245 Class B shares at cost		$ (24,233)	$ (24,233)
[1]	The operating lease right-of-use assets and liabilities recorded on the Company’s consolidated balance sheets generally do not include renewal options that have not yet been exercised. The Company does not consider a lease renewal exercise as reasonably certain until immediately before the necessary notification is provided to the landlord after consideration of market conditions and performance of the theatre.
[2]	Balances are presented net of historical accumulated impairment losses of $ 214,031 for the U.S. operating segment and $ 43,750 for the international operating segment.

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2021	Dec. 31, 2020
Treasury stock, shares	57,245	57,245
Class A common stock
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	10,000,000	10,000,000
Common stock, shares issued	1,500	1,500
Common stock, shares outstanding	1,500	1,500
Class B common stock
Common stock, par value	$ 0	$ 0
Common stock, shares authorized	1,000,000	1,000,000
Common stock, shares issued	239,893	239,893
Common stock, shares outstanding	182,648	182,648

CONSOLIDATED STATEMENTS OF INCO

CONSOLIDATED STATEMENTS OF INCOME (LOSS) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2021		Dec. 31, 2020		Dec. 31, 2019
Revenues
Total revenues		$ 1,510,464		$ 686,310		$ 3,283,099
Cost of operations
Film rentals and advertising		414,988		186,810		1,003,832
Concession supplies		97,875		48,647		206,441
Salaries and wages		232,844		145,031		410,086
Facility lease expense		280,032		279,764		346,094
Utilities and other		282,889		229,505		474,711
General and administrative expenses		(158,490)		(125,363)		(170,828)
Depreciation and amortization		265,363		259,776		261,155
Impairment of long-lived and other assets		20,845		152,706		57,001
Restructuring costs		(1,001)		20,369		0
(Gain) loss on disposal of assets and other		8,025		(8,923)		12,008
Total cost of operations		(1,760,350)		(1,439,048)		(2,942,156)
Operating income (loss)		(249,886)		(752,738)		340,943
Other income (expense)
Interest expense	[1]	(125,569)		(115,651)		(99,941)
Interest income		(6,316)		(4,780)		(12,570)
Loss on extinguishment of debt		(6,527)		0		0
Foreign currency exchange gain loss		(1,271)		(4,865)		(3,394)
Non-cash distribution from DCIP		0		12,915		0	[2]
Equity in income (loss) of affiliates		(25,045)		(38,745)		41,870
Total other expense		(162,492)		(158,186)		(64,646)
Income (loss) before income taxes		(412,378)		(910,924)		276,297
Income taxes		(32,280)		(303,637)		80,520
Net income (loss)		(380,098)		(607,287)		195,777
Less: Net income (loss) attributable to noncontrolling interests		568		(1,120)		2,462
Net income (loss) attributable to Cinemark USA, Inc.		(380,666)		(606,167)		193,315
Admissions
Revenues
Total revenues		780,040		356,508		1,805,321
Concession
Revenues
Total revenues		561,652		231,046		1,161,083
Other
Revenues
Total revenues		168,772		98,756		316,695
NCM
Other income (expense)
Distributions from NCM		77		6,975		12,873
Interest expense - NCM		23,612		23,595		28,624
DCIP
Other income (expense)
Distributions from DCIP		13,139		0		0
Non-cash distribution from DCIP	[3]	$ 0	[2]	$ 12,915	[2]	$ 0
[1]	Includes amortization of debt issuance costs.
[2]	Reflects non-cash distribution of projectors from DCIP (see Note 7). These distributions are reported entirely within the U.S. operating segment.
[3]	Recorded as non-cash distributions from DCIP on the consolidated statements of income (loss). See discussion at Distribution of Projectors from DCIP above.

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement Of Income And Comprehensive Income [Abstract]
Net loss	$ (380,098)	$ (607,287)	$ 195,777
Other comprehensive income (loss), net of tax
Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes of $(3278), net of settlements	15,944	(14,320)	(8,210)
Other comprehensive income (loss) in equity method investments	0	0	(142)
Foreign currency translation adjustments	(18,837)	(47,592)	(12,753)
Total other comprehensive loss, net of tax	(2,893)	(61,912)	(21,105)
Total comprehensive loss, net of tax	(382,991)	(669,199)	174,672
Comprehensive (income) loss attributable to noncontrolling interests	(568)	1,120	(2,462)
Comprehensive income attributable to Cinemark USA, Inc.	$ (383,559)	$ (668,079)	$ 172,210

CONSOLIDATED STATEMENTS OF CO_2

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement Of Income And Comprehensive Income [Abstract]
Unrealized loss due to fair value adjustments on interest rate swap agreements, taxes	$ (3,278)	$ 3,532	$ 2,692

CONSOLIDATED STATEMENTS OF EQUI

CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Thousands	Total	Revision of Prior Period, Accounting Standards Update, Adjustment	Treasury Stock	Additional Paid-in- Capital	Retained Earnings	Retained EarningsRevision of Prior Period, Accounting Standards Update, Adjustment	Accumulated Other Comprehensive Loss	Total Cinemark USA, Inc.'s Stockholder's Equity	Total Cinemark USA, Inc.'s Stockholder's EquityRevision of Prior Period, Accounting Standards Update, Adjustment	Noncontrolling Interests	Common StockClass A common stock	Common StockClass B common stock
Balance at Dec. 31, 2018	$ 1,429,636		$ (24,233)	$ 1,277,921	$ 433,033		$ (319,007)	$ 1,417,257		$ 12,379	$ 0	$ 49,543
Balance (in shares) at Dec. 31, 2018			(57)								2	240
Cumulative effect of change in accounting principle, net of taxes		$ 16,985				$ 16,985			$ 16,985
Share based awards compensation expense	13,697			13,697				13,697
Dividends paid to parent	(158,450)				(158,450)			(158,450)
Dividends paid to noncontrolling interests	(2,333)									(2,333)
Net income (loss)	195,777				193,315			193,315		2,462
Amortization of accumulated losses for amended swap agreements	0
Other comprehensive loss	(21,105)						(21,105)	(21,105)
Balance at Dec. 31, 2019	1,474,207		$ (24,233)	1,291,618	484,883		(340,112)	1,461,699		12,508	$ 0	$ 49,543
Balance (in shares) at Dec. 31, 2019			(57)								2	240
Share based awards compensation expense	19,007			19,007				19,007
Dividends paid to parent	(42,000)				(42,000)			(42,000)
Dividends paid to noncontrolling interests	(392)									(392)
Net income (loss)	(607,287)				(606,167)			(606,167)		(1,120)
Amortization of accumulated losses for amended swap agreements	3,371						3,371	3,371
Other comprehensive loss	(61,912)						(61,912)	(61,912)		0
Balance at Dec. 31, 2020	784,994		$ (24,233)	1,310,625	(163,284)		(398,653)	773,998		10,996	$ 0	$ 49,543
Balance (in shares) at Dec. 31, 2020			(57)								2	240
Share based awards compensation expense	28,348			28,348				28,348
Contributions received from parent	120,000			120,000				120,000
Net income (loss)	(380,098)				(380,666)			(380,666)		568
Amortization of accumulated losses for amended swap agreements	4,495						4,495	4,495
Other comprehensive loss	(2,893)						(2,893)	(2,893)		0
Balance at Dec. 31, 2021	$ 554,846		$ (24,233)	$ 1,458,973	$ (543,950)		$ (397,051)	$ 543,282		$ 11,564	$ 0	$ 49,543
Balance (in shares) at Dec. 31, 2021			(57)								2	240

CONSOLIDATED STATEMENTS OF EQ_2

CONSOLIDATED STATEMENTS OF EQUITY (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Statement Of Stockholders Equity [Abstract]
Cumulative effect of change in accounting principle, taxes		$ 6,054
Restructuring cost	$ 521

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Operating activities
Net income (loss)	$ (380,098)	$ (607,287)	$ 195,777
Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities:
Depreciation	262,681	254,987	256,118
Amortization of intangible and other assets	2,682	4,789	5,037
Amortization of debt issuance costs	7,282	6,359	5,311
Amortization of accumulated losses for amended swap agreements	4,495	3,371	0
Impairment of long-lived and other assets	20,845	152,706	57,001
Share based awards compensation expense	28,348	18,486	13,697
(Gain) loss on disposal of assets and other	8,025	(8,923)	12,008
Loss on extinguishment of debt	6,527	0	0
Non-cash rent expense	(3,451)	2,357	(4,360)
Equity in (income) loss of affiliates	25,045	38,745	(41,870)
Deferred income tax expenses	(38,108)	(39,379)	(1,843)
Distributions from equity investees	156	25,430	53,366
Non-cash distributions from equity investees	0	12,915	0	[1]
Changes in other assets and liabilities
Inventories	(2,858)	9,093	(2,367)
Accounts receivable	(49,352)	51,446	8,873
Income tax receivable	112,301	(154,850)	(794)
Prepaid expenses and other	(1,809)	2,787	(24,016)
Deferred charges and other assets, net	805	9,904	(8,495)
Accounts payable and accrued expenses	175,228	(104,269)	36,639
Income tax payable	(5,877)	2,289	(6,998)
Liabilities for uncertain tax positions	30,183	4,931	341
Other long-term liabilities	(17,894)	13,124	21,312
Net cash provided by (used for) operating activities	176,357	(334,903)	561,072
Investing activities
Additions to theatre properties and equipment and other	(95,542)	(83,930)	(303,627)
Proceeds from sale of assets and other	6,246	614	3,155
Acquisitions of theatres in the U.S. and international markets, net of cash acquired	0	0	(10,170)
Investment in joint ventures and other, net	0	(50)	0
Net cash used for investing activities	(89,296)	(83,366)	(310,642)
Financing activities
Dividends paid to parent	0	(42,000)	(158,450)
Contributions received from parent	120,000	0	0
Payroll taxes paid as a result of restricted stock withholdings	(4,102)	(5,437)	(2,308)
Proceeds from issuance of senior notes	1,170,000	250,000	0
Proceeds from other borrowings	13,475	22,322	0
Redemption of senior notes	(1,155,000)	0	0
Repayments of long-term debt	(10,284)	(6,691)	(7,984)
Payment of debt issuance costs	(17,272)	(7,859)	0
Fees paid related to debt refinancing	(2,058)	0	0
Payments on finance leases	(14,689)	(15,432)	(14,600)
Other	0	(392)	(2,333)
Net cash provided by (used for) financing activities	100,070	194,511	(185,675)
Effect of exchange rate changes on cash and cash equivalents	(4,992)	(3,919)	(2,756)
Increase (decrease) in cash and cash equivalents	182,139	(227,677)	61,999
Cash and cash equivalents:
Beginning of period	260,538	488,215	426,216
End of period	442,677	260,538	488,215
NCM
Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities:
Interest accrued on NCM screen advertising advances	23,612	23,595	0
Amortization of NCM screen advertising advances and other deferred revenue	$ (32,411)	$ (31,679)	$ (13,665)
[1]	Reflects non-cash distribution of projectors from DCIP (see Note 7). These distributions are reported entirely within the U.S. operating segment.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	CINEMARK USA, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (in thousands, except share and per share data) 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Business — Cinemark USA, Inc., a wholly-owned subsidiary of Cinemark Holdings, Inc., and its subsidiaries (the “Company”) operate in the motion picture exhibition industry, with theatres in the United States (“U.S.”) and in 15 countries in Latin America. Principles of Consolidation — The consolidated financial statements include the accounts of Cinemark USA, Inc. and its subsidiaries. Majority-owned subsidiaries that the Company has control of are consolidated while those affiliates of which the Company owns between 20 % and 50 % and does not control are accounted for under the equity method. Those affiliates of which the Company owns less than 20 % are generally accounted for under the cost method, unless the Company is deemed to have the ability to exercise significant influence over the affiliate, in which case the Company would account for its investment under the equity method. The results of these equity method investees are included in the consolidated financial statements effective from their date of formation or from their dates of acquisition. Intercompany balances and transactions are eliminated in consolidation. Cash and Cash Equivalents — Cash and cash equivalents consist of operating funds held in financial institutions, petty cash held by the theatres, highly liquid investments with original maturities of three months or less when purchased and restricted cash. The Company invests its cash primarily in money market funds, certificates of deposit, commercial paper or other similar funds. The Company maintains cash deposits required to support bank letters of credit issued for bank loans of certain of the Company’s international subsidiaries that totaled $ 25,767 as of December 31, 2021 and are considered restricted cash. See Note 11 for further discussion. Accounts Receivable – Accounts receivable, which are recorded at net realizable value, consist primarily of receivables related to screen advertising, screen rental, receivables related to discounted tickets and gift cards sold to third party retail locations, receivables from landlords related to theatre construction projects, rebates earned from the Company’s concession vendors and value-added and other non-income tax receivables. Inventories — Concession inventories are stated at the lower of cost (first-in, first-out method) or net realizable value. Theatre Properties and Equipment — Theatre properties and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is recorded using the straight-line method over the estimated useful lives of the assets as follows: Category Useful Life Buildings on owned land 40 years Buildings on leased land Lesser of lease term or useful life Land and buildings under finance leases (1) Lease term Theatre furniture and equipment 3 to 15 years Leasehold improvements Lesser of lease term or useful life (1) Amortization of finance lease assets is included in depreciation and amortization expense on the consolidated statements of income. Accumulated amortization of finance lease assets as of December 31, 2020 and 2021 was $ 47,961 and $ 57,778 , respectively. The Company evaluates long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable (qualitative evaluation). The Company also performs a full quantitative impairment evaluation on an annual basis. These qualitative and quantitative evaluations are described below: • Quantitative approach The Company performs a quantitative evaluation at the theatre level using estimat ed undiscounted cash flows from continuing use through the remainder of the theatre’s useful life. The remainder of the theatre’s useful life correlates with the remaining lease period, which includes the probability of the exercise of available renewal periods for leased properties, and the lesser of twenty years or the building’s remaining useful life for owned properties. If the estimated undiscounted cash flows are not sufficient to recover a long-lived asset’s carrying value, the Company then compares the carrying value of the asset group (theatre) with its estimated fair value. Significant judgment, including management’s estimate of future theatre level cash flows for each theatre is involved in estimating fair value. For its 2020 and 2021 long-lived impairment assessments, significant management judgement was involved in estimating impacts of the COVID-19 pandemic and the timing of recovery for each of the Company's theatres based on projected box office. Fair value is estimated based on a multiple of cash flows. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy, as defined by FASB ASC Topic 820-10-35, are based on projected operating performance, market transactions and industry trading multiples. • Qualitative approach The Company’s qualitative assessment considers relevant market transactions, industry trading multiples and recent developments that would impact its estimates of future cash flows as compared to its most recent quantitative impairment assessment. Goodwill and Other Intangible Assets — The Company evaluates goodwill for impairment annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value of the goodwill may not be fully recoverable. The Company evaluates goodwill for impairment at the reporting unit level and has allocated goodwill to the reporting unit based on an estimate of its relative fair value. Management considers the reporting unit to be each of its regions in the U.S. and each of its international countries with Honduras, El Salvador, Nicaragua, Costa Rica, Panama and Guatemala considered one reporting unit (the Company does not have goodwill recorded for all of its international locations). Under ASC Topic 350, Goodwill, Intangibles and Other (“ASC Topic 350”), the Company may perform a qualitative impairment assessment or a quantitative impairment assessment of our goodwill which are described below: • Quantitative approach Under a quantitative goodwill impairment analysis, the Company estimates the fair value of each reporting unit and compares it with its carrying value. Fair value is estimated using the market approach, which is the most common valuation approach for the Company’s industry and considers a multiple of cash flows for each reporting unit as the basis for fair value. Significant judgment including management’s estimate of future theatre level cash flows for each theatre is involved in estimating fair value of a reporting unit. For its 2020 and 2021 goodwill impairment assessments, significant management judgement was involved in estimating impacts of the COVID-19 pandemic and the timing of recovery for each of the Company's theatres based on projected box office. The Company’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on projected operating performance of each reporting unit, relevant market transactions and industry trading multiples. • Qualitative approach The Company’s qualitative assessment of goodwill for each reporting unit considers economic and market conditions, industry trading multiples and the impact of recent developments and events on the estimated fair values as determined during its most recent quantitative assessment. Tradename intangible assets are tested for impairment at least annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value may not be fully recoverable. Under ASC Topic 350, the Company can elect to perform a qualitative or quantitative impairment assessment for our tradename intangible assets as described below: • Quantitative approach The Company compares the carrying values of its tradename assets to their estimated fair values. Fair values are estimated by applying an estimated market royalty rate that could be charged for the use of the tradenames to forecasted future revenues, with an adjustment for the present value of such royalties. Significant judgment, including management’s estimate of market royalty rates and long-term revenue forecasts, is involved in estimating the tradename fair values. For its 2020 and 2021 tradename impairment assessments, significant management judgement was involved in estimating impacts of the COVID-19 pandemic and the timing of recovery for each of the Company's theatres based on projected box office. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, were based on projected revenue performance and expected industry trends. • Qualitative approach The Company’s qualitative assessment considers industry and market conditions and recent developments that may impact the revenue forecasts and other estimates as compared to its most recent quantitative assessment. The table below summarizes the Company’s intangible assets and the amortization method used for each type of intangible asset: Intangible Asset Amortization Method Goodwill Indefinite-lived Tradename Indefinite-lived and definite-lived. Definite-lived tradename asset has a remaining useful life of approximately five years. Other intangible assets Straight-line method over the terms of the underlying agreement or the expected useful life of the intangible asset. The remaining useful lives of these intangible assets range from one to four years . Lease Accounting — See Note 4 for discussion of the Company’s lease accounting policies. Deferred Charges and Other Assets — Deferred charges and other assets consist of construction, lease and other deposits, equipment to be placed in service, and other assets of a long-term nature. Self-Insurance Reserves — In the U.S., the Company is self-insured for general liability claims. For each of the years ended December 31, 2019, 2020 and 2021 , general liability claims were capped at $ 500 per occurrence with no aggregate annual cap. For its international locations, the Company is fully insured for general liability claims with little or no deductibles per occurrence. The Company has a fully-funded deductible workers compensation insurance plan under which the Company is responsible for pre-funding claims and is responsible for claims up to $ 250 per occurrence, with an annual cap of $ 5,000 for the years ended December 31, 2019, 2020 and 2021 . The Company is also self-insured for domestic medical claims with a cap of $ 250 per occurrence for the years ended December 31, 2019, 2020 and 2021. As of December 31, 2020 and 2021 , the Company’s self-insurance reserves were $ 9,034 and $ 6,810 , respectively, and are reflected in accrued other current liabilities on the consolidated balance sheets. Revenue Recognition — See Note 5 for discussion of revenue recognition and deferred revenue. Expenses — Film rental costs are subject to the film licensing arrangement and accrued based on the applicable box office receipts and either; 1) a sliding scale formula, which is generally established with the studio prior to the opening of the film, 2) a firm terms formula as negotiated prior to a film's theatrical run or 3) estimates of the final settlement rate, which occurs at the conclusion of the film run. Under a sliding scale formula, the Company pays a percentage of box office revenues using a pre-determined scale that is based upon box office performance of the film for its full run. Under a firm terms formula, the Company pays the distributor a percentage of box office receipts that can either be an aggregate rate for the full theatrical run or rates that decline over the term of the theatrical run. The settlement process allows for negotiation of film rental fees upon the conclusion of the film's theatrical run based upon how the film performs. Estimates are based on the expected success of a film. The success of a film can generally be determined a few weeks after a film is released when the initial box office performance of the film is known. If actual settlements are different than those estimates, film rental costs are adjusted at that time. Accounting for Share Based Awards — The Company measures the cost of employee services received in exchange for an equity award based on the fair value of the award on the date of the grant. The grant date fair value is based on Cinemark Holdings, Inc.'s stock price on the grant date. Such costs are recognized over the period during which an employee is required to provide service in exchange for the award (which is usually the vesting period). At the time of the grant, the Company also estimates the number of awards that will ultimately be forfeited. See Note 15 for discussion of the Company’s share based awards and related compensation expense. Income Taxes — The Company participates in the consolidated return of Cinemark Holdings, Inc. However, the Company's provision for income taxes is computed on a stand-alone basis. The Company uses an asset and liability approach to financial accounting and reporting for income taxes. Deferred income taxes are provided when tax laws and financial accounting standards differ with respect to the amount of income for a year and the basis of assets and liabilities. A valuation allowance is recorded to reduce the carrying amount of deferred tax assets unless it is more likely than not that such assets will be realized. Income taxes are provided on unremitted earnings from foreign subsidiaries unless such earnings are expected to be indefinitely reinvested. Income taxes have also been provided for potential tax assessments. The evaluation of an uncertain tax position is a two-step process. The first step is recognition: The Company determines whether it is more likely than not that a tax position will be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. In evaluating whether a tax position has met the more-likely-than-not recognition threshold, the Company should presume that the position would be examined by the appropriate taxing authority that would have full knowledge of all relevant information. The second step is measurement: A tax position that meets the more-likely-than-not recognition threshold is measured to determine the amount of benefit to recognize in the financial statements. The tax position is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. Differences between tax positions taken in a tax return and amounts recognized in the financial statements result in (1) a change in a liability for income taxes payable or (2) a change in an income tax refund receivable, a deferred tax asset or a deferred tax liability or both (1) and (2). The Company accrues interest and penalties on its uncertain tax positions as a component of income tax expense. See further discussion in Note 17. Segments — For the years ended December 31, 2019, 2020 and 2021 , the Company managed its business under two reportable operating segments, U.S. markets and international markets. See Note 19. Use of Estimates — The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the periods presented. The Company’s consolidated financial statements include amounts that are based on management’s best estimates and judgments. Actual results could differ from those estimates. Foreign Currency Translations — The assets and liabilities of the Company’s foreign subsidiaries are translated into U.S. dollars at current exchange rates as of the balance sheet date, and revenues and expenses are translated at average monthly exchange rates. The resulting translation adjustments are recorded in the consolidated balance sheets in accumulated other comprehensive loss. See Note 13 for a summary of the translation adjustments recorded in accumulated other comprehensive loss for the years ended December 31, 2019, 2020 and 2021. The Company recognizes foreign currency transaction gains and losses when changes in exchange rates impact transactions, other than intercompany transactions of a long-term investment nature, that have been denominated in a currency other than the functional currency. The Company deemed Argentina to be highly inflationary beginning July 1, 2018. A highly inflationary economy is defined as an economy with a cumulative inflation rate of approximately 100 percent or more over a three-year period. If a country’s economy is classified as highly inflationary, the financial statements of the foreign entity operating in that country must be remeasured to the functional currency of the reporting entity. The financial statements of the Company’s Argentina subsidiaries has been remeasured in U.S. dollars in accordance with ASC Topic 830, Foreign Currency Matters , effective beginning July 1, 2018. See further discussion in Note 13. Fair Value Measurements — According to authoritative guidance, inputs used in fair value measurements fall into three different categories; Level 1, Level 2 and Level 3. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 3 inputs are unobservable inputs for the asset or liability. See Note 12 for a discussion of our fair value measurements for the years ended December 31, 2019, 2020 and 2021. Acquisitions — The Company accounts for acquisitions under the acquisition method of accounting. The acquisition method requires that the acquired assets and liabilities, including contingencies, be recorded at fair value determined on the acquisition date and changes thereafter reflected in income. For certain acquisitions, the Company obtains independent third party valuation studies for certain of the assets acquired and liabilities assumed to assist the Company in determining fair value. The estimation of the fair value of the assets acquired and liabilities assumed involves a number of estimates and assumptions that could differ materially from the actual amounts realized. The Company provides assumptions, including both quantitative and qualitative information, about the specified asset or liability to the third party valuation firms. The Company primarily utilizes the third party to accumulate comparative data from multiple sources and assemble a report that summarizes the information obtained. The Company then uses the information to record estimated fair value. The third party valuation firms are supervised by Company personnel who are knowledgeable about valuations and fair value. The Company evaluates the appropriateness of the assumptions and valuation methodologies utilized by the third party valuation firm. Interest Rate Swaps – The Company evaluates its interest rate swap agreements, which are designated as cash flow hedges, to determine whether they are effective on a quarterly basis in accordance with ASC Topic 815, Derivatives and Hedging . The fair values of the interest rate swaps are estimated based on future estimated net cash flows considering forecasted interest rates for the terms of the interest rate swap agreements as compared to the fixed interest rates paid under the agreements. If deemed to be effective, fair value estimates are recorded on the consolidated balance sheets as an asset or liability with the related gains or losses reported as a component of accumulated other comprehensive loss. If the swaps are determined to not be effective, the gains or losses are recorded in interest expense on the consolidated income statement. See further discussion at Note 11. Restructuring Charges – During the year ended December 31, 2020, the Company recorded restructuring charges based on an approved and announced restructuring plan, specifically related to headcount reductions, the permanent closure of underperforming theatres and the write-down of related theatre assets. The costs of the restructuring actions were accrued based on estimates at the time the plan was formalized. Adjustments made to restructuring charges based on actual costs incurred were recorded during the year ended December 31, 2021. See further discussion in Note 3.

NEW ACCOUNTING PRONOUNCEMENTS

NEW ACCOUNTING PRONOUNCEMENTS	12 Months Ended
	Dec. 31, 2021
Accounting Changes And Error Corrections [Abstract]
NEW ACCOUNTING PRONOUNCEMENTS	2. NEW ACCOUNTING PRONOUNCEMENTS ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting , (“ASU 2020-04”) and ASU 2021-01, Reference Rate Reform (Topic 848): Scope , (“ASU 2021-01”). The purpose of ASU 2020-04 is to provide optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. More specifically, the amendments in ASU 2020-04 provide optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in ASU 2021-01 clarify that certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivatives that are affected by the discounting transition. The amendments in ASU 2020-04 and ASU 2021-01 are effective as of March 12, 2020 through December 31, 2022. The Company does not expect ASU 2020-04 and ASU 2021-01 to have a material impact on its consolidated financial statements. ASU 2021-10, Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance , (“ASU 2021-10”). The purpose of ASU 2021-10 is to provide annual disclosure guidance about transactions with a government that are by applying a grant or contribution accounting model by analogy. More specifically, the amendments in ASU 2021-10 require disclosure of a) the nature of the transactions and the related accounting policy used to account for the transactions, b) the line items on the balance sheet and income statement, including the amounts applicable to each line item, that are affected by the transactions and b) significant terms and conditions of the transactions, including commitments and contingencies. The amendments in ASU 2021-10 are effective for annual periods beginning after December 15, 2021. The amendments in ASU 2021-10 should be applied either a) prospectively to all transactions at the date of initial application and new transactions that are entered into after the date of initial application or b) retrospectively to those transactions. The Company does not expect ASU 2021-10 to have a material impact on its consolidated financial statements.

IMPACT OF THE COVID-19 PANDEMIC

IMPACT OF THE COVID-19 PANDEMIC	12 Months Ended
	Dec. 31, 2021
Risks And Uncertainties [Abstract]
IMPACT OF THE COVID-19 PANDEMIC	3. IMPACT OF THE COVID-19 PANDEMIC The COVID-19 pandemic has had an unprecedented impact on the world and the movie exhibition industry. The social and economic effects have been widespread. The Company temporarily closed its theatres in the U.S. and Latin America during March of 2020 at the onset of the COVID-19 outbreak. Additionally, the Company implemented various cash preservation strategies, including, but not limited to, temporary personnel and salary reductions, halting non-essential operating and capital expenditures, negotiating modified timing and/or abatement of contractual payments with landlords and other major suppliers, and the suspension of dividends to Cinemark Holdings, Inc. Throughout 2020 and 2021 the Company reopened theatres as soon as local restrictions and the status of the COVID-19 pandemic would allow. As of December 31, 2021, all of the Company's domestic and international theatres were open. The industry’s recovery to historical levels of new film content, both in terms of the number of new films and box office performance, is still underway, as the industry also continues to adjust to evolving theatrical release windows, competition from streaming and other delivery platforms, supply chain delays, inflationary pressures, labor shortages, wage rate pressures and other economic factors . Based on the Company’s current estimates of recovery, it believes it has, and will generate, sufficient cash to sustain operations. Nonetheless, the COVID-19 pandemic has had, and continues to have, adverse effects on the Company’s business, results of operations, cash flows and financial condition. Restructuring Charges During June 2020, Company management announced a restructuring plan to realign its operations to create a more efficient cost structure (referred to herein as the “Restructuring Plan”) in response to the COVID-19 pandemic. The Restructuring Plan primarily included a headcount reduction at its domestic corporate office and the permanent closure of certain domestic and international theatres. The following table summarized activity recorded during the years ended December 31, 2020 and 2021: U.S. Operating Segment International Operating Segment Consolidated Employee-related Costs Facility Closure Costs Total Charges Employee-related Costs Facility Closure Costs Total Charges Employee-related Costs Facility Closure Costs Total Charges Restructuring charges recorded during the year ended December 31, 2020 $ 8,964 $ 7,645 $ 16,609 $ 814 $ 2,946 $ 3,760 $ 9,778 $ 10,591 $ 20,369 Amounts paid ( 7,603 ) ( 1,649 ) ( 9,252 ) ( 814 ) ( 590 ) ( 1,404 ) ( 8,417 ) ( 2,239 ) ( 10,656 ) Noncash write-offs ( 521 ) ( 256 ) ( 777 ) — ( 2,195 ) ( 2,195 ) ( 521 ) ( 2,451 ) ( 2,972 ) Reserve balance at December 31, 2020 840 5,740 6,580 — 161 161 840 5,901 6,741 Amounts paid ( 350 ) ( 3,930 ) ( 4,280 ) — ( 27 ) ( 27 ) ( 350 ) ( 3,957 ) ( 4,307 ) Reserve adjustments (1) ( 94 ) ( 887 ) ( 981 ) — ( 20 ) ( 20 ) ( 94 ) ( 907 ) ( 1,001 ) Reserve balance at December 31, 2021 $ 396 $ 923 $ 1,319 $ — $ 114 $ 114 $ 396 $ 1,037 $ 1,433 (1) Amounts are primarily adjustments based on final facility lease payments for certain closed theatres as compared with original estimates recorded. The unpaid and accrued restructuring costs of $ 1,433 are reflected in accrued other current liabilities on the consolidated balance sheet as of December 31, 2021.

LEASE ACCOUNTING

LEASE ACCOUNTING	12 Months Ended
	Dec. 31, 2021
Leases [Abstract]
LEASE ACCOUNTING	4. LEASE ACCOUNTING Real Estate Leases — The Company conducts a significant part of its theatre operations in leased properties under noncancelable operating and finance leases with base terms generally ranging from 10 to 25 years . In addition to fixed lease payments, some of the leases provide for variable lease payments and some require the payment of taxes, insurance and other costs applicable to the property. Variable lease payments include payments based on a percentage of retail sales or a percentage of retail sales over defined thresholds. Other variable lease payments include payments adjusted periodically for inflation, changes in attendance or changes in average ticket price. The Company can renew, at its option, many of its leases at defined or then market rental rates for various renewal periods. Some leases also provide for escalating rent payments throughout the lease term. The Company also leases certain office and warehouse facilities in the U.S. and in international locations, which generally only include fixed payments. The Company recognizes fixed lease expense for the operating leases on a straight-line basis over the lease term. The Company’s real estate lease agreements do not contain any residual value guarantees or restrictive covenants. Equipment Leases — The Company leases certain equipment under operating leases, including trash compactors and various other equipment used in the day-to-day operation of its theatres. Certain of the leases require fixed lease payments to be made over the duration of the lease term, while others are variable in nature based on usage or sales. Certain of these leases are month-to-month, while others have noncancelable terms ranging from 5 to 6 years . The Company’s equipment lease agreements do not contain any residual value guarantees or restrictive covenants. The Company leased digital projectors through October 2020. See further discussion of the leased projectors in Note 9. Lease Deferrals and Abatements — Upon the temporary closure of theatres in March 2020, the Company began negotiating the deferral of rent and other lease-related payments with its landlords while theatres remained closed. These discussions and negotiations have remained ongoing as the Company continues to be impacted by the COVID-19 pandemic. These negotiations resulted in amendments to the leases that involve varying concessions, including the abatement of rent payments during closure, deferral of all or a portion of rent payments to later periods and deferrals of rent payments combined with an early exercise of an existing renewal option or extension of the lease term. In certain locations, the Company is entitled to rent-free periods while theatres remain closed in accordance with local regulations. Total payments deferred as of December 31, 2020 were approximately $ 66,178 , $ 48,366 of which is included in accrued other current liabilities and $ 17,812 of which is included in other long term liabilities on the consolidated balance sheet. Total payments deferred as of December 31, 2021 were $ 31,903 , all of which is included in accrued other current liabilities on the consolidated balance sheet. In April 2020, the FASB staff released guidance indicating that in response to the COVID-19 pandemic, an entity would not have to analyze each contract to determine whether enforceable rights and obligations for concessions exist in the contract and could elect to apply or not apply the lease modification guidance in ASC Topic 842, Leases to those contracts. The election is available for concessions related to the effects of the COVID-19 pandemic that do not result in a substantial increase in the rights of the lessor or the obligations of the lessee. For example, this election is available for concessions that result in the total payments required by the modified contract being substantially the same as or less than total payments required by the original contract. The Company elected to not remeasure the lease liabilities and right-of-use assets for those leases where the concessions and deferrals did not result in a significant change in total payments under the lease and where the remaining lease term did not significantly change as a result of the negotiation. For those leases that were extended as a result of the negotiation to defer rent payments, the Company recalculated the related lease liability and right-of-use asset based on the new terms. The following table represents the operating and finance right-of-use assets and lease liabilities as of the periods indicated. As of As of Leases Classification December 31, 2020 December 31, 2021 Assets (1) Operating lease assets Operating lease assets $ 1,278,191 $ 1,230,790 Finance lease assets Theatre properties and equipment, net of accumulated depreciation (2) 99,195 80,513 Total lease assets $ 1,377,386 $ 1,311,303 Liabilities (1) Current Operating Current portion of operating lease obligations $ 208,593 $ 217,092 Finance Current portion of finance lease obligations 16,407 14,605 Noncurrent Operating Operating lease obligations, less current portion 1,138,142 1,078,260 Finance Finance lease obligations, less current portion 124,609 102,571 Total lease liabilities $ 1,487,751 $ 1,412,528 (1) The operating lease right-of-use assets and liabilities recorded on the Company’s consolidated balance sheets generally do not include renewal options that have not yet been exercised. The Company does not consider a lease renewal exercise as reasonably certain until immediately before the necessary notification is provided to the landlord after consideration of market conditions and performance of the theatre. (2) Finance lease assets are net of accumulated amortization of $ 47,961 and $ 57,778 as of December 31, 2020 and 2021, respectively. As of December 31, 2021 , the Company had signed lease agreements with total noncancelable lease payments of approximately $ 90,032 related to theatre leases that had not yet commenced. The timing of lease commencement is dependent on the completion of construction of the related theatre facility. Additionally, these amounts are based on estimated square footage and costs to construct each facility and may be subject to adjustment upon final completion of each construction project. In accordance with ASC Topic 842, fixed minimum lease payments related to these theatres are not included in the right-of-use assets and lease liabilities as of December 31, 2021. The following table represents the Company’s aggregate lease costs, by lease classification, for the periods indicated. Year Ended Year Ended Year Ended Lease Cost Classification December 31, 2019 December 31, 2020 December 31, 2021 Operating lease costs Equipment (1) Utilities and other $ 9,172 $ 3,324 $ 2,342 Real Estate (2)(3) Facility lease expense 346,222 275,056 280,968 Total operating lease costs $ 355,394 $ 278,380 $ 283,310 Finance lease costs Depreciation of leased assets Depreciation and amortization $ 14,734 $ 14,662 $ 12,634 Interest on lease liabilities Interest expense 7,786 7,014 5,916 Total finance lease costs $ 22,520 $ 21,676 $ 18,550 (1) Includes approximately $ 4,700 $ ( 465 ) and $ 1,842 of short-term lease payments for the years ended December 31, 2019,. 2020 and 2021, respectively. The amount for the year ended December 31, 2020 was impacted by i) a decrease in short term lease payments while theatres were closed and ii) rent abatements on leases that were not recalculated in accordance with the FASB guidance discussed above, which resulted in variable rent credits in the amount of the rent abatements. (2) Includes approximately $ 68,799 , $ 7,058 and $ 11,791 of variable lease payments based on a change in index, such as CPI or inflation, variable payments based on revenues or attendance and variable common area maintenance costs for the years ended December 31, 2019, 2020 and 2021, respectively. The amount for the year ended December 31, 2020 was impacted by rent abatements on leases that were not recalculated in accordance with the FASB guidance discussed above, which resulted in variable rent credits in the amount of the rent abatements. (3) Approximately $ 1,614 , $ 1,445 and $ 1,304 of lease payments are included in general and administrative expenses primarily related to office leases for the years ended December 31, 2019, 2020 and 2021, respectively. The following table represents the maturity of lease liabilities, by lease classification, as of December 31, 2021. Operating Finance Years Ending Leases Leases Total 2022 (1) $ 274,005 $ 19,820 $ 293,825 2023 252,772 19,131 271,903 2024 220,455 18,050 238,505 2025 193,375 16,453 209,828 2026 156,573 11,984 168,557 After 2026 447,815 58,694 506,509 Total lease payments $ 1,544,995 $ 144,132 $ 1,689,127 Less: Interest 249,643 26,956 276,599 Present value of lease liabilities $ 1,295,352 $ 117,176 $ 1,412,528 (1) Amounts do not include rent payments deferred under amendments as discussed at Lease Deferrals and Abatements above. The following table represents the weighted-average remaining lease term and discount rate, disaggregated by lease classification, as of December 31, 2021. As of Lease Term and Discount Rate December 31, 2021 Weighted-average remaining lease term (years) (1) Operating leases - equipment 2.9 Operating leases - real estate 7.3 Finance leases - equipment 3.4 Finance leases - real estate 8.9 Weighted-average discount rate (2) Operating leases - equipment 3.8 % Operating leases - real estate 4.9 % Finance leases - equipment 4.7 % Finance leases - real estate 4.9 % (1) The lease assets and liabilities recorded on the Company’s consolidated balance sheets generally do not include renewal options that have not yet been executed. The Company does not consider a lease renewal exercise as reasonably certain until immediately before the necessary notification is provided to the landlord after consideration of market conditions and performance of the theatre. (2) The discount rate for each lease represents the incremental borrowing rate at which the Company would borrow, on a collateralized basis, over a similar term and at an amount equal to the lease payments in a similar economic environment. The following table represents the minimum cash lease payments included in the measurement of lease liabilities and the non-cash addition of right-of-use assets for the periods presented. Year Ended Year Ended Year Ended Other Information December 31, 2019 December 31, 2020 December 31, 2021 Cash paid for amounts included in the measurement of lease liabilities Cash outflows for operating leases $ 281,895 $ 271,787 $ 269,677 Cash outflows for finance leases - operating activities $ 7,576 $ 6,985 $ 5,910 Cash outflows for finance leases - financing activities $ 14,600 $ 15,432 $ 14,689 Non-cash amount of leased assets obtained in exchange for: Operating lease liabilities $ 114,113 $ 132,717 $ 180,055 Finance lease liabilities $ 21,535 $ — $ 725 Lessor Arrangements Under the Company’s Exhibitor Services Agreement (“ESA”) with National CineMedia, LLC (“NCM”), the nonconsecutive periods of use of the theatre screens by NCM qualify as a lease in accordance with ASC Topic 842. See further discussion in Note 6. The Company rents its theatre auditoriums for corporate meetings, screenings, education and training sessions and other private events. These rentals, which are not significant to the Company, are generally one-time events and the related revenue is reflected as other revenue on the consolidated statements of income (loss).

REVENUE RECOGNITION

REVENUE RECOGNITION	12 Months Ended
	Dec. 31, 2021
Revenue From Contract With Customer [Abstract]
REVENUE RECOGNITION	5. REVENUE RECOGNITION Revenue Recognition Policy The Company’s patrons have the option to purchase movie tickets well in advance of a movie showtime or right before the movie showtime, or at any point in between those two timeframes depending on seat availability. The Company recognizes such admissions revenue when the showtime for a purchased movie ticket has passed. Concession revenue is recognized when products are sold to the consumer. Other revenues primarily consist of screen advertising and screen rental revenues, promotional income, studio trailer placements and transactional fees. Except for NCM screen advertising advances discussed below in Note 9, these revenues are generally recognized when the Company has performed the related services. The Company sells gift cards and discount ticket vouchers called Supersavers, the proceeds from which are recorded as deferred revenue. Deferred revenue for gift cards and discount ticket vouchers is recognized when they are redeemed for concession items or, if redeemed for movie tickets, when the showtime has passed. The Company generally records breakage revenue on gift cards and discount ticket vouchers based on redemption activity and historical experience with unused balances. The Company offers a subscription program in the U.S. whereby patrons can pay a monthly or annual fee to receive a monthly credit for use towards a future movie ticket purchase. The Company records the subscription program fees as deferred revenue and records admissions revenue when the showtime for a movie ticket purchased with a credit has passed. The Company has loyalty programs in the U.S. and many of its international locations that either have a prepaid annual fee or award points to customers as purchases are made. For those loyalty programs that have a prepaid annual fee, the Company recognizes the fee collected as other revenue on a straight-line basis over the term of the program. For those loyalty programs that award points to customers based on their purchases, the Company records a portion of the original transaction proceeds as deferred revenue based on the number of reward points issued to customers and recognizes the deferred revenue when the customer redeems such points. The value of loyalty points issued is based on the estimated fair value of the rewards offered. The Company records breakage revenue generally upon the expiration of loyalty points and subscription credits. Advances collected on concession and other contracts are deferred and recognized during the period in which the Company satisfies the related performance obligations, which may differ from the period in which the advances are collected. Accounts receivable included approximately $ 6,232 and $ 23,453 of receivables related to contracts with customers as of December 31, 2020 and 2021, respectively. The Company did no t record any assets related to the costs to obtain or fulfill a contract with customers during the years ended December 31, 2020 or 2021. Disaggregation of Revenue The following tables present revenues for the periods indicated, disaggregated based on major type of good or service and by reportable operating segment. Year Ended December 31, 2021 U.S. International Operating Operating Major Goods/Services Segment (1) Segment Consolidated Admissions revenues $ 671,750 $ 108,290 $ 780,040 Concession revenues 482,750 78,902 561,652 Screen advertising, screen rental and promotional revenues 66,192 17,892 84,084 Other revenues 72,930 11,758 84,688 Total revenues $ 1,293,622 $ 216,842 $ 1,510,464 Year Ended December 31, 2020 U.S. International Operating Operating Major Goods/Services Segment (1) Segment Consolidated Admissions revenues $ 291,636 $ 64,872 $ 356,508 Concession revenues 189,561 41,485 231,046 Screen advertising, screen rental and promotional revenues 46,199 16,332 62,531 Other revenues 29,513 6,712 36,225 Total revenues $ 556,909 $ 129,401 $ 686,310 Year Ended December 31, 2019 U.S. International Operating Operating Major Goods/Services Segment (1) Segment Consolidated Admissions revenues $ 1,431,790 $ 373,531 $ 1,805,321 Concession revenues 936,241 224,842 1,161,083 Screen advertising, screen rental and promotional revenues 128,839 35,888 164,727 Other revenues 84,033 67,935 151,968 Total revenues $ 2,580,903 $ 702,196 $ 3,283,099 (1) U.S. segment revenues exclude intercompany transactions with the international operating segment. See Note 19 for additional information on intercompany eliminations. The following tables present revenues for the periods indicated, disaggregated based on timing of revenue recognition (as discussed above). Year Ended December 31, 2021 U.S. International Operating Operating Segment (1) Segment Consolidated Goods and services transferred at a point in time $ 1,201,206 $ 193,658 $ 1,394,864 Goods and services transferred over time 92,416 23,184 115,600 Total $ 1,293,622 $ 216,842 $ 1,510,464 Year Ended December 31, 2020 U.S. International Operating Operating Segment (1) Segment Consolidated Goods and services transferred at a point in time $ 497,338 $ 109,997 $ 607,335 Goods and services transferred over time 59,571 19,404 78,975 Total $ 556,909 $ 129,401 $ 686,310 Year Ended December 31, 2019 U.S. International Operating Operating Segment (1) Segment Consolidated Goods and services transferred at a point in time $ 2,488,716 $ 621,785 $ 3,110,501 Goods and services transferred over time 92,187 80,411 172,598 Total $ 2,580,903 $ 702,196 $ 3,283,099 (1) U.S. segment revenues exclude intercompany transactions with the international operating segment. See Note 19 for additional information on intercompany eliminations. Screen Advertising Advances and Other Deferred Revenue The following table presents changes in the Company’s deferred revenue for the years ended December 31, 2020 and 2021: Deferred Revenue NCM Screen (1) Other Deferred (2) Balance at January 1, 2020 $ 348,354 $ 138,426 Amounts recognized as accounts receivable — 2,915 Cash received from customers in advance — 56,772 Common units received from NCM (see Note 8) 3,620 — Interest accrued related to significant financing component 23,595 — Revenue recognized during period ( 31,314 ) ( 57,625 ) Foreign currency translation adjustments — ( 1,658 ) Balance at December 31, 2020 344,255 138,830 Amounts recognized as accounts receivable — 2,170 Cash received from customers in advance — 132,179 Common units received from NCM (see Note 8) 10,237 — Interest accrued related to significant financing component 23,612 — Revenue recognized during period ( 32,078 ) ( 111,228 ) Foreign currency translation adjustments — ( 1,693 ) Balance at December 31, 2021 $ 346,026 $ 160,258 (1) See Significant Financing Component in Note 6 for discussion of NCM screen advertising advances and maturity of balances as of December 31, 2021. (2) Includes liabilities associated with outstanding gift cards and discount ticket vouchers, points or rebates outstanding under the Company’s loyalty and membership programs and revenues not yet recognized for screen advertising and other promotional activities. Amount is classified as accounts payable and accrued expenses or other long-term liabilities on the consolidated balance sheets. The table below summarizes the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied for other deferred revenue in the table above as of December 31, 2021 and when the Company expects to recognize this revenue. Year Ended December 31, Remaining Performance Obligations 2022 2023 Thereafter Total Other deferred revenue $ 138,945 21,313 — $ 160,258

INVESTMENT IN NATIONAL CINEMEDI

INVESTMENT IN NATIONAL CINEMEDIA LLC	12 Months Ended
	Dec. 31, 2021
NCM
INVESTMENT IN NATIONAL CINEMEDIA LLC	6. INVESTMENT IN NATIONAL CINEMEDIA LLC Summary of Activity with NCM Below is a summary of activity with NCM included in the Company’s consolidated financial statements for the periods indicated. See Note 5 for discussion of related revenue recognition. Investment in NCM NCM Screen Advertising Advances Distributions from NCM (3) Equity Other Revenue Interest Expense Cash Received Balance as of January 1, 2019 $ 275,592 $ ( 350,242 ) Receipt of common units due to annual common unit adjustment 1,552 ( 1,552 ) — — — — — Revenues earned under ESA (1) — — — — ( 13,782 ) — 13,782 Interest accrued related to significant financing component — ( 28,624 ) — — — 28,624 — Receipt of excess cash distributions ( 23,452 ) — ( 11,631 ) — — — 35,083 Receipt under tax receivable agreement ( 2,492 ) — ( 1,242 ) — — — 3,734 Equity in earnings 14,592 — — ( 14,592 ) — — — Amortization of screen advertising advances — 32,064 — — ( 32,064 ) — — Balance as of and for the year ended December 31, 2019 $ 265,792 $ ( 348,354 ) $ ( 12,873 ) $ ( 14,592 ) $ ( 45,846 ) $ 28,624.00 $ 52,599 Receipt of common units due to annual common unit adjustment 3,620 ( 3,620 ) — — — — — Revenues earned under ESA (1) — — — — ( 4,689 ) — 4,689 Interest accrued related to significant financing component — ( 23,595 ) — — — 23,595 — Receipt of excess cash distributions ( 12,022 ) — ( 5,914 ) — — — 17,936 Receipt under tax receivable agreement ( 2,146 ) — ( 1,061 ) — — — 3,207 Equity in loss ( 10,627 ) — — 10,627 — — — Impairment of investment in NCM (2) ( 92,655 ) — — — — — — Amortization of screen advertising advances — 31,314 — — ( 31,314 ) — — Balance as of and for the year ended December 31, 2020 $ 151,962 $ ( 344,255 ) $ ( 6,975 ) $ 10,627 $ ( 36,003 ) $ 23,595 $ 25,832 Receipt of common units due to annual common unit adjustment 10,237 ( 10,237 ) — — — — — Revenues earned under ESA (1) — — — — ( 12,001 ) — 12,001 Interest accrued related to significant financing component — ( 23,612 ) — — — 23,612 — Receipt under tax receivable agreement ( 156 ) — ( 77 ) — — — 233 Equity in loss ( 26,599 ) — — 26,599 — — — Amortization of screen advertising advances — 32,078 — — ( 32,078 ) — — Balance as of and for the year ended December 31, 2021 $ 135,444 $ ( 346,026 ) $ ( 77 ) $ 26,599 $ ( 44,079 ) $ 23,612 $ 12,234 (1) Amounts include the per patron and per digital screen theatre access fees due to the Company, net of amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire. The amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire were approximately $ 11,478 , $ 2,605 and $ 4,952 for the years ended December 31, 2019, 2020 and 2021, respectively. Amounts unpaid to the Company and recorded in accounts receivable on the consolidated balance sheets were $ 636 and $ 4,498 as of the years ended December 31, 2020 and 2021, respectively. (2) Recorded in impairment of long-lived and other assets on the consolidated income statement for the year ended December 31, 2020. See further discussion at Fair Value of Investment in NCM below. (3) (3) Excess cash distributions from NCM decreased beginning in the second quarter of 2020 primarily as a result of the impact of the COVID-19 discussed at Note 3. Excess cash distributions will be restricted through December 2023 in accordance with the credit agreement amendment NCM recently entered into with its lenders. In addition to the activity in the table above, the Company made payments to NCM of approximately $ 61 , $ 9 and $ 8 during the years ended December 31, 2019, 2020 and 2021, respectively, related to certain equipment used for digital advertising, which is included in theatre furniture and equipment on the consolidated balance sheets. Investment in National CineMedia NCM operates a digital in-theatre network in the U.S. for providing cinema advertising. The Company entered into an ESA with NCM, pursuant to which NCM primarily provides advertising to our theatres. On February 13, 2007, National Cinemedia, Inc. (“NCMI”), an entity that serves as the sole manager of NCM, completed an initial public offering (“IPO”) of its common stock. In connection with the NCMI initial public offering, the Company amended its operating agreement and the ESA. At the time of the NCMI IPO and as a result of amending the ESA, the Company received approximately $ 174,000 in cash consideration from NCM. The proceeds were recorded as deferred revenue or NCM screen advertising advances and were being amortized over the term of the Amended and Restated ESA, or through February 2041 . Following the NCMI IPO, the Company does not recognize undistributed equity in the earnings on its original NCM membership units (referred to herein as the Company’s Tranche 1 Investment) until NCM’s future net earnings, less distributions received, surpass the amount of the excess distribution. The Company recognizes equity in earnings on its Tranche 1 Investment only to the extent it receives cash distributions from NCM. The Company recognizes cash distributions it receives from NCM on its Tranche 1 Investment as a component of earnings as Distributions from NCM. The Company believes that the accounting model provided by ASC Topic 323-10-35-22 for recognition of equity investee losses in excess of an investor’s basis is analogous to the accounting for equity income subsequent to recognizing an excess distribution. Common Unit Adjustments In addition to the consideration received upon the NCMI IPO and ESA modification in 2007, the Company also periodically receives consideration in the form of common units from NCM. Pursuant to a Common Unit Adjustment Agreement dated as of February 13, 2007 between NCMI and the Company, annual adjustments to the common membership units are made primarily based on increases or decreases in the number of theatre screens operated and theatre attendance generated by each Founding Member. As discussed in Note 6 to the Company’s financial statements as included in its 2018 Annual Report on Form 10-K, the common units received (collectively referred to as the Company’s “Tranche 2 Investment”) are recorded at estimated fair value as an increase in the Company’s investment in NCM with an offset to deferred revenue or NCM screen advertising advances. The Company’s Tranche 2 Investment is accounted for following the equity method, with undistributed equity earnings related to its Tranche 2 Investment included as a component of earnings in equity in income of affiliates and distributions received related to its Tranche 2 Investment are recorded as a reduction of investment basis. During March 2021, NCM performed its annual common unit adjustment calculation under the Common Unit Adjustment Agreement. As a result of the calculation, the Company received an additional 2,311,482 common units of NCM, on April 14, 2021. The Company recorded these additional common units at an estimated fair value of $ 10,237 with a corresponding adjustment to NCM screen advertising advances. The fair value of the common units received was estimated based on the market price of NCMI common stock (Level 1 input as defined in FASB ASC Topic 820) at the time the common units were determined, adjusted for volatility associated with the estimated time period it would take to convert the common units and register the respective shares. Below is a summary of common units received by the Company under the Common Unit Adjustment (“CUA”) Agreement during the years ended December 31, 2019, 2020 and 2021: Event Date Common Units Received Number of Common Units Received Fair Value of Common Units Received 2019 annual common unit adjustment 3/31/2019 219,056 $ 1,552 2020 annual common unit adjustment 3/31/2020 1,112,368 $ 3,620 2021 annual common unit adjustment 4/14/2021 2,311,482 $ 10,237 Fair Value of Investment in NCM As of December 31, 2021, the Company owned a total of 43,161,550 common units of NCM, which represented an interest of approximately 26 %. The estimated fair value of the Company’s investment in NCM was approximately $ 121,284 based on NCMI’s stock price as of December 31, 2021 of $ 2.81 per share (Level 1 input as defined in FASB ASC Topic 820), which was below the Company's carrying value of $ 135,444 . NCM, Inc.’s stock price may vary due to the performance of the business, industry trends, general and economic conditions and other factors, including those resulting from the impact of the COVID-19 pandemic (see Note 3). The Company does not believe that the decline in NCM, Inc.’s stock price is other than temporary as the share price was only below the Company's carrying value of NCM for less than one month at the end of 2021. Therefore, no impairment of the Company’s investment in NCM was recorded during the year ended December 31, 2021. During the year ended December 31, 2020, the Company's investment in NCM was written down by $ 92,655 , with a corresponding charge to impairment expense, in accordance with ASC 323-10-35 based on the NCM, Inc's stock price as of December 31, 2020. The write-down was due to the prolonged period of time, approximately ten months, which the share price of NCM, Inc.'s stock was below the Company’s carrying value per common unit of its investment in NCM through December 31, 2020. Exhibitor Services Agreement As previously discussed, the Company’s domestic theatres are part of the in-theatre digital network operated by NCM, the terms of which are defined in the ESA. NCM provides advertising to its theatres through its branded “ Noovie ” pre-show entertainment program and also handles lobby promotions and displays for our theatres. The Company receives a monthly theatre access fee for participation in the NCM network and also earns screen advertising or screen rental revenue on a per patron basis. Prior to September 17, 2019, the ESA was accounted for under ASC Topic 606, Revenue from Contracts with Customers. Effective September 17, 2019, the Company signed an amendment to the ESA, under which the Company will provide incremental advertising time to NCM and has extended the term through February 2041 . Since the agreement was amended, the Company was required to evaluate the revised contract under ASC Topic 842, Leases , and as a result, determined that the ESA met the definition of a lease. The Company leases nonconsecutive periods of use of its domestic theatre screens to NCM for purposes of showing third party advertising content. The lease, which is classified as an operating lease, generally requires variable lease payments based on the number of patrons attending the showtimes during which such advertising is shown. The lease agreement is considered short-term due to the fact that the nonconsecutive periods of use, or advertising time slots, are set on a weekly basis. The revenues earned under the ESA, both before and after the amendment, are reflected in other revenue on the consolidated income statement. The recognition of revenue related to the deferred revenue or NCM screen advertising advances will continue to be recorded on a straight-line basis over the new term of the amended ESA through February 2041. Year Ended December 31, Remaining Maturity 2022 2023 2024 2025 2026 Thereafter Total NCM screen advertising advances (1) $ 9,119 9,749 10,424 11,147 11,922 293,665 $ 346,026 (1) Amounts are net of the estimated interest to be accrued for the periods presented. Significant Financing Component As noted above, the Company received approximately $ 174,000 in cash consideration from NCM at the time of NCMI's IPO and also periodically receives consideration in the form of common units (discussed at Common Unit Adjustments above) from NCM in exchange for exclusive access to the Company’s newly opened domestic screens under the ESA. Due to the significant length of time between receiving the consideration from NCM and fulfillment of the related performance obligation, the ESA includes an implied significant financing component, as per the guidance in ASC Topic 606. The interest expense was calculated using the Company’s incremental borrowing rates at the time the cash and each tranche of common units were received from NCM, which ranged from 4.4 % to 8.3 %. Effective September 17, 2019, upon the Company’s evaluation and determination that ASC Topic 842 applies to the amended ESA, the Company determined it acceptable to apply the significant financing component guidance from ASC Topic 606 by analogy as the economic substance of the agreement represents a financing arrangement. Summary Financial Information for NCM The tables below present summary financial information for NCM for its fiscal periods indicated: Year Ended Year Ended Year Ended December 26, 2019 December 31, 2020 December 30, 2021 Revenues $ 444,800 $ 89,887 $ 114,639 Operating income (loss) $ 155,700 $ ( 59,671 ) $ ( 68,576 ) Net income (loss) $ 98,800 $ ( 115,753 ) $ ( 134,562 ) As of As of December 31, 2020 December 30, 2021 Current assets $ 142,566 $ 114,620 Noncurrent assets $ 685,643 $ 658,438 Current liabilities $ 46,872 $ 66,806 Noncurrent liabilities $ 1,072,207 $ 1,114,712 Members' deficit $ ( 290,870 ) $ ( 408,460 )

OTHER INVESTMENTS

OTHER INVESTMENTS	12 Months Ended
	Dec. 31, 2021
Financial Support For Nonconsolidated Legal Entity [Abstract]
OTHER INVESTMENTS	7. OTHER INVESTMENTS Below is a summary of activity for each of the Company’s other investments for the periods indicated: DCIP AC JV, DCDC FE Concepts Other Total Balance at January 1, 2019 $ 125,252 $ 5,266 $ 2,255 $ 19,918 $ 4,075 $ 156,766 Equity in income (loss) 23,281 3,276 1,120 ( 399 ) — 27,278 Equity in comprehensive loss ( 141 ) — — — — ( 141 ) Cash distributions received ( 23,696 ) ( 3,520 ) ( 206 ) — — ( 27,422 ) Other (1) — — — — ( 1,196 ) ( 1,196 ) Balance at December 31, 2019 $ 124,696 $ 5,022 $ 3,169 $ 19,519 $ 2,879 $ 155,285 Equity in loss ( 24,559 ) ( 1,277 ) ( 1,036 ) ( 1,246 ) — ( 28,118 ) Cash contributions 50 — — — — 50 Cash distributions received ( 10,383 ) — ( 878 ) — — ( 11,261 ) Non-cash distribution received (2) ( 89,804 ) — — — — ( 89,804 ) Other (3) — — — — ( 2,426 ) ( 2,426 ) Balance at December 31, 2020 $ — $ 3,745 $ 1,255 $ 18,273 $ 453 $ 23,726 Equity in income (loss) — ( 34 ) 583 1,005 — 1,554 Other (1) — — — — ( 75 ) ( 75 ) Balance at December 31, 2021 $ — $ 3,711 $ 1,838 $ 19,278 $ 378 $ 25,205 (1) Consists primarily of mark-to-market adjustment on an investment in marketable securities. (2) Consists of projectors distributed to the Company from DCIP as discussed below. (3) Consists primarily of the impairment of a cost method investment in the year ended December 31, 2020 (see Note 9 for discussion of impairments recorded) and mark-to-market adjustment on an investment in marketable securities. Digital Cinema Implementation Partners LLC (“DCIP”) On February 12, 2007, the Company, AMC and Regal (the “Exhibitors”) entered into a joint venture known as DCIP to facilitate the implementation of digital cinema in the Company’s theatres and to establish agreements with major motion picture studios for the financing of digital cinema. On March 10, 2010, DCIP and its subsidiaries completed an initial financing transaction to enable the purchase, deployment and leasing of digital projection systems to the Exhibitors under equipment lease and installation agreements. On March 31, 2011, DCIP obtained incremental financing necessary to complete the deployment of digital projection systems. DCIP also entered into long-term Digital Cinema Deployment Agreements (“DCDAs”) with six major motion picture studios pursuant to which Kasima LLC, one of DCIP’s subsidiaries, receives a virtual print fee ("VPF") each time the studio books a film or certain other content on the leased digital projection systems. Other content distributors entered into similar DCDAs that provide for the payment of VPFs for bookings of the distributor's content on a leased digital projection system. The DCDAs end on the earlier to occur of (i) the tenth anniversary of the "mean deployment date" for all digital projection systems scheduled to be deployed over a period of up to five years , or (ii) the date DCIP achieves "cost recoupment", each as defined in the DCDAs. Cost recoupment occurs when revenues attributable to the digital projection systems exceed the financing, deployment, administration and other costs associated with the purchase of the digital projection systems. The DCDA’s expired in October 2021. Pursuant to the operating agreement between the Exhibitors and DCIP, DCIP began to distribute excess cash generated from their operations to the Exhibitors during 2019. As the DCDA’s have expired and the MELA between the Company and Kasima has been terminated, as discussed below, DCIP and its subsidiaries no longer have regular operations, and final distributions are expected to be made to the Company during the first half of 2022. Below is summary financial information for DCIP as of and for the periods indicated: Year ended December 31, 2019 2020 2021 Revenues $ 171,531 $ 30,561 $ 54,383 Operating income (loss) $ 99,812 $ ( 105,691 ) $ 43,062 Net income (loss) $ 95,820 $ ( 114,243 ) $ 45,323 As of December 31, 2020 December 31, 2021 Current assets $ 36,372 $ 22,947 Noncurrent assets $ 205 $ — Current liabilities $ 39,844 $ 11,631 Noncurrent liabilities $ 687 $ — Members' equity (deficit) $ ( 3,954 ) $ 11,316 As of December 31, 2021, the Company had a 33 % voting interest in DCIP and a 24.3 % economic interest in DCIP. Prior to the distribution received during November 2020, as discussed below, the Company accounted for its investment in DCIP and its subsidiaries under the equity method of accounting. Distribution of Digital Projectors from DCIP Through October 31, 2020, the Company leased digital projection systems under a master equipment lease agreement with Kasima LLC (“Kasima”), which is an indirect subsidiary of DCIP and a related party to the Company. The Company amended the master equipment lease agreement (“MELA”) with Kasima effective November 1, 2020, which resulted in the termination of the MELA and a lease termination fee to be paid by the Company on a monthly basis until a) cost recoupment is met or b) the DCDA agreements between DCIP and the major studios have been terminated. Upon termination of the MELA, DCIP distributed the digital projection equipment to the Company. The Company paid the monthly lease termination fee through October 2021. The Company accounted for the lease termination and projector distribution during the year ended December 31, 2020 as follows: • The Company wrote off the operating lease right of use assets and lease liabilities of $ 7,468 and $ 14,102 , respectively, and recorded a gain of $ 6,634 in gain (loss) on sale of assets and other. • The Company recorded a lease termination liability of $ 4,169 and a corresponding loss in gain (loss) on sale of assets and other. The lease termination payments were paid in full during the year ended December 31, 2021. • The Company recorded the fair value of the projectors received from DCIP of $ 102,719 as equipment, with a corresponding reduction in its investment in DCIP of $ 89,804 and a $ 12,915 non-cash distribution reflected in non-cash distributions from DCIP on the consolidate statements of income (loss). In accordance with ASC 323-10-35, since the non-cash distribution exceeded the book value of its investment in DCIP, the Company suspended equity method accounting. The Company will resume equity method accounting if the value of its investment in DCIP exceeds the sum of the excess noncash distribution noted above and any future excess cash distributions. Cash distributions prior to the suspension of equity method accounting were recorded as a reduction of the Company's investment in DCIP during the years ended December 31, 2019 and 2020. Additional distributions received after the suspension of equity method accounting were recorded as cash distributions from DCIP on the consolidated statement of income for the year ended December 31, 2021. Summary of DCIP Transactions In addition to the activity presented in the other investments table above, the Company had the following transactions with DCIP during the periods indicated: Year Ended December 31, 2019 2020 2021 Equipment lease payments (1)(2) $ 4,399 $ 1,729 $ — Warranty reimbursements from DCIP (2) $ ( 11,800 ) $ ( 6,997 ) $ ( 798 ) Management services fees (2) $ 596 $ 208 $ 49 Cash distributions from DCIP (3) $ 23,696 $ 10,383 $ 13,139 Non-cash distributions from DCIP (4) $ — $ 12,915 $ — (1) Excludes lease termination payments of $ 695 and $ 3,895 made during the years ended December 31, 2020 and 2021, respectively. See discussion of MELA termination at Distribution of Digital Projectors above. (2) Amounts reflected in utilities and other costs on the consolidated statements of income (loss). (3) Recorded as a reduction in the Company's investment in DCIP for the years ended December 31, 2019 and 2020. Recorded in cash distributions from DCIP on the consolidated statements of income (loss) for the year ended December 31, 2021. See discussion at Distribution of Projectors from DCIP above. (4) Recorded as non-cash distributions from DCIP on the consolidated statements of income (loss). See discussion at Distribution of Projectors from DCIP above. AC JV, LLC During December 2013, the Company, Regal, AMC (the “AC Founding Members”) and NCM entered into a series of agreements that resulted in the formation of AC JV, LLC (“AC”), a joint venture that owns “Fathom Events” (consisting of Fathom Events and Fathom Consumer Events) formerly operated by NCM. The Fathom Events business focuses on the marketing and distribution of live and pre-recorded entertainment programming to various theatre operators to provide additional programs to augment their feature film schedule. The Company paid event fees to AC of $ 15,376 , $ 3,740 and $ 6,161 for the years ended December 31, 2019, 2020 and 2021, respectively, which are included in film rentals and advertising costs on the consolidated statements of income (loss). The Company accounts for its investment in AC under the equity method of accounting. Digital Cinema Distribution Coalition The Company is a party to a joint venture with certain exhibitors and distributors called Digital Cinema Distribution Coalition (“DCDC”). DCDC operates a satellite distribution network that distributes all digital content to U.S. theatres via satellite. The Company has an approximate 14.6 % ownership in DCDC. The Company paid approximately $ 896 , $ 428 and $ 574 to DCDC during the years ended December 31, 2019, 2020 and 2021, respectively, related to content delivery services, which is included in film rentals and advertising costs on the consolidated statements of income (loss). The Company accounts for its investment in DCDC under the equity method of accounting. FE Concepts, LLC During April 2018, the Company, through its wholly-owned indirect subsidiary CNMK Texas Properties, LLC (“CNMK”), formed a joint venture, FE Concepts, LLC (“FE Concepts”) with AWSR Investments, LLC (“AWSR”), an entity owned by Lee Roy Mitchell and Tandy Mitchell. In December of 2019, FE Concepts opened a family entertainment center that offers bowling, gaming, movies and other amenities. The Company and AWSR each invested approximately $ 20,000 and each have a 50 % voting interest in FE Concepts. The Company accounts for its investment in FE Concepts under the equity method of accounting. The Company has a theatre services agreement with FE Concepts under which it receives service fees for providing film booking and equipment monitoring services for the facility. The Company recorded $ 64 , $ 34 and $ 62 of related service fees during the years ended December 31, 2019, 2020 and 2021, respectively. Additional Considerations Each of the investments above have been adversely impacted by the COVID-19 pandemic (see Note 3). The Company does not believe that any resulting decline in value of the underlying investments is other than temporary as the Company and other industry participants, who also have equity ownership interests in certain of the above investments, have reopened theatres and new film content has been released on a more consistent basis and theatre attendance has improved. The Company expects the industry to recover gradually over time. The Company performed a qualitative impairment analysis for its equity investments during the fourth quarter of 2021. Based on the analysis performed, no impairment was recorded for the year ended December 31, 2021.

GOODWILL AND INTANGIBLE ASSETS,

GOODWILL AND INTANGIBLE ASSETS, NET	12 Months Ended
	Dec. 31, 2021
Goodwill And Intangible Assets Disclosure [Abstract]
GOODWILL AND INTANGIBLE ASSETS, NET	8. GOODWILL AND INTANGIBLE ASSETS, NET The Company’s goodwill was as follows: U.S. International Total Balance at December 31, 2019 (1) $ 1,182,853 $ 100,518 $ 1,283,371 Impairment (2) — ( 16,128 ) ( 16,128 ) Foreign currency translation adjustments — ( 13,403 ) ( 13,403 ) Balance at December 31, 2020 (3) $ 1,182,853 $ 70,987 $ 1,253,840 Foreign currency translation adjustments — ( 5,049 ) ( 5,049 ) Balance at December 31, 2021 (3) $ 1,182,853 $ 65,938 $ 1,248,791 (1) Balances are presented net of historical accumulated impairment losses of $ 214,031 for the U.S. operating segment and $ 27,622 for the international operating segment. (2) See Note 11 for discussion of impairment evaluations performed during the year ended December 31, 2020. (3) Balances are presented net of historical accumulated impairment losses of $ 214,031 for the U.S. operating segment and $ 43,750 for the international operating segment. I ntangible assets activity and balances consisted of the following for the periods indicated: Balance at January 1, 2020 Amortization Other (1) Balance at December 31, 2020 Intangible assets with finite lives: Gross carrying amount $ 84,953 $ — $ ( 2,521 ) $ 82,432 Accumulated amortization ( 63,870 ) ( 4,746 ) 200 ( 68,416 ) Total intangible assets with finite lives, net $ 21,083 $ ( 4,746 ) $ ( 2,321 ) $ 14,016 Intangible assets with indefinite lives: Tradename and other 300,686 — ( 507 ) 300,179 Total intangible assets, net $ 321,769 $ ( 4,746 ) $ ( 2,828 ) $ 314,195 Balance at January 1, 2021 Additions (2) Amortization Other (3) Balance at December 31, 2021 Intangible assets with finite lives: Gross carrying amount $ 82,432 $ — $ — $ ( 665 ) $ 81,767 Accumulated amortization ( 68,416 ) — ( 2,639 ) — ( 71,055 ) Total net intangible assets with finite lives $ 14,016 $ — $ ( 2,639 ) $ ( 665 ) $ 10,712 Intangible assets with indefinite lives: Tradename and other 300,179 146 — ( 194 ) 300,131 Total intangible assets, net $ 314,195 $ 146 $ ( 2,639 ) $ ( 859 ) $ 310,843 (1) Includes the write-off of fully amortized intangible assets, foreign currency translation adjustments and impairment recorded related to a previously acquired theatre leasehold interest in Brazil. See Note 11 for discussion of impairment evaluations performed during the year ended December 31, 2020. (2) Amount represents licenses acquired to sell alcohol beverage for certain theatres. (3) Includes foreign currency translation adjustments and impairment recorded related to a previously acquired theatre leasehold interest in Brazil. See Note 11 for discussion of impairment evaluations performed during the year ended December 31, 2021. Estimated aggregate future amortization expense for intangible assets is as follows: Year ended December 31, 2022 $ 2,468 Year ended December 31, 2023 2,416 Year ended December 31, 2024 2,416 Year ended December 31, 2025 1,898 Year ended December 31, 2026 1,514 Total $ 10,712

IMPAIRMENT OF LONG-LIVED AND OT

IMPAIRMENT OF LONG-LIVED AND OTHER ASSETS	12 Months Ended
	Dec. 31, 2021
Impairment Or Disposal Of Tangible Assets Disclosure [Abstract]
IMPAIRMENT OF LONG-LIVED ASSETS	9. IMPAIRMENT OF LONG-LIVED AND OTHER ASSETS The Company reviews for impairment indicators related to its long-lived assets on a quarterly basis and goodwill on an annual basis or whenever events or changes in circumstances indicate the carrying amount of those assets may not be fully recoverable. Due to the continuing impacts of the COVID-19 pandemic (see Note 3), the Company performed asset impairment evaluations during each quarter during the year ended December 31, 2021. The following table is a summary of the evaluations performed for each quarter by asset classification. Asset Impairment Valuation Valuation Category Test Approach Multiple First and second quarters Goodwill Qualitative N/A N/A Tradename intangible assets Qualitative N/A N/A Other long-lived assets Qualitative N/A N/A Third quarter Goodwill Qualitative N/A N/A Tradename intangible assets Qualitative N/A N/A Other long-lived assets Quantitative Market 3.1 to 6 times Fourth quarter Goodwill Quantitative Market 3.7 to 7 times Tradename intangible assets Quantitative Income N/A Other long-lived assets Quantitative Market 3.7 to 6 times See Note 1 for a discussion of the Company’s impairment policy and a description of qualitative and quantitative impairment assessments. The Company’s impairment charges were as follows for the periods indicated: Year Ended December 31, 2019 2020 2021 U.S. segment Theatre properties $ 36,005 $ 12,398 $ 6,371 Theatre operating lease right-of-use assets 10,457 13,216 6,804 Investment in NCM (1) — 92,655 — Cost method investment — 2,500 — U.S. total 46,462 120,769 13,175 International segment Theatre properties 8,821 9,951 4,002 Theatre operating lease right-of-use assets 1,718 5,025 3,210 Goodwill — 16,128 — Intangible assets, net — 833 458 International total 10,539 31,937 7,670 Total impairment $ 57,001 $ 152,706 $ 20,845 (1) See Note 6 for discussion of investment in NCM. For the year ended December 31, 2019, the long-lived asset impairment charges recorded during each of the periods presented were for certain new concept theatres being developed and tested by the Company and other theatres that were individually impacted by increased competition, adverse changes in market demographics, or adverse changes in the development or the conditions of the areas surrounding the theatre. For the years ended December 31, 2020 and 2021, impairment charges were primarily due to the prolonged impact of the COVID-19 pandemic, as discussed in Note 3. Additionally, impairment charges recorded for the year ended December 31, 2021 reflected the continued uncertainty of industry recovery levels and the impact on estimated cash flows for specific assets.

ACCRUED OTHER CURRENT LIABILITI

ACCRUED OTHER CURRENT LIABILITIES	12 Months Ended
	Dec. 31, 2021
Accrued Liabilities And Other Liabilities [Abstract]
ACCRUED OTHER CURRENT LIABILITIES	10. ACCRUED OTHER CURRENT LIABILITIES Accrued other current liabilities consisted of the following as of the periods presented: December 31, 2020 2021 Gift card liability (1) $ 43,448 $ 54,521 Discount vouchers (SuperSavers) liability (1) 38,882 34,836 Accrued lease payable (2) 48,366 31,903 Other 70,906 103,106 Total $ 201,602 $ 224,366 (1) See discussion at Revenue Recognition Policy in Note 5. See discussion at Lease Deferrals and Abatements in Note 4.

LONG-TERM DEBT

LONG-TERM DEBT	12 Months Ended
	Dec. 31, 2021
Debt Disclosure [Abstract]
LONG-TERM DEBT	11. LONG-TERM DEBT Long-term debt consisted of the following for the periods presented: December 31, 2020 2021 Cinemark USA, Inc. term loan due 2025 $ 639,731 $ 633,136 Cinemark USA, Inc. 8.750% senior secured notes due 2025 250,000 250,000 Cinemark USA, Inc. 5.875% senior notes due 2026 — 405,000 Cinemark USA, Inc. 5.250% senior notes due 2028 — 765,000 Cinemark USA, Inc. 5.125% senior notes due 2022 400,000 — Cinemark USA, Inc. 4.875% senior notes due 2023 755,000 — Other 23,169 30,200 Total long-term debt carrying value 2,067,900 2,083,336 Less: Current portion 18,056 24,254 Less: Debt debt issuance costs, net of accumulated amortization 24,888 30,390 Long-term debt, less current portion, net of unamortized debt issuance costs $ 2,024,956 $ 2,028,692 Fair Value of Long Term Debt The Company estimates the fair value of its long-term debt primarily using quoted market prices, which fall under Level 2 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35. The carrying value of the Company’s long term debt as of December 31, 2020 and 2021 is shown in the table above. The fair value of the Company’s total long term debt was $ 1,978,322 and $ 2,057,957 as of December 31, 2020 and 2021, respectively. Senior Secured Credit Facility Cinemark USA, Inc. has a senior secured credit facility that includes a $ 700,000 term loan and a $ 100,000 revolving line of credit (the “Credit Agreement”). Under the amended Credit Agreement, quarterly principal payments of $ 1,649 are due on the term loan through December 31, 2024 , with a final principal payment of $ 613,351 due on March 29, 2025 . Interest on the term loan accrues at Cinemark USA, Inc.’s option at: (A) the base rate equal to the greater of (1) the US “Prime Rate” as quoted in The Wall Street Journal or if no such rate is quoted therein, in a Federal Reserve Board statistical release, (2) the federal funds effective rate plus 0.50 %, and (3) a one-month Eurodollar-based rate plus 1.0 %, plus, in each case, a margin of 0.75 % per annum, or (B) a Eurodollar-based rate for a period of 1, 2, 3, 6, 9 or 12 months plus a margin of 1.75 % per annum. Interest on the revolving line of credit accrues, at our option, at: (A) a base rate equal to the greater of (1) the US “Prime Rate” as quoted in The Wall Street Journal or if no such rate is quoted therein, in a Federal Reserve Board statistical release, (2) the federal funds effective rate plus 0.50%, and (3) a one-month Eurodollar-based rate plus 1.0%, plus, in each case, a margin that ranges from 0.50% to 1.25 % per annum, or (B) a Eurodollar-based rate for a period of 1, 2, 3, 6, 9 or 12 months plus a margin that ranges from 1.50 % to 2.25 % per annum. The margin of the revolving credit line is determined by the consolidated net senior secured leverage ratio as defined in the Credit Agreement. As of December 31 2021, the applicable margin was 2.25 %, however, there were no borrowing outstanding under the revolving line of credit. As of December 31, 2021, there was $ 633,136 outstanding under the term loan. The average interest rate on outstanding term loan borrowings under the Credit Agreement at December 31, 2021 was approximately 3.4 % per annum, after giving effect to the interest rate swaps discussed below. Cinemark USA, Inc.’s obligations under the Credit Agreement are guaranteed by Cinemark Holdings, Inc. and certain of Cinemark USA, Inc.’s domestic subsidiaries and are secured by mortgages on certain fee and leasehold properties and security interests in substantially all of Cinemark USA, Inc.’s and the guarantors’ personal property, including, without limitation, pledges of all of Cinemark USA, Inc.’s capital stock, all of the capital stock of certain of Cinemark USA, Inc.’s domestic subsidiaries and 65 % of the voting stock of certain of its foreign subsidiaries. The Credit Agreement contains usual and customary negative covenants for agreements of this type, including, but not limited to, restrictions on Cinemark USA, Inc.’s ability, and in certain instances, its subsidiaries’ and our ability, to consolidate or merge or liquidate, wind up or dissolve; substantially change the nature of its business; sell, transfer or dispose of assets; create or incur indebtedness; create liens; pay dividends or repurchase stock; and make capital expenditures and investments. If Cinemark USA, Inc. has borrowings outstanding on the revolving line of credit, it is required to keep a consolidated net senior secured leverage ratio, as defined in the Credit Agreement, not to exceed 4.25 to 1. See discussion below regarding recent covenant waivers. The dividend restriction contained in the Credit Agreement prevents the Company and any of its subsidiaries from paying a dividend or otherwise distributing cash to its stockholders unless (1) the Company is not in default, and the distribution would not cause Cinemark USA, Inc. to be in default, under the Credit Agreement; and (2) the aggregate amount of certain dividends, distributions, investments, redemptions and capital expenditures made since December 18, 2012, including dividends declared by the board of directors, is less than the sum of (a) the aggregate amount of cash and cash equivalents received by Cinemark Holdings, Inc. or Cinemark USA, Inc. as common equity since December 18, 2012, (b) Cinemark USA, Inc.’s consolidated EBITDA minus 1.75 times its consolidated interest expense, each as defined in the Credit Agreement, and (c) certain other defined amounts (collectively the “Applicable Amount”). The covenant waiver described below further limits, and the covenant waiver amendment described below may further limit, Cinemark USA's and its subsidiaries' ability to pay a dividend or otherwise distribute cash to its stockholders. As of December 31, 2021, Cinemark USA, Inc. could have distributed up to approximately $ 2,700,000 to its parent company and sole stockholder, Cinemark Holdings, Inc. On April 17, 2020, in conjunction with the issuance of the 8.750 % Secured Notes discussed below, the Company obtained a waiver of the leverage covenant, which applies when amounts are outstanding under the revolving line of credit, from the majority of revolving lenders under the Credit Agreement for the fiscal quarters ending September 30, 2020 and December 31, 2020. The waiver was subject to certain liquidity thresholds, restrictions on investments and the use of the Applicable Amount. On August 21, 2020, in conjunction with the issuance of Cinemark Holdings, Inc.'s 4.500% convertible senior notes , the Company further amended the waiver of the leverage covenant to extend through the fiscal quarter ending September 30, 2021. The amendment also i) modifies the maintenance covenant calculation beginning with the calculation for the trailing twelve-month period ended December 31, 2021, ii) for purposes of testing the consolidated net senior secured leverage ratio for the fiscal quarters ending on December 31, 2021, March 31, 2022 and June 30, 2022, permits the Company to substitute Consolidated EBITDA for the first three fiscal quarters of 2019 in lieu of Consolidated EBITDA for the corresponding fiscal quarters of 2021, (iii) modifies the restrictions imposed by the covenant waiver, and (iv) makes such other changes to permit the issuance of Cinemark Holdings, Inc.'s 4.500 % convertible senior notes . Under the modified calculation, the consolidated net senior secured leverage ratio was 1.1 to 1 as of December 31, 2021. On June 15, 2021, in conjunction with the issuance of the 5.25 % Senior Notes discussed below, the Credit Agreement was amended to, among other things, extend the maturity of the revolving credit line from November 28, 2022 to November 28, 2024 . The Company incurred debt issuance costs of approximately $ 500 in connection with the extension of the revolving line of credit, which are recorded as a reduction of long-term debt on the consolidated balance sheet. 5.875% Senior Notes On March 16, 2021, Cinemark USA, Inc. issued $ 405,000 aggregate principal amount of 5.875 % senior notes due 2026, at par value (the “5.875% Senior Notes”). Proceeds, after payment of fees, were used to fund a cash tender offer to purchase any and all of Cinemark USA’s 5.125% Senior Notes (the “5.125% Senior Notes”) and to redeem any of the 5.125% Senior Notes that remained outstanding after the tender offer. See further discussion of the tender offer below. Interest on the 5.875% Senior Notes is payable on March 15 and September 15 of each year. The 5.875% Senior Notes mature on March 15, 2026 . The Company incurred debt issuance costs of approximately $ 6,021 in connection with the issuance, which are recorded as a reduction of long-term debt on the consolidated balance sheet. The 5.875% Senior Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by certain of Cinemark USA, Inc.’s subsidiaries that guarantee, assume or become liable with respect to any of Cinemark USA, Inc.’s or a guarantor’s debt. The 5.875% Senior Notes and the guarantees are senior unsecured obligations and rank equally in right of payment with all of Cinemark USA, Inc.’s and its guarantor’s existing and future senior debt and are senior in right of payment to all of Cinemark USA, Inc.’s and its guarantors’ existing and future senior subordinated debt. The 5.875% Senior Notes and the guarantees are effectively subordinated to all of Cinemark USA, Inc.’s and its guarantor’s existing and future secured debt to the extent of the value of the collateral securing such debt, including all borrowings under Cinemark USA, Inc.’s amended senior secured credit facility. The 5.875% Senior Notes and the guarantees are structurally subordinated to all existing and future debt and other liabilities of Cinemark USA, Inc.’s subsidiaries that do not guarantee the 5.875% Senior Notes. The indenture to the 5.875% Senior Notes contains covenants that limit, among other things, the ability of Cinemark USA, Inc. and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. Upon a change of control, as defined in the indenture, the Company would be required to make an offer to repurchase the 5.875% Senior Notes at a price equal to 101 % of the aggregate principal amount outstanding plus accrued and unpaid interest, if any, through the date of repurchase. The indenture governing the 5.875% Senior Notes allows Cinemark USA, Inc. to incur additional indebtedness if we satisfy the coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances. Prior to March 15, 2023, Cinemark USA, Inc. may redeem all or any part of the 5.875% Senior Notes at its option at 100% of the principal amount plus a make-whole premium plus accrued and unpaid interest on the 5.875% Senior Notes to the date of redemption. After March 15, 2023, Cinemark USA, Inc. may redeem the 5.875% Senior Notes in whole or in part at redemption prices specified in the indenture. In addition, prior to March 15, 2023, Cinemark USA, Inc. may redeem up to 40% of the aggregate principal amount of the 5.875% Senior Notes from the net proceeds of certain equity offerings at the redemption price set forth in the indenture. 5.250% Senior Notes On June 15, 2021, Cinemark USA, Inc. issued $ 765,000 aggregate principal amount of 5.25 % senior notes due 2028, at par value (the “5.25% Senior Notes”). Proceeds, after payment of fees, were used to redeem all of Cinemark USA’s 4.875 % $ 755,000 aggregate principal amount of Senior Notes due 2023 (the “4.875% Senior Notes”). Interest on the 5.25% Senior Notes is payable on January 15 and July 15 of each year, beginning January 15, 2022. The 5.25% Senior Notes mature on July 15, 2028 . The Company incurred debt issuance costs of approximately $ 10,684 in connection with the issuance, which are recorded as a reduction of long-term debt on the consolidated balance sheet. The 5.25% Senior Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by certain of Cinemark USA, Inc.’s subsidiaries that guarantee, assume or become liable with respect to any of Cinemark USA, Inc.’s or a guarantor’s debt. The 5.25% Senior Notes and the guarantees will be Cinemark USA’s and the guarantors’ senior unsecured obligations and (i) rank equally in right of payment to Cinemark USA’s and the guarantors’ existing and future senior debt, including borrowings under Cinemark USA’s Credit Agreement (as defined below) and Cinemark USA’s existing senior notes, (ii) rank senior in right of payment to Cinemark USA’s and the guarantors’ future subordinated debt, (iii) are effectively subordinated to all of Cinemark USA’s and the guarantors’ existing and future secured debt, including all obligations under the Credit Agreement and Cinemark USA’s 8.750 % senior secured notes due 2025, in each case to the extent of the value of the collateral securing such debt, (iv) are structurally subordinated to all existing and future debt and other liabilities of Cinemark USA’s non-guarantor subsidiaries, and (v) are structurally senior to Cinemark Holdings, Inc.'s 4.500 % convertible senior notes. The indenture to the 5.25% Senior Notes contains covenants that limit, among other things, the ability of Cinemark USA, Inc. and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. Upon a change of control, as defined in the indenture, the Company would be required to make an offer to repurchase the 5.25% Senior Notes at a price equal to 101 % of the aggregate principal amount outstanding plus accrued and unpaid interest, if any, through the date of repurchase. The indenture governing the 5.25% Senior Notes allows Cinemark USA, Inc. to incur additional indebtedness if we satisfy the coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances . Prior to July 15, 2024, Cinemark USA, Inc. may redeem all or any part of the 5.25% Senior Notes at its option at 100% of the principal amount plus a make-whole premium plus accrued and unpaid interest on the 5.25% Senior Notes to the date of redemption. On or after July 15, 2024, Cinemark USA, Inc. may redeem the 5.25% Senior Notes in whole or in part at redemption prices specified in the indenture. In addition, prior to July 15, 2024, Cinemark USA, Inc. may redeem up to 40% of the aggregate principal amount of the 5.25% Senior Notes from the net proceeds of certain equity offerings at the redemption price set forth in the indenture, so long as at least 60% of the principal amount of the 5.25% Senior Notes remains outstanding immediately after each such redemption. 8.750% Secured Notes On April 20, 2020, Cinemark USA, Inc. issued $ 250,000 aggregate principal amount of 8.750 % senior secured notes due 2025 (the “8.750% Secured Notes”). The 8.750% Secured Notes will mature on May 1, 2025 . Interest on the 8.750% Secured Notes is payable on May 1 and November 1 of each year. The 8.750% Secured Notes are fully and unconditionally guaranteed on a joint and several senior basis by certain of Cinemark USA, Inc.’s subsidiaries that guarantee, assume or in any other manner become liable with respect to any of Cinemark USA, Inc.’s or its guarantors’ other debt. If Cinemark USA, Inc. cannot make payments on the 8.750% Secured Notes when they are due, Cinemark USA, Inc.’s guarantors must make them instead. Under certain circumstances, the guarantees may be released without action by, or the consent of, the holders of the 8.750% Secured Notes. The indenture governing the 8.750% Secured Notes contains covenants that limit, among other things, the ability of Cinemark USA, Inc. and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. Upon a change of control, as defined in the indenture governing the 8.750% Secured Notes, Cinemark USA, Inc. would be required to make an offer to repurchase the 8.750% Secured Notes at a price equal to 101 % of the aggregate principal amount outstanding plus accrued and unpaid interest, if any, through the date of repurchase. The indenture governing the 8.750% Secured Notes allows Cinemark USA, Inc. to incur additional indebtedness if it satisfies a coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances. Prior to May 1, 2022, Cinemark USA, Inc. may redeem all or any part of the 8.750% Secured Notes at its option at 100% of the principal amount plus a make-whole premium plus accrued and unpaid interest on the 8.750% Secured Notes to the date of redemption. On or after May 1, 2022, Cinemark USA, Inc. may redeem the 8.750% Secured Notes in whole or in part at redemption prices specified in the indenture. In addition, prior to May 1, 2022, Cinemark USA, Inc. may redeem up to 40 % of the aggregate principal amount of the 8.750% Secured Notes from the net proceeds of certain equity offerings at the redemption price set forth in the indenture, so long as at least 60% of the principal amount of the 8.750% Secured Notes remains outstanding immediately after each such redemption. 4.875% Senior Notes On May 21, 2021, Cinemark USA, Inc. issued a conditional notice of optional redemption to redeem the $ 755,000 outstanding principal amount of the 4.875 % Senior Notes. In connection therewith, Cinemark USA deposited with Wells Fargo Bank, N.A., as Trustee for the 4.875% Senior Notes (the “Trustee”), funds sufficient to redeem all 4.875% Senior Notes remaining outstanding on June 21, 2021 (the “Redemption Date”). The redemption payment (the “Redemption Payment”) included $755,000 of outstanding principal at the redemption price equal to 100 .000% of the principal amount plus accrued and unpaid interest thereon to the Redemption Date. Upon deposit of the Redemption Payment with the Trustee on June 15, 2021, the indenture governing the 4.875% Senior Notes was fully satisfied and discharged. The Company recorded a loss on extinguishment of debt of $ 3,919 , which included the write-off of $ 3,301 of unamortized debt issuance costs and the payment of $ 618 in legal fees during the year ended December 31, 2021. 5.125% Senior Notes On March 16, 2021, Cinemark USA, Inc. completed a tender offer to purchase its previously outstanding 5.125 % Senior Notes, of which $ 333,990 was tendered at the expiration of the offer. On March 16, 2021, Cinemark USA, Inc. also issued a notice of optional redemption to redeem the remaining $ 66,010 principal amount of the 5.125% Senior Notes. In connection therewith, Cinemark USA deposited with Wells Fargo Bank, N.A., as Trustee for the 5.125% Senior Notes (the “Trustee”), funds sufficient to redeem all 5.125% Notes remaining outstanding on April 15, 2021 (the “Redemption Date”). The redemption payment (the “Redemption Payment”) included $66,010 of outstanding principal at the redemption price equal to 100 .000% of the principal amount plus accrued and unpaid interest thereon to the Redemption Date. Upon deposit of the Redemption Payment with the Trustee on March 16, 2021, the indenture governing the 5.125% Senior Notes was fully satisfied and discharged. The Company recorded a loss on extinguishment of debt of $ 2,603 during the year ended December 31, 2021, which included the write-off of $ 1,168 of unamortized debt issuance costs and the payment of $ 1,435 in tender and legal fees Additional Borrowings of International Subsidiaries During the years ended December 31, 2020 and 2021, certain of the Company’s international subsidiaries borrowed an aggregate of $ 35,797 under various local loans. Below is a summary of loans outstanding as of December 31, 2021: Loan Balances as of Interest Rates as of Loan Description(s) December 31, 2021 December 31, 2021 Covenants Maturity Colombia loans $ 2,741 4.9% to 5.2% Negative and maintenance covenants June 2023 and Peru loans $ 4,879 1.0% to 4.8% Negative covenants June and December 2023 Brazil loans $ 18,376 4.0% to 8.7% Negative covenants November 2022, October 2023 and January 2029 Chile loans $ 4,204 3.5% Negative and maintenance covenants November 2023 Total $ 30,200 During the year ended December 31, 2021, the Company obtained a waiver of the maintenance covenant related to the bank loans in Chile through June 30, 2022. Additionally, the Company deposited cash into a collateral account to support the issuance of letters of credit to the lenders for certain of the international loans noted above. The total amount deposited as of December 31, 2021 was $ 25,767 and is considered restricted cash. Covenant Compliance The indentures governing the 5.875% Senior Notes, the 5.25% Senior Notes and the 8.750% Secured Notes ("the indentures") contain covenants that limit, among other things, the ability of Cinemark USA, Inc. and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. As of December 31, 2021, Cinemark USA, Inc. could have distributed up to approximately $ 3,000,000 to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the indentures, subject to its available cash and other borrowing restrictions outlined in the indentures. Upon a change of control, as defined in the indentures, Cinemark USA, Inc. would be required to make an offer to repurchase the 5.875% Senior Notes, the 5.25% Senior Notes and the 8.750% Secured Notes at a price equal to 101 % of the aggregate principal amount outstanding plus accrued and unpaid interest, if any, through the date of repurchase. The indentures allow Cinemark USA, Inc. to incur additional indebtedness if we satisfy the coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances. The required minimum coverage ratio is 2 to 1 and our actual ratio as of December 31, 2021 was 0.6 to 1 . See also discussion of dividend restrictions and the consolidated net senior secured leverage ratio under the Credit Agreement at Senior Secured Credit Facility above. As of December 31, 2021, the Company believes it was in full financial compliance with all agreements, including related covenants, governing its outstanding debt. Debt Maturity The Company’s long-term debt, excluding unamortized debt issuance costs, at December 31, 2021 matures as follows: 2022 $ 24,254 2023 12,285 2024 6,983 2025 863,538 2026 405,000 Thereafter 771,276 Total $ 2,083,336 Interest Rate Swap Agreements Effective March 31, 2020, the Company amended and extended its three then existing interest rate swap agreements and entered into a fourth interest rate swap agreement, all of which are used to hedge a portion of the interest rate risk associated with the variable interest rates on the Company’s term loan debt and qualify for cash flow hedge accounting. Upon amending the interest rate swap agreements effective March 31,2020, the Company determined that the interest payments hedged with the agreements are still probable to occur, therefore the loss that accumulated on the swaps prior to the amendments of $ 29,359 is being amortized to interest expense through December 31, 2022, the original maturity dates of the swaps. Approximately $ 3,371 and $ 4,495 was recorded in amortization of accumulated losses for amended swaps in the consolidated income statement for the years ended December 31, 2020 and 2021, respectively. The fair values of the interest rate swaps are recorded on the Company’s consolidated balance sheets as an asset or liability with the related gains or losses reported as a component of accumulated other comprehensive loss. The changes in fair value are reclassified from accumulated other comprehensive loss into earnings in the same period that the hedged items affect earnings. The valuation technique used to determine fair value is the income approach and under this approach, the Company uses projected future interest rates as provided by counterparty to the interest rate swap agreement and the fixed rates that the Company is obligated to pay under the agreement. Therefore, the Company’s measurements use significant unobservable inputs, which fall in Level 2 of the U.S. GAAP hierarchy as defined by FASB ASC Topic 820-10-35. The Company is assessing the impact of reference rate reform, as well as the impact of ASU 2020-04 and ASU 2021-01, on the Company's interest rate swaps. See further discussion at Note 2. Below is a summary of the Company’s interest rate swap agreements designated as cash flow hedges as of December 31, 2021: Estimated Fair Value at Notional December 31, Amount Effective Date Pay Rate Receive Rate Expiration Date 2021 (1) $ 137,500 December 31, 2018 2.12 % 1-Month LIBOR December 31, 2024 $ 4,313 $ 175,000 December 31, 2018 2.12 % 1-Month LIBOR December 31, 2024 5,537 $ 137,500 December 31, 2018 2.19 % 1-Month LIBOR December 31, 2024 4,611 $ 150,000 March 31, 2020 0.57 % 1-Month LIBOR March 31, 2022 164 Total $ 14,625 (1) Approximately $ 7,884 is included in accrued other current liabilities and $ 6,741 is included in other long-term liabilities on the consolidated balance sheet as of December 31, 2021.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	12 Months Ended
	Dec. 31, 2021
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	12. FAIR VALUE MEASUREMENTS The Company determines fair value measurements in accordance with FASB ASC Topic 820, which establishes a fair value hierarchy under which an asset or liability is categorized based on the lowest level of input significant to its fair value measurement. The levels of input defined by FASB ASC Topic 820 are as follows: Level 1 – quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date; Level 2 – other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly; and Level 3 – unobservable and should be used to measure fair value to the extent that observable inputs are not available. Below is a summary of liabilities measured at fair value on a recurring basis by the Company under FASB ASC Topic 820 as of the periods presented: As of Carrying Fair Value Description December 31, Value Level 1 Level 2 Level 3 Interest rate swap liabilities 2020 $ 33,847 $ — $ 33,847 $ — Interest rate swap liabilities 2021 $ 14,625 $ — $ 14,625 $ — The Company also uses the market and income approach for fair value measurements on a nonrecurring basis in the impairment evaluations of its long-lived assets (see Note 1 and Note 9). Additionally, the Company uses the market approach to estimate the fair value of its long-term debt (see Note 11). There were no changes in valuation techniques during the period. There were no transfers in or out of Level 1, Level 2 or Level 3 during the years ended December 31, 2019, 2020 and 2021 .

FOREIGN CURRENCY TRANSLATION

FOREIGN CURRENCY TRANSLATION	12 Months Ended
	Dec. 31, 2021
Foreign Currency [Abstract]
FOREIGN CURRENCY TRANSLATION	13. FOREIGN CURRENCY TRANSLATION The accumulated other comprehensive loss account in stockholders’ equity of $ 398,653 and $ 397,051 at December 31, 2020 and 2021 , respectively, includes the cumulative foreign currency losses of $ 375,644 and $ 394,481 , respectively, from translating the financial statements of the Company’s international subsidiaries and the change in fair values of the Company’s interest rate swap agreements designated as hedges. As of December 31, 2021 , all foreign countries where the Company has operations, other than Argentina, are non-highly inflationary, and the local currency is the same as the functional currency in all of the locations. Thus, any fluctuation in the currency results in a cumulative foreign currency translation adjustment recorded to accumulated other comprehensive loss. The Company deemed Argentina to be highly inflationary beginning July 1, 2018. A highly inflationary economy is defined as an economy with a cumulative inflation rate of approximately 100 percent or more over a three-year period. If a country’s economy is classified as highly inflationary, the financial statements of the foreign entity operating in that country must be remeasured to the functional currency of the reporting entity. The financial statements of the Company’s Argentina subsidiaries has been remeasured in U.S. dollars in accordance with ASC Topic 830, Foreign Currency Matters , effective beginning July 1, 2018. Below is a summary of the impact of translating the financial statements of the Company’s international subsidiaries, whose functional currency is other than the US dollar, for the periods presented. Other Comprehensive Income (Loss) Exchange Rate as of December 31, Year Ended December 31, Country 2019 2020 2021 2019 2020 2021 Brazil 4.02 5.20 5.57 $ ( 8,140 ) $ ( 42,698 ) $ ( 4,696 ) Colombia 3,277.14 3,432.50 3,981.16 ( 362 ) ( 2,183 ) ( 140 ) Chile 736.86 714.14 852.02 ( 5,158 ) 1,228 ( 10,890 ) Peru 3.37 3.65 4.02 257 ( 3,403 ) ( 2,785 ) All other 650 ( 536 ) ( 326 ) $ ( 12,753 ) $ ( 47,592 ) $ ( 18,837 ) As noted above, beginning July 1, 2018, Argentina was deemed highly inflationary. The impact of translating Argentina financial results to U.S. dollars, subsequent to June 30, 2018, has been recorded in foreign currency exchange gain (loss) on the Company’s consolidated statements of income (loss). A gain of $ 1,243 and $ 195 were recorded for the years ended December 31, 2020 and 2021, respectively .

NONCONTROLLING INTERESTS IN SUB

NONCONTROLLING INTERESTS IN SUBSIDIARIES	12 Months Ended
	Dec. 31, 2021
Noncontrolling Interest [Abstract]
NONCONTROLLING INTERESTS IN SUBSIDIARIES	14. NONCONTROLLING INTERESTS IN SUBSIDIARIES Noncontrolling interests in subsidiaries of the Company were as follows as of the periods presented: December 31, 2020 2021 Cinemark Partners II — 49.2 % interest $ 7,706 $ 7,989 Laredo Theatres – 25 % interest 1,681 2,018 Greeley Ltd. — 49 % interest 1,101 1,048 Other 508 509 Total $ 10,996 $ 11,564 There were no changes in the Company’s ownership interest in its subsidiaries during the years ended December 31, 2019, 2020 and 2021.

CAPITAL STOCK

CAPITAL STOCK	12 Months Ended
	Dec. 31, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
CAPITAL STOCK	15. CAPITAL STOCK Common and Preferred Stock — Cinemark USA, Inc. has 1,500 shares of Class A common stock and 182,648 shares of Class B common stock outstanding, all of which are held by Cinemark Holdings, Inc. Holders of Class A common stock have exclusive voting rights. Holders of Class B common stock have no voting rights except upon any proposed amendments to the articles of incorporation. However, they may convert their Class B common stock, at their option, to Class A common stock. In the event of any liquidation, holders of the Class A and Class B common stock will be entitled to their pro-rata share of assets remaining after any holders of preferred stock have received their preferential amounts based on their respective shares held. The Company has 1,000,000 shares of preferred stock, $ 1.00 par value, authorized with no ne issued or outstanding. The rights and preferences of preferred stock will be determined by the Board of Directors at the time of issuance. The Company’s ability to pay dividends is effectively limited by the terms of its indentures and its senior secured credit facility, which also significantly restricts the ability of certain of the Company’s subsidiaries to pay dividends directly or indirectly to it. See Note 11 for a discussion of restrictions contained within the debt agreements. Restricted Stock — Below is a summary of restricted stock activity for Cinemark Holdings, Inc. for the years ended December 31, 2019, 2020 and 2021. Year Ended Year Ended Year Ended December 31, 2019 December 31, 2020 December 31, 2021 Shares of Weighted Shares of Weighted Shares of Weighted Outstanding at January 1 704,353 $ 38.68 783,823 $ 37.53 1,431,975 $ 21.11 Granted 315,899 $ 37.34 1,555,361 $ 17.68 1,241,742 $ 21.91 Vested ( 209,821 ) $ 41.10 ( 832,609 ) $ 29.30 ( 617,607 ) $ 20.92 Forfeited ( 26,608 ) $ 37.69 ( 74,600 ) $ 30.72 ( 61,714 ) $ 18.96 Outstanding at December 31 783,823 $ 37.53 1,431,975 $ 21.11 1,994,396 $ 21.73 During the year ended December 31, 2021 , Cinemark Holdings, Inc. granted 1,241,742 shares of restricted stock to its directors and employees of the Company. The fair value of the restricted stock granted was determined based on the market value of Cinemark Holdings, Inc.’s common stock on the dates of grant, which ranged from $ 16.09 to $ 24.48 per share. The Company assumed forfeiture rates ranging from 0 % to 10 % for the restricted stock awards. Restricted stock grants to directors vest over a one-year period. Restricted stock grants to employees vest over periods ranging from one year to four years based on continued service. The recipients of restricted stock are entitled to receive dividends to the extent they are declared by Cinemark Holdings, Inc. and to vote their respective shares, however, the sale and transfer of the restricted stock is prohibited during the restriction period. Below is a summary of restricted stock award activity recorded for the periods indicated. Year Ended December 31, 2019 2020 2021 Compensation expense recognized by the Company during the (1) $ 9,266 $ 14,555 $ 21,923 Additional compensation expense recognized by Cinemark $ 919 $ 918 $ 923 Fair value of restricted shares held by Company employees that $ 7,044 $ 16,493 $ 9,669 Fair value of restricted shares held by Cinemark Holdings, Inc.’s $ 980 $ 377 $ 1,329 Income tax benefit recognized upon vesting of restricted stock $ 1,271 $ 5,475 $ 769 Additional income tax benefit recognized upon vesting of $ 245 $ 145 $ 279 (1) The former CEO of the Company retired on December 31, 2021, and all of his outstanding unvested shares vested upon his retirement in accordance with his employment agreement. The Company recorded incremental compensation expense of $ 4,277 related to the accelerated vesting of these awards during the year ended December 31, 2021. As of December 31, 2021 , the remaining unrecognized compensation expense related to these restricted stock awards was approximately $ 23,234 , of which $ 22,568 will be recognized by the Company and $ 648 of which will be recognized by Cinemark Holdings, Inc. The weighted average period over which this remaining compensation expense will be recognized is approximately two years . Restricted Stock Units — During the years ended December 31, 2019 and 2020 , Cinemark Holdings, Inc. granted restricted stock units representing 306,651 and 436,681 of hypothetical shares of Cinemark Holdings, Inc.’s common stock, respectively, to employees of the Company. The grant date fair value for units issued during the year ended December 31, 2019 was $ 36.77 per unit. The grant date fair value for the units issued during the year ended December 31, 2020 was $ 32.12 per unit. Based upon the terms of the award agreements, the restricted stock units vest based on a combination of financial performance factors and continued service. The financial performance factors are based on an implied equity value concept that determines an internal rate of return (“IRR”) for a two year measurement period, as defined in the award agreement, based on a formula utilizing a multiple of Adjusted EBITDA subject to certain specified adjustments (as defined in the restricted stock unit award agreement) . The financial performance factors for the restricted stock units have a threshold, target and maximum level of payment opportunity and vest on a prorata basis according to the IRR achieved by the Company during the performance period. All payouts of restricted stock units that vest will be subject to an additional service requirement and will be paid in the form of common stock if the participant continues to provide services through the fourth anniversary of the grant date . At the time of each of the restricted stock unit grants, the Company assumes the IRR level to be reached for the defined measurement period will be the target IRR level in determining the amount of compensation expense to record for such grants. If and when additional information becomes available to indicate that something other than the target IRR level will be achieved, the Company adjusts compensation expense on a prospective basis over the remaining service period. The Company assumed forfeiture rates ranging from 0 % to 5 % for the restricted stock unit awards granted during 2019 and 2020. Restricted stock unit award participants are eligible to receive dividend equivalent payments if and at the time the restricted stock unit awards vest. During the year ended December 31, 2021, the Compensation Committee of Cinemark Holdings, Inc.'s Board of Directors ("Compensation Committee") evaluated the impact of the COVID-19 pandemic on the performance metric used for the restricted stock unit awards granted during 2019 and 2020 and determined that the COVID-19 pandemic significantly impacted the Company’s ability to meet the performance metric. The Compensation Committee made a discretionary decision to certify the vest of the 2019 and 2020 restricted stock unit awards at target based upon the unforeseen, external circumstances that were beyond management’s control, the projected macroeconomic conditions through 2021 and beyond, and the uncertain timing as to the recovery of the Company’s industry. The requirement to satisfy the applicable service period under the restricted stock unit awards was not changed. In addition, the Compensation Committee determined that it would not be appropriate to issue restricted stock units during the year ended December 31, 2021 due to the aforementioned macroeconomic conditions and industry recovery. In lieu of restricted stock units, the Compensation Committee granted restricted stock with a four-year vest period. See Restricted Stock discussion above for other relevant terms of such awards. Below is a summary of activity for restricted stock unit awards for Cinemark Holdings, Inc. for the periods indicated: Year Ended December 31, 2019 2020 2021 Number of restricted stock unit awards that vested during the period 90,895 208,204 232,200 Fair value of restricted stock unit awards that vested during the period $ 3,658 $ 5,050 $ 4,095 Accumulated dividends paid upon vesting of restricted stock unit awards (1) $ 386 $ 942 $ 62 Compensation expense recognized during the period (2) $ 4,430 $ 3,931 $ 6,425 Income tax benefit related to stock unit awards $ 397 $ 788 $ 691 (1) Approximately $ 296 of dividends were payable to the former CEO on December 31, 2021 and were paid in January 2022. These dividends were included in other current liabilities on the consolidated balance sheet as of December 31, 2021. (2) The former CEO of the Company retired on December 31, 2021, and all of his outstanding unvested restricted stock units vested upon his retirement in accordance with his employment agreement. The Company recorded incremental compensation expense of $ 2,374 related to the accelerated vesting of these awards during the year ended December 31, 2021. As of December 31, 2021 , the Company had restricted stock units outstanding that represented a total of 344,071 of hypothetical shares of common stock, which is the maximum number of shares that could vest related to the outstanding units. As of December 31, 2021 , the remaining unrecognized compensation expense related to the outstanding restricted stock unit awards was $ 3,616 . The weighted average period over which this remaining compensation expense will be recognized is approximately one year.

SUPPLEMENTAL CASH FLOW INFORMAT

SUPPLEMENTAL CASH FLOW INFORMATION	12 Months Ended
	Dec. 31, 2021
Supplemental Cash Flow Elements [Abstract]
SUPPLEMENTAL CASH FLOW INFORMATION	16. SUPPLEMENTAL CASH FLOW INFORMATION The following is provided as supplemental information to the consolidated statements of cash flows: Year Ended December 31, 2019 2020 2021 Cash paid for interest $ 93,907 $ 102,859 $ 87,797 Cash paid (refunds received) for income taxes, net $ 88,670 $ ( 116,916 ) $ ( 136,512 ) Cash deposited in restricted accounts (1) $ — $ 13,847 $ 11,920 Noncash operating activities: Interest expense - NCM (see Note 6) $ ( 28,624 ) $ ( 23,595 ) $ ( 23,612 ) Noncash investing activities: Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment (2) $ 22,013 $ ( 13,259 ) $ 20,100 Theatre properties acquired under finance leases $ 21,535 $ — $ 725 Theatre properties acquired as distribution from equity investee (see Note 7) $ — $ 102,719 $ — Investment in NCM – receipt of common units (see Note 6) $ 1,552 $ 3,620 $ 10,237 (1) Funds are held as collateral for letters of credit associated with certain of the Company’s international subsidiary loans. See further discussion in Note 11. (2) Additions to theatre properties and equipment included in accounts payable as of December 31, 2020 and 2021 were $ 28,250 and $ 8,150 , respectively.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
INCOME TAXES	17. INCOME TAXES On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act was enacted in response to the global COVID-19 pandemic. The CARES Act allowed corporate taxpayers to carry back operating losses generated in 2018, 2019 and 2020. As a result of the impact of the COVID-19 pandemic on the Company’s business, it generated significant net operating losses during the years ended December 31, 2020 and December 31, 2021. The Company carried back 2020 losses and recorded tax benefits of $ 185,220 related to the NOL carryback provision. Losses incurred in 2021 are not available for carryback and are reported as net operating loss carryforwards. The Company’s provision for federal and foreign income tax expense for continuing operations consisted of the following: Year Ended December 31, 2019 2020 2021 Income (loss) before income taxes: U.S. $ 238,108 $ ( 767,767 ) $ ( 362,537 ) Foreign 38,189 ( 143,157 ) ( 49,841 ) Total $ 276,297 $ ( 910,924 ) $ ( 412,378 ) Current and deferred income taxes were as follows: Year Ended December 31, 2019 2020 2021 Current: Federal $ 45,758 $ ( 264,944 ) $ 4,026 Foreign 24,022 397 794 State 12,583 289 1,008 Total current expense $ 82,363 $ ( 264,258 ) $ 5,828 Deferred: Federal $ ( 298 ) $ ( 50,924 ) $ ( 36,666 ) Foreign 5 13,266 409 State ( 1,550 ) ( 1,721 ) ( 1,851 ) Total deferred taxes $ ( 1,843 ) $ ( 39,379 ) $ ( 38,108 ) Income taxes $ 80,520 $ ( 303,637 ) $ ( 32,280 ) A reconciliation between income tax expense and taxes computed by applying the applicable statutory federal income tax rate to income before income taxes is as follows: Year Ended December 31, 2019 2020 2021 Computed statutory tax expense $ 58,022 $ ( 191,295 ) $ ( 86,599 ) State and local income taxes, net of federal income tax impact 8,555 ( 1,153 ) ( 689 ) Changes in valuation allowance 2,532 46,731 54,306 Foreign tax rate differential 4,646 ( 6,633 ) ( 4,466 ) Foreign tax credits 4,143 — — Impacts related to COVID-19 pandemic (1) — ( 185,220 ) — Changes in uncertain tax positions 197 24,879 5,658 Other, net 2,425 9,054 ( 490 ) Income taxes $ 80,520 $ ( 303,637 ) $ ( 32,280 ) (1) The amount for the year ended December 31, 2020 includes benefits of a rate differential on earnings of $ 120,680 , tax losses with respect to investments in foreign subsidiaries and a write down of certain intercompany receivables associated with the Company’s foreign subsidiaries of $ 135,599 , offset by a tax charge for the remeasurement of deferred taxes and tax attributes of $ 49,866 and dislodged foreign tax credits not benefited of $ 21,193 . As of December 31, 2021 , the Company had approximately $ 94,107 of accumulated undistributed earnings and profits, approximately $ 168,307 of which was subject to the one-time transition tax pursuant to the 2017 Tax Cuts and Jobs Act. Additional tax due on the repatriation of previously-taxed earnings would generally be foreign withholding and U.S. state income taxes. The Company does not intend to repatriate these offshore earnings and profits, and therefore has not recorded any deferred taxes on such earnings. The Company considers any excess of the amount for financial reporting over the tax basis of its investment in its foreign subsidiaries to be indefinitely reinvested. At this time, the determination of deferred tax liabilities on this amount is not practicable. Deferred Income Taxes The tax effects of significant temporary differences and tax loss and tax credit carryforwards comprising the net long-term deferred income tax liabilities as of the periods presented consisted of the following: December 31, 2020 2021 Deferred liabilities: Theatre properties and equipment $ 118,051 $ 100,547 Finance lease assets 24,202 19,564 Operating lease right-of-use assets 297,452 288,205 Intangible asset – other 41,297 45,587 Intangible asset – tradenames 72,268 71,877 Investment in partnerships 20,402 16,128 Total deferred liabilities 573,672 541,908 Deferred assets: Deferred revenue – NCM 83,998 84,084 Deferred revenue – Other 6,208 3,661 Prepaid rent 5,255 3,365 Gift Cards 9,265 8,354 Operating lease obligations 313,552 304,462 Finance lease obligations 31,284 25,611 Tax impact of items in accumulated other comprehensive income and additional paid-in-capital 9,916 4,391 Restricted stock 2,489 5,376 Accrued expenses 3,552 4,326 Other tax loss carryforwards 89,320 121,631 Other tax credit and attribute carryforwards 121,698 145,449 Other expenses, not currently deductible for tax purposes 10,780 14,277 Total deferred assets 687,317 724,987 Net deferred income tax (asset) liability before valuation allowance ( 113,645 ) ( 183,079 ) Valuation allowance against deferred assets – non-current 203,606 240,847 Net deferred income tax liability $ 89,961 $ 57,768 Net deferred tax (asset) liability – Foreign $ 7,280 $ 6,737 Net deferred tax liability – U.S. 82,681 51,031 Total $ 89,961 $ 57,768 The Company continued to generate net operating losses in 2021 as a result of COVID-19 and such losses will be carried forward. As noted previously, net operating losses generated in 2020 were carried back to earlier years. Most of the state and all foreign jurisdictions in which the Company operates, however, only allow for net operating losses to be carried forward with varying expiration dates. A majority of our foreign tax credit carryforwards expire in 2023, 2026 and 2027, with the remainder expiring in 2028. Federal net operating losses have an indefinite carryforward period. Foreign net operating losses have varying carryforward periods with some being indefinite. Similarly, state net operating losses have varying carryforward periods with some being indefinite. The Company assesses the likelihood that it will be able to recover its deferred tax assets against future sources of taxable income and reduces the carrying amounts of deferred tax assets by recording a valuation allowance, if, based on all available evidence, the Company believes it is more likely than not that all or a portion of such assets will not be realized. During the year ended December 31, 2021 the Company continued to generate significant pre-tax losses and remained in a three-year cumulative pre-tax loss. Consistent with December 31, 2020, this is heavily weighted as objectively verifiable negative evidence. As a result, the Company is unable to include future projected earnings in assessing the recoverability of its deferred tax assets. The Company has established a valuation allowance against certain deferred tax assets for which the ultimate realization of future benefits is uncertain. Expiring carryforwards and the required valuation allowances are adjusted annually. After application of the valuation allowances described above, the Company anticipates that no limitations will apply with respect to utilization of any of the other deferred tax assets described above. The Company’s valuation allowance changed from $ 203,606 as of December 31, 2020 to $ 240,847 as of December 31, 2021 (see Note 21). The increase relates to foreign tax credits and other deferred tax assets for which ultimate realization is uncertain. The valuation allowance associated with these deferred tax assets is primarily a result of not having sufficient income from deferred tax liability reversals in future periods to support the realization of the deferred tax assets. When the Company begins to generate taxable income at a normal level, the Company expects to reverse the valuation allowances with an offsetting increase to reported earnings. Uncertain Tax Positions The following is a reconciliation of the total amounts of unrecognized tax benefits excluding interest and penalties for the periods presented: Year Ended December 31, 2019 2020 2021 Balance at January 1, $ 10,561 $ 10,235 $ 46,528 Gross increases - tax positions in prior periods 1 32,417 5,790 Gross decreases - tax positions in prior periods — ( 88 ) ( 1,611 ) Gross increases - current period tax positions 202 4,010 3,465 Settlements ( 522 ) — ( 122 ) Foreign currency translation adjustments ( 7 ) ( 46 ) ( 11 ) Balance at December 31, $ 10,235 $ 46,528 $ 54,039 The Company had $ 51,643 and $ 60,601 of unrecognized tax benefits, including interest and penalties, as of December 31, 2020 and 2021 , respectively. Of these amounts, $ 51,643 and $ 60,601 represent the amount of unrecognized tax benefits that, if recognized, would impact the effective income tax rate for the years ended December 31, 2020 and 2021 , respectively. The Company had $ 5,114 and $ 6,561 accrued for interest and penalties as of December 31, 2020 and 2021, respectively. The Company prepares and files income tax returns based upon its interpretation of tax laws and regulations and record estimates based upon these judgments and interpretations. In the normal course of business, the Company’s income tax returns are subject to examination by various taxing authorities. Such examinations may result in future tax and interest assessments by these taxing authorities. Inherent uncertainties exist in estimates of tax contingencies due to changes in tax law resulting from legislation, regulation, and/or as concluded through the various jurisdictions' tax court systems. Significant judgment is exercised in applying complex tax laws and regulations across multiple global jurisdictions where we conduct our operations. The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by the taxing authorities, including resolutions of any related appeals or litigation processes, based upon the technical merits of the position. The Company is no longer subject to income tax audits from the Internal Revenue Service for years before 2018. The Company is no longer subject to state income tax examinations by tax authorities in its major state jurisdictions for years before 2017. The Company is no longer subject to non-U.S. income tax examinations by tax authorities in its major non-U.S. tax jurisdictions for years before 2006. The Company is currently under audit in California for tax years 2017 and 2018 and is under audit in the non-U.S. tax jurisdiction of Brazil.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Dec. 31, 2021
Commitments And Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	18. COMMITMENTS AND CONTINGENCIES Employment Agreements — As of December 31, 2021 , the Company had employment agreements with Lee Roy Mitchell, Sean Gamble, Melissa Thomas, Valmir Fernandes and Michael Cavalier. These employment agreements are subject to automatic extensions for a one year period, unless the employment agreements are terminated. The base salaries stipulated in the employment agreements are subject to review at least annually during the term of the agreements for increase (but not decrease) by the Compensation Committee. Management personnel subject to these employment agreements are eligible to receive annual cash incentive bonuses upon the Company meeting certain performance targets established by the Compensation Committee. Retirement Savings Plan — The Company has a 401(k) retirement savings plan (“401(k) Plan”) for the benefit of all eligible employees and makes discretionary matching contributions as determined annually in accordance with the 401(k) Plan. Employer matching contribution payments of $ 1,562 and $ 2,123 were made during the years ended December 31, 2020 and 2021 , respectively. A liability of approximately $ 3,728 was recorded as of December 31, 2021 for employer contribution payments to be made in 2022 for the remaining amounts owed for plan year 2021. Legal Proceedings From time to time, the Company is involved in various legal proceedings arising from the ordinary course of its business operations, such as personal injury claims, employment matters, patent claims, landlord-tenant disputes, contractual disputes with landlords over certain termination rights or the right to discontinue rent payments due to the COVID-19 pandemic and other contractual disputes, some of which are covered by insurance. The Company believes its potential liability with respect to proceedings currently pending is not material, individually or in the aggregate, to the Company’s financial position, results of operations and cash flows. Cinemark Holdings, Inc., et al vs Factory Mutual Insurance Company . The Company filed suit on November 18, 2020, in the District Court, 471st Judicial District, Collin County, Texas. On December 22, 2020, the case was moved to the US District Court for the Eastern District of Texas, Sherman Division. The Company submitted a claim under its property insurance policy issued by Factory Mutual Insurance Company (the “FM Policy”) for losses sustained as a result of the closure of the Company’s theatres due to the COVID-19 pandemic. Factory Mutual Insurance Company (“FM”) denied the Company’s claim. The Company is seeking damages resulting from FM’s breach of contract, FM’s bad faith conduct and a declaration of the parties’ rights under the FM Policy. The Company cannot predict the outcome of this litigation . Intertrust Technologies Corporation (“Intertrust”) v. Cinemark Holdings, Inc., Regal, AMC, et al . This case was filed against the Company on August 7, 2019 in the Eastern District of Texas – Marshall Division alleging patent infringement. The Company firmly maintains that the contentions of the Plaintiff are without merit. The parties have reached a settlement, announced settlement to the Court, and are in the process of memorializing the agreed-to deal terms in final definitive agreements, to be followed by a dismissals of the case with prejudice. The settlement is recorded in (gain) loss on sale of assets and other on the consolidated statement of income (loss) for the year ended December 31, 2021. Lakeenya Neal, et al v. Cinemark Holdings, Inc., et al. This class action lawsuit was filed against the Company on December 10, 2021, in the Central District of Los Angeles County Superior Court of the State of California alleging certain violations of the Fair and Accurate Credit Transactions Act. We firmly maintain that the allegations are without merit and will vigorously defend this lawsuit. The Company cannot predict the outcome of this litigation.

SEGMENTS

SEGMENTS	12 Months Ended
	Dec. 31, 2021
Segment Reporting [Abstract]
SEGMENTS	19. SEGMENTS The Company manages its U.S. market and its international market as separate reportable operating segments, with the international segment consisting of operations in Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay. Each segment’s revenue is derived from admissions and concession sales and other ancillary revenues. The Company uses Adjusted EBITDA, as shown in the reconciliation table below, as the primary measure of segment profit and loss to evaluate performance and allocate its resources. The Company does not report asset information by segment because that information is not used to evaluate Company performance or allocate resources between segments. The following table is a breakdown of select financial information by reportable operating segment for the periods presented: Year Ended December 31, 2019 2020 2021 Revenues U.S. $ 2,594,246 $ 559,184 $ 1,296,343 International 702,196 129,401 216,842 Eliminations ( 13,343 ) ( 2,275 ) ( 2,721 ) Total revenues $ 3,283,099 $ 686,310 $ 1,510,464 Adjusted EBITDA (1) U.S. $ 616,799 $ ( 225,663 ) $ 85,886 International 129,884 ( 49,899 ) ( 4,271 ) Total Adjusted EBITDA $ 746,683 $ ( 275,562 ) $ 81,615 Capital expenditures U.S. $ 230,561 $ 64,026 $ 78,305 International 73,066 19,904 17,237 Total capital expenditures $ 303,627 $ 83,930 $ 95,542 (1) Distributions from equity investees are reported entirely within the U.S. operating segment. The following table sets forth a reconciliation of net income to Adjusted EBITDA for the periods presented: Year Ended December 31, 2019 2020 2021 Net income (loss) $ 195,777 $ ( 607,287 ) $ ( 380,098 ) Add (deduct): Income taxes 80,520 ( 303,637 ) ( 32,280 ) Interest expense (1) 99,941 115,651 125,569 Loss on extinguishment of debt — — 6,527 Other (income) expense (2) ( 22,422 ) 62,425 43,612 Distributions from DCIP (3) 23,696 10,383 — Other cash distributions from equity investees (4) 29,670 15,047 156 Non-cash distributions from DCIP (5) — ( 12,915 ) — Depreciation and amortization 261,155 259,776 265,363 Impairment of long-lived and other assets 57,001 152,706 20,845 (Gain) loss on disposal of assets and other 12,008 ( 8,923 ) 8,025 Restructuring charges — 20,369 ( 1,001 ) Non-cash rent expense ( 4,360 ) 2,357 ( 3,451 ) Share based awards compensation expense 13,697 18,486 28,348 Adjusted EBITDA $ 746,683 $ ( 275,562 ) $ 81,615 (1) Includes amortization of debt issuance costs. (2) Includes interest income, foreign currency exchange loss, interest expense – NCM and equity in income (loss) of affiliates and excludes distributions from NCM. (3) See discussion of cash distributions from DCIP, which were recorded as a reduction of the Company’s investment in DCIP for the years ended December 31, 2019 and 2020, in Note 7. These distributions are reported entirely within the U.S. operating segment. (4) Reflects cash distributions received from equity investees, other than those from DCIP noted above, that were recorded as a reduction of the respective investment balances (see Notes 6 and 7). These distributions are reported entirely within the U.S. operating segment. (5) Reflects non-cash distribution of projectors from DCIP (see Note 7). These distributions are reported entirely within the U.S. operating segment. Financial Information About Geographic Area The following tables are a breakdown of select financial information by geographic area for the periods presented: Year Ended December 31, 2019 2020 2021 Revenues U.S. $ 2,594,246 $ 559,184 $ 1,296,343 Brazil 302,074 59,321 73,468 Other international countries 400,122 70,080 143,374 Eliminations ( 13,343 ) ( 2,275 ) ( 2,721 ) Total $ 3,283,099 $ 686,310 $ 1,510,464 As of December 31, 2020 2021 Theatre properties and equipment, net U.S. $ 1,392,780 $ 1,208,701 Brazil 72,080 56,750 Other international countries 150,202 117,395 Total $ 1,615,062 $ 1,382,846

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	12 Months Ended
	Dec. 31, 2021
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	20. RELATED PARTY TRANSACTIONS The Company manages a theatre for Laredo Theatres, Ltd. (“Laredo”). The Company is the sole general partner and owns 75 % of the limited partnership interests of Laredo. Lone Star Theatres, Inc. owns the remaining 25 % of the limited partnership interests in Laredo and is 100 % owned by Mr. David Roberts, Lee Roy Mitchell’s son-in-law. Lee Roy Mitchell is Cinemark Holdings, Inc.’s Chairman of the Board and directly and indirectly owns approximately 9 % of Cinemark Holdings, Inc.’s common stock. Under the agreement, management fees are paid by Laredo to the Company at a rate of 5 % of annual theatre revenues up to $ 50,000 and 3 % of annual theatre revenues in excess of $ 50,000 . The Company recorded $ 694 , $ 146 and $ 399 of management fee revenue during the years ended December 31, 2019, 2020 and 2021, respectively. All such amounts are included in the Company’s consolidated financial statements with the intercompany amounts eliminated in consolidation. Walter Hebert, Mr. Mitchell’s brother-in-law, previously served as the Executive Vice President – Purchasing of the Company and retired in July 2021. Mr. Hebert now serves as a consultant to the Company until July 2022. During the year ended December 31, 2021, the Company paid Mr. Hebert $ 122 for consulting services. The Company has an Aircraft Time Sharing Agreement with Copper Beech Capital, LLC to use, on occasion, a private aircraft owned by Copper Beech Capital, LLC. Copper Beech Capital, LLC is owned by Mr. Mitchell and his wife, Tandy Mitchell. The private aircraft is used by Mr. Mitchell and other executives who accompany Mr. Mitchell to business meetings for the Company. The Company reimburses Copper Beech Capital, LLC the actual costs of fuel usage and the expenses of the pilots, landing fees, storage fees and similar expenses incurred during the trip. For the years ended December 31, 2019, 2020 and 2021 , the aggregate amounts paid to Copper Beech Capital, LLC for the use of the aircraft was approximately $ 114 , $ 12 and $ 23 , respectively. The Company currently leases 13 theatres from Syufy Enterprises, LP (“Syufy”) or affiliates of Syufy. Raymond Syufy is one of Cinemark Holdings, Inc.’s directors and is an officer of the general partner of Syufy. For the years ended December 31, 2019, 2020 and 2021 , the Company paid total rent of approximately $ 25,678 , $ 23,810 and $ 23,317 , respectively, to Syufy. During 2019, the Company began providing digital equipment support to drive-in theatres owned by Syufy. The Company recorded approximately $ 30 , $ 0 and $ 55 of management fees related to these services during the years ended December 31, 2019, 2020 and 2021, respectively. The Company has a 50 % voting interest in FE Concepts, a joint venture with AWSR, an entity owned by Lee Roy Mitchell and Tandy Mitchell. FE Concepts operates a family entertainment center that offers bowling, gaming, movies and other amenities. See Note 7 for further discussion. The Company has a theatre services agreement with FE Concepts under which the Company receives service fees for providing film booking and equipment monitoring services for the facility. The Company recorded $ 64 , $ 34 and $ 62 of service fees during the years ended December 31, 2019, 2020 and 2021, respectively. The Company has paid certain fees and expenses on behalf of its parent, Cinemark Holdings, Inc. and Cinemark Holdings, Inc. has paid income taxes on behalf of the Company. The Company paid cash dividends to Cinemark Holdings, Inc. of $ 158,450 , $ 42,000 and $ 0 during the years ended December 31, 2019, 2020 and 2021, respectively. Additionally, the Company received a cash contribution from Cinemark Holdings, Inc. of $ 120,000 during the year ended December 31, 2021. The Company had a receivable from Cinemark Holdings, Inc. of $ 36,775 and $ 46,651 as of December 31, 2020 and 2021, respectively.

VALUATION AND QUALIFYING ACCOUN

VALUATION AND QUALIFYING ACCOUNTS	12 Months Ended
	Dec. 31, 2021
Valuation And Qualifying Accounts [Abstract]
VALUATION AND QUALIFYING ACCOUNTS	21. VALUATION AND QUALIFYING ACCOUNTS The Company’s valuation allowance for deferred tax assets for the periods presented were as follows: Valuation Allowance for Deferred Taxes Balance at January 1, 2019 $ 54,725 Additions 7,611 Deductions ( 1,977 ) Balance at December 31, 2019 $ 60,359 Additions 144,239 Deductions ( 992 ) Balance at December 31, 2020 $ 203,606 Additions 52,516 Deductions ( 10,974 ) Currency translation ( 4,301 ) Balance at December 31, 2021 $ 240,847

UNAUDITED SUPPLEMENTAL SCHEDULE

UNAUDITED SUPPLEMENTAL SCHEDULES	12 Months Ended
	Dec. 31, 2021
Supplemental Financial Information For Indentures [Abstract]
UNAUDITED SUPPLEMENTAL SCHEDULES	UNAUDITED SUPPLEMENTAL SCHEDULES As required by the indentures governing the Company’s 5.250% Senior Notes, 5.875% Senior Notes and 8.750% Secured Notes (collectively the “Notes”), the Company has included in this filing, financial information for its subsidiaries that have been designated as unrestricted subsidiaries as defined by the indentures. As required by the indentures governing the Notes, the Company has included a condensed consolidating balance sheet and condensed consolidating statements of income, comprehensive income and cash flows for the Company and its subsidiaries. These supplementary schedules separately identify the Company’s restricted subsidiaries and unrestricted subsidiaries as required by the indentures. CINEMARK USA, INC. AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION DECEMBER 31, 2021 (in thousands) Restricted Unrestricted Group Group Eliminations Consolidated Assets Current assets Cash and cash equivalents $ 342,603 $ 100,074 $ — $ 442,677 Other current assets 338,664 ( 119,168 ) ( 5,719 ) 213,777 Total current assets 681,267 ( 19,094 ) ( 5,719 ) 656,454 Theatre properties and equipment, net 1,382,846 — — 1,382,846 Operating lease right-of-use assets, net 1,230,790 — — 1,230,790 Other assets 1,794,697 319,387 ( 371,542 ) 1,742,542 Total assets $ 5,089,600 $ 300,293 $ ( 377,261 ) $ 5,012,632 Liabilities and equity Current liabilities Current portion of long-term debt $ 24,254 $ — $ — $ 24,254 Current portion of operating lease obligations 217,092 — — 217,092 Current portion of finance lease obligations 14,605 — — 14,605 Accounts payable and accrued expenses 510,366 — ( 5,719 ) 504,647 Total current liabilities 766,317 — ( 5,719 ) 760,598 Long-term liabilities Long-term debt, less current portion 2,293,215 — ( 264,523 ) 2,028,692 Operating lease obligations, less current portion 1,078,260 — — 1,078,260 Finance lease obligations, less current portion 102,571 — — 102,571 Other long-term liabilities and deferrals 475,666 11,999 — 487,665 Total long-term liabilities 3,949,712 11,999 ( 264,523 ) 3,697,188 Commitments and contingencies Equity 373,571 288,294 ( 107,019 ) 554,846 Total liabilities and equity $ 5,089,600 $ 300,293 $ ( 377,261 ) $ 5,012,632 Note: "Restricted Group" and "Unrestricted Group" are defined in the indentures for the senior notes. CINEMARK USA, INC. AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATING STATEMENT OF LOSS INFORMATION YEAR ENDED DECEMBER 31, 2021 (in thousands) Restricted Unrestricted Group Group Eliminations Consolidated Revenues $ 1,510,464 $ — $ — $ 1,510,464 Cost of operations — Theatre operating costs 1,308,628 — — 1,308,628 General and administrative expenses 158,472 18 — 158,490 Depreciation and amortization 265,363 — — 265,363 Impairment of long-lived assets 20,845 — — 20,845 Restructuring costs ( 1,001 ) — — ( 1,001 ) Loss on sale of assets and other 8,025 — — 8,025 Total cost of operations 1,760,332 18 — 1,760,350 Operating loss ( 249,868 ) ( 18 ) — ( 249,886 ) Other income (expense) ( 169,057 ) 6,565 — ( 162,492 ) Loss before income taxes ( 418,925 ) 6,547 — ( 412,378 ) Income taxes ( 33,758 ) 1,478 — ( 32,280 ) Net loss ( 385,167 ) 5,069 — ( 380,098 ) Less: Net income attributable to noncontrolling interests 568 — — 568 Net loss attributable to Cinemark USA, Inc. $ ( 385,735 ) $ 5,069 $ — $ ( 380,666 ) Note: "Restricted Group" and "Unrestricted Group" are defined in the indentures for the senior notes. CINEMARK USA, INC. AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE LOSS INFORMATION YEAR ENDED DECEMBER 31, 2021 (in thousands) Restricted Unrestricted Group Group Eliminations Consolidated Net loss $ ( 385,167 ) $ 5,069 $ — $ ( 380,098 ) Other comprehensive loss, net of tax Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes of $( 3278 ), net of settlements 15,944 — — 15,944 Foreign currency translation adjustments ( 18,837 ) — — ( 18,837 ) Total other comprehensive loss, net of tax ( 2,893 ) — — ( 2,893 ) Total comprehensive loss, net of tax ( 388,060 ) 5,069 — ( 382,991 ) Comprehensive income attributable to noncontrolling interests ( 568 ) — — ( 568 ) Comprehensive loss attributable to Cinemark USA, Inc. $ ( 388,628 ) $ 5,069 $ — $ ( 383,559 ) Note: "Restricted Group" and "Unrestricted Group" are defined in the indentures for the senior notes. CINEMARK USA, INC. AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED DECEMBER 31, 2021 (in thousands) Restricted Unrestricted Group Group Eliminations Consolidated Operating activities Net loss $ ( 385,167 ) $ 5,069 $ — $ ( 380,098 ) Adjustments to reconcile net loss to cash used for operating activities 306,069 9,659 — 315,728 Changes in assets and liabilities 242,356 ( 1,629 ) — 240,727 Net cash provided by (used for) operating activities 163,258 13,099 — 176,357 Investing activities Additions to theatre properties and equipment ( 95,542 ) — — ( 95,542 ) Proceeds from sale of theatre properties and equipment and other 6,246 — — 6,246 Investments and loans to affiliates — ( 7,785 ) 7,785 — Net cash used for investing activities ( 89,296 ) ( 7,785 ) 7,785 ( 89,296 ) Financing activities Contributions from parent 120,000 — — 120,000 Borrowings from parent/subsidiary 7,785 — ( 7,785 ) — Proceeds from issuance of senior notes 1,170,000 — — 1,170,000 Proceeds from other borrowings 13,475 — — 13,475 Redemptions of senior notes ( 1,155,000 ) — — ( 1,155,000 ) Repayments on long-term debt ( 10,284 ) — — ( 10,284 ) Payment of debt issuance costs ( 17,272 ) — — ( 17,272 ) Payments on finance leases ( 14,689 ) — — ( 14,689 ) Other ( 6,160 ) — — ( 6,160 ) Net cash provided by (used for) financing activities 107,855 — ( 7,785 ) 100,070 Effect of exchange rate changes on cash and cash ( 4,992 ) — — ( 4,992 ) Decrease in cash and cash equivalents 176,825 5,314 — 182,139 Cash and cash equivalents: Beginning of year 165,778 94,760 — 260,538 End of year $ 342,603 $ 100,074 $ — $ 442,677 Note: "Restricted Group" and "Unrestricted Group" are defined in the indentures for the senior notes.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Business	Business — Cinemark USA, Inc., a wholly-owned subsidiary of Cinemark Holdings, Inc., and its subsidiaries (the “Company”) operate in the motion picture exhibition industry, with theatres in the United States (“U.S.”) and in 15 countries in Latin America.
Principles of Consolidation	Principles of Consolidation — The consolidated financial statements include the accounts of Cinemark USA, Inc. and its subsidiaries. Majority-owned subsidiaries that the Company has control of are consolidated while those affiliates of which the Company owns between 20 % and 50 % and does not control are accounted for under the equity method. Those affiliates of which the Company owns less than 20 % are generally accounted for under the cost method, unless the Company is deemed to have the ability to exercise significant influence over the affiliate, in which case the Company would account for its investment under the equity method. The results of these equity method investees are included in the consolidated financial statements effective from their date of formation or from their dates of acquisition. Intercompany balances and transactions are eliminated in consolidation.
Cash and Cash Equivalents	Cash and Cash Equivalents — Cash and cash equivalents consist of operating funds held in financial institutions, petty cash held by the theatres, highly liquid investments with original maturities of three months or less when purchased and restricted cash. The Company invests its cash primarily in money market funds, certificates of deposit, commercial paper or other similar funds. The Company maintains cash deposits required to support bank letters of credit issued for bank loans of certain of the Company’s international subsidiaries that totaled $ 25,767 as of December 31, 2021 and are considered restricted cash. See Note 11 for further discussion.
Accounts Receivable	Accounts Receivable – Accounts receivable, which are recorded at net realizable value, consist primarily of receivables related to screen advertising, screen rental, receivables related to discounted tickets and gift cards sold to third party retail locations, receivables from landlords related to theatre construction projects, rebates earned from the Company’s concession vendors and value-added and other non-income tax receivables.
Inventories	Inventories — Concession inventories are stated at the lower of cost (first-in, first-out method) or net realizable value.
Theatre Properties and Equipment	Theatre Properties and Equipment — Theatre properties and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is recorded using the straight-line method over the estimated useful lives of the assets as follows: Category Useful Life Buildings on owned land 40 years Buildings on leased land Lesser of lease term or useful life Land and buildings under finance leases (1) Lease term Theatre furniture and equipment 3 to 15 years Leasehold improvements Lesser of lease term or useful life (1) Amortization of finance lease assets is included in depreciation and amortization expense on the consolidated statements of income. Accumulated amortization of finance lease assets as of December 31, 2020 and 2021 was $ 47,961 and $ 57,778 , respectively. The Company evaluates long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable (qualitative evaluation). The Company also performs a full quantitative impairment evaluation on an annual basis. These qualitative and quantitative evaluations are described below: • Quantitative approach The Company performs a quantitative evaluation at the theatre level using estimat ed undiscounted cash flows from continuing use through the remainder of the theatre’s useful life. The remainder of the theatre’s useful life correlates with the remaining lease period, which includes the probability of the exercise of available renewal periods for leased properties, and the lesser of twenty years or the building’s remaining useful life for owned properties. If the estimated undiscounted cash flows are not sufficient to recover a long-lived asset’s carrying value, the Company then compares the carrying value of the asset group (theatre) with its estimated fair value. Significant judgment, including management’s estimate of future theatre level cash flows for each theatre is involved in estimating fair value. For its 2020 and 2021 long-lived impairment assessments, significant management judgement was involved in estimating impacts of the COVID-19 pandemic and the timing of recovery for each of the Company's theatres based on projected box office. Fair value is estimated based on a multiple of cash flows. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy, as defined by FASB ASC Topic 820-10-35, are based on projected operating performance, market transactions and industry trading multiples. • Qualitative approach The Company’s qualitative assessment considers relevant market transactions, industry trading multiples and recent developments that would impact its estimates of future cash flows as compared to its most recent quantitative impairment assessment.
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets — The Company evaluates goodwill for impairment annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value of the goodwill may not be fully recoverable. The Company evaluates goodwill for impairment at the reporting unit level and has allocated goodwill to the reporting unit based on an estimate of its relative fair value. Management considers the reporting unit to be each of its regions in the U.S. and each of its international countries with Honduras, El Salvador, Nicaragua, Costa Rica, Panama and Guatemala considered one reporting unit (the Company does not have goodwill recorded for all of its international locations). Under ASC Topic 350, Goodwill, Intangibles and Other (“ASC Topic 350”), the Company may perform a qualitative impairment assessment or a quantitative impairment assessment of our goodwill which are described below: • Quantitative approach Under a quantitative goodwill impairment analysis, the Company estimates the fair value of each reporting unit and compares it with its carrying value. Fair value is estimated using the market approach, which is the most common valuation approach for the Company’s industry and considers a multiple of cash flows for each reporting unit as the basis for fair value. Significant judgment including management’s estimate of future theatre level cash flows for each theatre is involved in estimating fair value of a reporting unit. For its 2020 and 2021 goodwill impairment assessments, significant management judgement was involved in estimating impacts of the COVID-19 pandemic and the timing of recovery for each of the Company's theatres based on projected box office. The Company’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on projected operating performance of each reporting unit, relevant market transactions and industry trading multiples. • Qualitative approach The Company’s qualitative assessment of goodwill for each reporting unit considers economic and market conditions, industry trading multiples and the impact of recent developments and events on the estimated fair values as determined during its most recent quantitative assessment. Tradename intangible assets are tested for impairment at least annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value may not be fully recoverable. Under ASC Topic 350, the Company can elect to perform a qualitative or quantitative impairment assessment for our tradename intangible assets as described below: • Quantitative approach The Company compares the carrying values of its tradename assets to their estimated fair values. Fair values are estimated by applying an estimated market royalty rate that could be charged for the use of the tradenames to forecasted future revenues, with an adjustment for the present value of such royalties. Significant judgment, including management’s estimate of market royalty rates and long-term revenue forecasts, is involved in estimating the tradename fair values. For its 2020 and 2021 tradename impairment assessments, significant management judgement was involved in estimating impacts of the COVID-19 pandemic and the timing of recovery for each of the Company's theatres based on projected box office. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, were based on projected revenue performance and expected industry trends. • Qualitative approach The Company’s qualitative assessment considers industry and market conditions and recent developments that may impact the revenue forecasts and other estimates as compared to its most recent quantitative assessment. The table below summarizes the Company’s intangible assets and the amortization method used for each type of intangible asset: Intangible Asset Amortization Method Goodwill Indefinite-lived Tradename Indefinite-lived and definite-lived. Definite-lived tradename asset has a remaining useful life of approximately five years. Other intangible assets Straight-line method over the terms of the underlying agreement or the expected useful life of the intangible asset. The remaining useful lives of these intangible assets range from one to four years .
Lease Accounting	Lease Accounting — See Note 4 for discussion of the Company’s lease accounting policies.
Deferred Charges and Other Assets	Deferred Charges and Other Assets — Deferred charges and other assets consist of construction, lease and other deposits, equipment to be placed in service, and other assets of a long-term nature.
Self-Insurance Reserves	Self-Insurance Reserves — In the U.S., the Company is self-insured for general liability claims. For each of the years ended December 31, 2019, 2020 and 2021 , general liability claims were capped at $ 500 per occurrence with no aggregate annual cap. For its international locations, the Company is fully insured for general liability claims with little or no deductibles per occurrence. The Company has a fully-funded deductible workers compensation insurance plan under which the Company is responsible for pre-funding claims and is responsible for claims up to $ 250 per occurrence, with an annual cap of $ 5,000 for the years ended December 31, 2019, 2020 and 2021 . The Company is also self-insured for domestic medical claims with a cap of $ 250 per occurrence for the years ended December 31, 2019, 2020 and 2021. As of December 31, 2020 and 2021 , the Company’s self-insurance reserves were $ 9,034 and $ 6,810 , respectively, and are reflected in accrued other current liabilities on the consolidated balance sheets.
Revenue Recognition	Revenue Recognition — See Note 5 for discussion of revenue recognition and deferred revenue.
Expenses	Expenses — Film rental costs are subject to the film licensing arrangement and accrued based on the applicable box office receipts and either; 1) a sliding scale formula, which is generally established with the studio prior to the opening of the film, 2) a firm terms formula as negotiated prior to a film's theatrical run or 3) estimates of the final settlement rate, which occurs at the conclusion of the film run. Under a sliding scale formula, the Company pays a percentage of box office revenues using a pre-determined scale that is based upon box office performance of the film for its full run. Under a firm terms formula, the Company pays the distributor a percentage of box office receipts that can either be an aggregate rate for the full theatrical run or rates that decline over the term of the theatrical run. The settlement process allows for negotiation of film rental fees upon the conclusion of the film's theatrical run based upon how the film performs. Estimates are based on the expected success of a film. The success of a film can generally be determined a few weeks after a film is released when the initial box office performance of the film is known. If actual settlements are different than those estimates, film rental costs are adjusted at that time.
Accounting for Share Based Awards	Accounting for Share Based Awards — The Company measures the cost of employee services received in exchange for an equity award based on the fair value of the award on the date of the grant. The grant date fair value is based on Cinemark Holdings, Inc.'s stock price on the grant date. Such costs are recognized over the period during which an employee is required to provide service in exchange for the award (which is usually the vesting period). At the time of the grant, the Company also estimates the number of awards that will ultimately be forfeited. See Note 15 for discussion of the Company’s share based awards and related compensation expense.
Income Taxes	Income Taxes — The Company participates in the consolidated return of Cinemark Holdings, Inc. However, the Company's provision for income taxes is computed on a stand-alone basis. The Company uses an asset and liability approach to financial accounting and reporting for income taxes. Deferred income taxes are provided when tax laws and financial accounting standards differ with respect to the amount of income for a year and the basis of assets and liabilities. A valuation allowance is recorded to reduce the carrying amount of deferred tax assets unless it is more likely than not that such assets will be realized. Income taxes are provided on unremitted earnings from foreign subsidiaries unless such earnings are expected to be indefinitely reinvested. Income taxes have also been provided for potential tax assessments. The evaluation of an uncertain tax position is a two-step process. The first step is recognition: The Company determines whether it is more likely than not that a tax position will be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. In evaluating whether a tax position has met the more-likely-than-not recognition threshold, the Company should presume that the position would be examined by the appropriate taxing authority that would have full knowledge of all relevant information. The second step is measurement: A tax position that meets the more-likely-than-not recognition threshold is measured to determine the amount of benefit to recognize in the financial statements. The tax position is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. Differences between tax positions taken in a tax return and amounts recognized in the financial statements result in (1) a change in a liability for income taxes payable or (2) a change in an income tax refund receivable, a deferred tax asset or a deferred tax liability or both (1) and (2). The Company accrues interest and penalties on its uncertain tax positions as a component of income tax expense. See further discussion in Note 17.
Segments	Segments — For the years ended December 31, 2019, 2020 and 2021 , the Company managed its business under two reportable operating segments, U.S. markets and international markets. See Note 19.
Use of Estimates	Use of Estimates — The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the periods presented. The Company’s consolidated financial statements include amounts that are based on management’s best estimates and judgments. Actual results could differ from those estimates.
Foreign Currency Translations	Foreign Currency Translations — The assets and liabilities of the Company’s foreign subsidiaries are translated into U.S. dollars at current exchange rates as of the balance sheet date, and revenues and expenses are translated at average monthly exchange rates. The resulting translation adjustments are recorded in the consolidated balance sheets in accumulated other comprehensive loss. See Note 13 for a summary of the translation adjustments recorded in accumulated other comprehensive loss for the years ended December 31, 2019, 2020 and 2021. The Company recognizes foreign currency transaction gains and losses when changes in exchange rates impact transactions, other than intercompany transactions of a long-term investment nature, that have been denominated in a currency other than the functional currency. The Company deemed Argentina to be highly inflationary beginning July 1, 2018. A highly inflationary economy is defined as an economy with a cumulative inflation rate of approximately 100 percent or more over a three-year period. If a country’s economy is classified as highly inflationary, the financial statements of the foreign entity operating in that country must be remeasured to the functional currency of the reporting entity. The financial statements of the Company’s Argentina subsidiaries has been remeasured in U.S. dollars in accordance with ASC Topic 830, Foreign Currency Matters , effective beginning July 1, 2018. See further discussion in Note 13.
Fair Value Measurements	Fair Value Measurements — According to authoritative guidance, inputs used in fair value measurements fall into three different categories; Level 1, Level 2 and Level 3. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 3 inputs are unobservable inputs for the asset or liability. See Note 12 for a discussion of our fair value measurements for the years ended December 31, 2019, 2020 and 2021.
Acquisitions	Acquisitions — The Company accounts for acquisitions under the acquisition method of accounting. The acquisition method requires that the acquired assets and liabilities, including contingencies, be recorded at fair value determined on the acquisition date and changes thereafter reflected in income. For certain acquisitions, the Company obtains independent third party valuation studies for certain of the assets acquired and liabilities assumed to assist the Company in determining fair value. The estimation of the fair value of the assets acquired and liabilities assumed involves a number of estimates and assumptions that could differ materially from the actual amounts realized. The Company provides assumptions, including both quantitative and qualitative information, about the specified asset or liability to the third party valuation firms. The Company primarily utilizes the third party to accumulate comparative data from multiple sources and assemble a report that summarizes the information obtained. The Company then uses the information to record estimated fair value. The third party valuation firms are supervised by Company personnel who are knowledgeable about valuations and fair value. The Company evaluates the appropriateness of the assumptions and valuation methodologies utilized by the third party valuation firm.
Interest Rate Swaps	Interest Rate Swaps – The Company evaluates its interest rate swap agreements, which are designated as cash flow hedges, to determine whether they are effective on a quarterly basis in accordance with ASC Topic 815, Derivatives and Hedging . The fair values of the interest rate swaps are estimated based on future estimated net cash flows considering forecasted interest rates for the terms of the interest rate swap agreements as compared to the fixed interest rates paid under the agreements. If deemed to be effective, fair value estimates are recorded on the consolidated balance sheets as an asset or liability with the related gains or losses reported as a component of accumulated other comprehensive loss. If the swaps are determined to not be effective, the gains or losses are recorded in interest expense on the consolidated income statement. See further discussion at Note 11.
Restructuring Charges	Restructuring Charges – During the year ended December 31, 2020, the Company recorded restructuring charges based on an approved and announced restructuring plan, specifically related to headcount reductions, the permanent closure of underperforming theatres and the write-down of related theatre assets. The costs of the restructuring actions were accrued based on estimates at the time the plan was formalized. Adjustments made to restructuring charges based on actual costs incurred were recorded during the year ended December 31, 2021. See further discussion in Note 3.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Estimated Useful Life of Assets	Depreciation is recorded using the straight-line method over the estimated useful lives of the assets as follows: Category Useful Life Buildings on owned land 40 years Buildings on leased land Lesser of lease term or useful life Land and buildings under finance leases (1) Lease term Theatre furniture and equipment 3 to 15 years Leasehold improvements Lesser of lease term or useful life (1) Amortization of finance lease assets is included in depreciation and amortization expense on the consolidated statements of income. Accumulated amortization of finance lease assets as of December 31, 2020 and 2021 was $ 47,961 and $ 57,778 , respectively.
Intangible Assets and Amortization Method	The table below summarizes the Company’s intangible assets and the amortization method used for each type of intangible asset: Intangible Asset Amortization Method Goodwill Indefinite-lived Tradename Indefinite-lived and definite-lived. Definite-lived tradename asset has a remaining useful life of approximately five years. Other intangible assets Straight-line method over the terms of the underlying agreement or the expected useful life of the intangible asset. The remaining useful lives of these intangible assets range from one to four years .

IMPACT OF THE COVID-19 PANDEM_2

IMPACT OF THE COVID-19 PANDEMIC (Tables)	12 Months Ended
	Dec. 31, 2021
Unusual Or Infrequent Item [Line Items]
Schedule of Restructuring Plan and Obligations Remained Outstanding	The following table summarized activity recorded during the years ended December 31, 2020 and 2021: U.S. Operating Segment International Operating Segment Consolidated Employee-related Costs Facility Closure Costs Total Charges Employee-related Costs Facility Closure Costs Total Charges Employee-related Costs Facility Closure Costs Total Charges Restructuring charges recorded during the year ended December 31, 2020 $ 8,964 $ 7,645 $ 16,609 $ 814 $ 2,946 $ 3,760 $ 9,778 $ 10,591 $ 20,369 Amounts paid ( 7,603 ) ( 1,649 ) ( 9,252 ) ( 814 ) ( 590 ) ( 1,404 ) ( 8,417 ) ( 2,239 ) ( 10,656 ) Noncash write-offs ( 521 ) ( 256 ) ( 777 ) — ( 2,195 ) ( 2,195 ) ( 521 ) ( 2,451 ) ( 2,972 ) Reserve balance at December 31, 2020 840 5,740 6,580 — 161 161 840 5,901 6,741 Amounts paid ( 350 ) ( 3,930 ) ( 4,280 ) — ( 27 ) ( 27 ) ( 350 ) ( 3,957 ) ( 4,307 ) Reserve adjustments (1) ( 94 ) ( 887 ) ( 981 ) — ( 20 ) ( 20 ) ( 94 ) ( 907 ) ( 1,001 ) Reserve balance at December 31, 2021 $ 396 $ 923 $ 1,319 $ — $ 114 $ 114 $ 396 $ 1,037 $ 1,433 (1) Amounts are primarily adjustments based on final facility lease payments for certain closed theatres as compared with original estimates recorded.

LEASE ACCOUNTING (Tables)

LEASE ACCOUNTING (Tables)	12 Months Ended
	Dec. 31, 2021
Leases [Abstract]
Schedule of Operating and Finance Right-of-Use Assets and Lease Liabilities	The following table represents the operating and finance right-of-use assets and lease liabilities as of the periods indicated. As of As of Leases Classification December 31, 2020 December 31, 2021 Assets (1) Operating lease assets Operating lease assets $ 1,278,191 $ 1,230,790 Finance lease assets Theatre properties and equipment, net of accumulated depreciation (2) 99,195 80,513 Total lease assets $ 1,377,386 $ 1,311,303 Liabilities (1) Current Operating Current portion of operating lease obligations $ 208,593 $ 217,092 Finance Current portion of finance lease obligations 16,407 14,605 Noncurrent Operating Operating lease obligations, less current portion 1,138,142 1,078,260 Finance Finance lease obligations, less current portion 124,609 102,571 Total lease liabilities $ 1,487,751 $ 1,412,528 (1) The operating lease right-of-use assets and liabilities recorded on the Company’s consolidated balance sheets generally do not include renewal options that have not yet been exercised. The Company does not consider a lease renewal exercise as reasonably certain until immediately before the necessary notification is provided to the landlord after consideration of market conditions and performance of the theatre. (2) Finance lease assets are net of accumulated amortization of $ 47,961 and $ 57,778 as of December 31, 2020 and 2021, respectively.
Schedule of Aggregate Lease Costs by Lease Classification	The following table represents the Company’s aggregate lease costs, by lease classification, for the periods indicated. Year Ended Year Ended Year Ended Lease Cost Classification December 31, 2019 December 31, 2020 December 31, 2021 Operating lease costs Equipment (1) Utilities and other $ 9,172 $ 3,324 $ 2,342 Real Estate (2)(3) Facility lease expense 346,222 275,056 280,968 Total operating lease costs $ 355,394 $ 278,380 $ 283,310 Finance lease costs Depreciation of leased assets Depreciation and amortization $ 14,734 $ 14,662 $ 12,634 Interest on lease liabilities Interest expense 7,786 7,014 5,916 Total finance lease costs $ 22,520 $ 21,676 $ 18,550 (1) Includes approximately $ 4,700 $ ( 465 ) and $ 1,842 of short-term lease payments for the years ended December 31, 2019,. 2020 and 2021, respectively. The amount for the year ended December 31, 2020 was impacted by i) a decrease in short term lease payments while theatres were closed and ii) rent abatements on leases that were not recalculated in accordance with the FASB guidance discussed above, which resulted in variable rent credits in the amount of the rent abatements. (2) Includes approximately $ 68,799 , $ 7,058 and $ 11,791 of variable lease payments based on a change in index, such as CPI or inflation, variable payments based on revenues or attendance and variable common area maintenance costs for the years ended December 31, 2019, 2020 and 2021, respectively. The amount for the year ended December 31, 2020 was impacted by rent abatements on leases that were not recalculated in accordance with the FASB guidance discussed above, which resulted in variable rent credits in the amount of the rent abatements. (3) Approximately $ 1,614 , $ 1,445 and $ 1,304 of lease payments are included in general and administrative expenses primarily related to office leases for the years ended December 31, 2019, 2020 and 2021, respectively.
Schedule of Maturity of Lease Liabilities by Lease Classification	The following table represents the maturity of lease liabilities, by lease classification, as of December 31, 2021. Operating Finance Years Ending Leases Leases Total 2022 (1) $ 274,005 $ 19,820 $ 293,825 2023 252,772 19,131 271,903 2024 220,455 18,050 238,505 2025 193,375 16,453 209,828 2026 156,573 11,984 168,557 After 2026 447,815 58,694 506,509 Total lease payments $ 1,544,995 $ 144,132 $ 1,689,127 Less: Interest 249,643 26,956 276,599 Present value of lease liabilities $ 1,295,352 $ 117,176 $ 1,412,528 (1) Amounts do not include rent payments deferred under amendments as discussed at Lease Deferrals and Abatements above.
Schedule of Weighted-Average Remaining Lease Term and Discount Rate	The following table represents the weighted-average remaining lease term and discount rate, disaggregated by lease classification, as of December 31, 2021. As of Lease Term and Discount Rate December 31, 2021 Weighted-average remaining lease term (years) (1) Operating leases - equipment 2.9 Operating leases - real estate 7.3 Finance leases - equipment 3.4 Finance leases - real estate 8.9 Weighted-average discount rate (2) Operating leases - equipment 3.8 % Operating leases - real estate 4.9 % Finance leases - equipment 4.7 % Finance leases - real estate 4.9 % (1) The lease assets and liabilities recorded on the Company’s consolidated balance sheets generally do not include renewal options that have not yet been executed. The Company does not consider a lease renewal exercise as reasonably certain until immediately before the necessary notification is provided to the landlord after consideration of market conditions and performance of the theatre. (2) The discount rate for each lease represents the incremental borrowing rate at which the Company would borrow, on a collateralized basis, over a similar term and at an amount equal to the lease payments in a similar economic environment.
Schedule of Minimum Cash Lease Payments	The following table represents the minimum cash lease payments included in the measurement of lease liabilities and the non-cash addition of right-of-use assets for the periods presented. Year Ended Year Ended Year Ended Other Information December 31, 2019 December 31, 2020 December 31, 2021 Cash paid for amounts included in the measurement of lease liabilities Cash outflows for operating leases $ 281,895 $ 271,787 $ 269,677 Cash outflows for finance leases - operating activities $ 7,576 $ 6,985 $ 5,910 Cash outflows for finance leases - financing activities $ 14,600 $ 15,432 $ 14,689 Non-cash amount of leased assets obtained in exchange for: Operating lease liabilities $ 114,113 $ 132,717 $ 180,055 Finance lease liabilities $ 21,535 $ — $ 725

REVENUE RECOGNITION (Tables)

REVENUE RECOGNITION (Tables)	12 Months Ended
	Dec. 31, 2021
Revenue From Contract With Customer [Abstract]
Summary of Revenues Disaggregated Based on Type of Good Or Service By Reportable Operating Segment and On Timing of Revenue Recognition	The following tables present revenues for the periods indicated, disaggregated based on major type of good or service and by reportable operating segment. Year Ended December 31, 2021 U.S. International Operating Operating Major Goods/Services Segment (1) Segment Consolidated Admissions revenues $ 671,750 $ 108,290 $ 780,040 Concession revenues 482,750 78,902 561,652 Screen advertising, screen rental and promotional revenues 66,192 17,892 84,084 Other revenues 72,930 11,758 84,688 Total revenues $ 1,293,622 $ 216,842 $ 1,510,464 Year Ended December 31, 2020 U.S. International Operating Operating Major Goods/Services Segment (1) Segment Consolidated Admissions revenues $ 291,636 $ 64,872 $ 356,508 Concession revenues 189,561 41,485 231,046 Screen advertising, screen rental and promotional revenues 46,199 16,332 62,531 Other revenues 29,513 6,712 36,225 Total revenues $ 556,909 $ 129,401 $ 686,310 Year Ended December 31, 2019 U.S. International Operating Operating Major Goods/Services Segment (1) Segment Consolidated Admissions revenues $ 1,431,790 $ 373,531 $ 1,805,321 Concession revenues 936,241 224,842 1,161,083 Screen advertising, screen rental and promotional revenues 128,839 35,888 164,727 Other revenues 84,033 67,935 151,968 Total revenues $ 2,580,903 $ 702,196 $ 3,283,099 (1) U.S. segment revenues exclude intercompany transactions with the international operating segment. See Note 19 for additional information on intercompany eliminations. The following tables present revenues for the periods indicated, disaggregated based on timing of revenue recognition (as discussed above). Year Ended December 31, 2021 U.S. International Operating Operating Segment (1) Segment Consolidated Goods and services transferred at a point in time $ 1,201,206 $ 193,658 $ 1,394,864 Goods and services transferred over time 92,416 23,184 115,600 Total $ 1,293,622 $ 216,842 $ 1,510,464 Year Ended December 31, 2020 U.S. International Operating Operating Segment (1) Segment Consolidated Goods and services transferred at a point in time $ 497,338 $ 109,997 $ 607,335 Goods and services transferred over time 59,571 19,404 78,975 Total $ 556,909 $ 129,401 $ 686,310 Year Ended December 31, 2019 U.S. International Operating Operating Segment (1) Segment Consolidated Goods and services transferred at a point in time $ 2,488,716 $ 621,785 $ 3,110,501 Goods and services transferred over time 92,187 80,411 172,598 Total $ 2,580,903 $ 702,196 $ 3,283,099 (1) U.S. segment revenues exclude intercompany transactions with the international operating segment. See Note 19 for additional information on intercompany eliminations.
Changes in Deferred Revenues	The following table presents changes in the Company’s deferred revenue for the years ended December 31, 2020 and 2021: Deferred Revenue NCM Screen (1) Other Deferred (2) Balance at January 1, 2020 $ 348,354 $ 138,426 Amounts recognized as accounts receivable — 2,915 Cash received from customers in advance — 56,772 Common units received from NCM (see Note 8) 3,620 — Interest accrued related to significant financing component 23,595 — Revenue recognized during period ( 31,314 ) ( 57,625 ) Foreign currency translation adjustments — ( 1,658 ) Balance at December 31, 2020 344,255 138,830 Amounts recognized as accounts receivable — 2,170 Cash received from customers in advance — 132,179 Common units received from NCM (see Note 8) 10,237 — Interest accrued related to significant financing component 23,612 — Revenue recognized during period ( 32,078 ) ( 111,228 ) Foreign currency translation adjustments — ( 1,693 ) Balance at December 31, 2021 $ 346,026 $ 160,258 (1) See Significant Financing Component in Note 6 for discussion of NCM screen advertising advances and maturity of balances as of December 31, 2021. (2) Includes liabilities associated with outstanding gift cards and discount ticket vouchers, points or rebates outstanding under the Company’s loyalty and membership programs and revenues not yet recognized for screen advertising and other promotional activities. Amount is classified as accounts payable and accrued expenses or other long-term liabilities on the consolidated balance sheets.
Aggregate Amount of Transaction Price Allocated To Performance Obligation That Are Unsatisfied And Expected To Be Recognized	The table below summarizes the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied for other deferred revenue in the table above as of December 31, 2021 and when the Company expects to recognize this revenue. Year Ended December 31, Remaining Performance Obligations 2022 2023 Thereafter Total Other deferred revenue $ 138,945 21,313 — $ 160,258

INVESTMENT IN NATIONAL CINEME_2

INVESTMENT IN NATIONAL CINEMEDIA LLC (Tables)	12 Months Ended
	Dec. 31, 2021
Aggregate Amount of Transaction Price Allocated To Performance Obligation That Are Unsatisfied And Expected To Be Recognized	The table below summarizes the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied for other deferred revenue in the table above as of December 31, 2021 and when the Company expects to recognize this revenue. Year Ended December 31, Remaining Performance Obligations 2022 2023 Thereafter Total Other deferred revenue $ 138,945 21,313 — $ 160,258
Summary Financial Information	The tables below present summary financial information for NCM for its fiscal periods indicated: Year Ended Year Ended Year Ended December 26, 2019 December 31, 2020 December 30, 2021 Revenues $ 444,800 $ 89,887 $ 114,639 Operating income (loss) $ 155,700 $ ( 59,671 ) $ ( 68,576 ) Net income (loss) $ 98,800 $ ( 115,753 ) $ ( 134,562 ) As of As of December 31, 2020 December 30, 2021 Current assets $ 142,566 $ 114,620 Noncurrent assets $ 685,643 $ 658,438 Current liabilities $ 46,872 $ 66,806 Noncurrent liabilities $ 1,072,207 $ 1,114,712 Members' deficit $ ( 290,870 ) $ ( 408,460 )
NCM
Summary of Activity With Equity Investee Included in the Company's Condensed Consolidated Financial Statements	Below is a summary of activity with NCM included in the Company’s consolidated financial statements for the periods indicated. See Note 5 for discussion of related revenue recognition. Investment in NCM NCM Screen Advertising Advances Distributions from NCM (3) Equity Other Revenue Interest Expense Cash Received Balance as of January 1, 2019 $ 275,592 $ ( 350,242 ) Receipt of common units due to annual common unit adjustment 1,552 ( 1,552 ) — — — — — Revenues earned under ESA (1) — — — — ( 13,782 ) — 13,782 Interest accrued related to significant financing component — ( 28,624 ) — — — 28,624 — Receipt of excess cash distributions ( 23,452 ) — ( 11,631 ) — — — 35,083 Receipt under tax receivable agreement ( 2,492 ) — ( 1,242 ) — — — 3,734 Equity in earnings 14,592 — — ( 14,592 ) — — — Amortization of screen advertising advances — 32,064 — — ( 32,064 ) — — Balance as of and for the year ended December 31, 2019 $ 265,792 $ ( 348,354 ) $ ( 12,873 ) $ ( 14,592 ) $ ( 45,846 ) $ 28,624.00 $ 52,599 Receipt of common units due to annual common unit adjustment 3,620 ( 3,620 ) — — — — — Revenues earned under ESA (1) — — — — ( 4,689 ) — 4,689 Interest accrued related to significant financing component — ( 23,595 ) — — — 23,595 — Receipt of excess cash distributions ( 12,022 ) — ( 5,914 ) — — — 17,936 Receipt under tax receivable agreement ( 2,146 ) — ( 1,061 ) — — — 3,207 Equity in loss ( 10,627 ) — — 10,627 — — — Impairment of investment in NCM (2) ( 92,655 ) — — — — — — Amortization of screen advertising advances — 31,314 — — ( 31,314 ) — — Balance as of and for the year ended December 31, 2020 $ 151,962 $ ( 344,255 ) $ ( 6,975 ) $ 10,627 $ ( 36,003 ) $ 23,595 $ 25,832 Receipt of common units due to annual common unit adjustment 10,237 ( 10,237 ) — — — — — Revenues earned under ESA (1) — — — — ( 12,001 ) — 12,001 Interest accrued related to significant financing component — ( 23,612 ) — — — 23,612 — Receipt under tax receivable agreement ( 156 ) — ( 77 ) — — — 233 Equity in loss ( 26,599 ) — — 26,599 — — — Amortization of screen advertising advances — 32,078 — — ( 32,078 ) — — Balance as of and for the year ended December 31, 2021 $ 135,444 $ ( 346,026 ) $ ( 77 ) $ 26,599 $ ( 44,079 ) $ 23,612 $ 12,234 (1) Amounts include the per patron and per digital screen theatre access fees due to the Company, net of amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire. The amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire were approximately $ 11,478 , $ 2,605 and $ 4,952 for the years ended December 31, 2019, 2020 and 2021, respectively. Amounts unpaid to the Company and recorded in accounts receivable on the consolidated balance sheets were $ 636 and $ 4,498 as of the years ended December 31, 2020 and 2021, respectively. (2) Recorded in impairment of long-lived and other assets on the consolidated income statement for the year ended December 31, 2020. See further discussion at Fair Value of Investment in NCM below. (3) (3) Excess cash distributions from NCM decreased beginning in the second quarter of 2020 primarily as a result of the impact of the COVID-19 discussed at Note 3. Excess cash distributions will be restricted through December 2023 in accordance with the credit agreement amendment NCM recently entered into with its lenders.
Summary of Common Units Received Under Common Unit Adjustment Agreement	Below is a summary of common units received by the Company under the Common Unit Adjustment (“CUA”) Agreement during the years ended December 31, 2019, 2020 and 2021: Event Date Common Units Received Number of Common Units Received Fair Value of Common Units Received 2019 annual common unit adjustment 3/31/2019 219,056 $ 1,552 2020 annual common unit adjustment 3/31/2020 1,112,368 $ 3,620 2021 annual common unit adjustment 4/14/2021 2,311,482 $ 10,237
NCM Screen Advertising Advances
Aggregate Amount of Transaction Price Allocated To Performance Obligation That Are Unsatisfied And Expected To Be Recognized	The recognition of revenue related to the deferred revenue or NCM screen advertising advances will continue to be recorded on a straight-line basis over the new term of the amended ESA through February 2041. Year Ended December 31, Remaining Maturity 2022 2023 2024 2025 2026 Thereafter Total NCM screen advertising advances (1) $ 9,119 9,749 10,424 11,147 11,922 293,665 $ 346,026 Amounts are net of the estimated interest to be accrued for the periods presented.

OTHER INVESTMENTS (Tables)

OTHER INVESTMENTS (Tables)	12 Months Ended
	Dec. 31, 2021
Summary of Activity for Each of Company's Other Investments	Below is a summary of activity for each of the Company’s other investments for the periods indicated: DCIP AC JV, DCDC FE Concepts Other Total Balance at January 1, 2019 $ 125,252 $ 5,266 $ 2,255 $ 19,918 $ 4,075 $ 156,766 Equity in income (loss) 23,281 3,276 1,120 ( 399 ) — 27,278 Equity in comprehensive loss ( 141 ) — — — — ( 141 ) Cash distributions received ( 23,696 ) ( 3,520 ) ( 206 ) — — ( 27,422 ) Other (1) — — — — ( 1,196 ) ( 1,196 ) Balance at December 31, 2019 $ 124,696 $ 5,022 $ 3,169 $ 19,519 $ 2,879 $ 155,285 Equity in loss ( 24,559 ) ( 1,277 ) ( 1,036 ) ( 1,246 ) — ( 28,118 ) Cash contributions 50 — — — — 50 Cash distributions received ( 10,383 ) — ( 878 ) — — ( 11,261 ) Non-cash distribution received (2) ( 89,804 ) — — — — ( 89,804 ) Other (3) — — — — ( 2,426 ) ( 2,426 ) Balance at December 31, 2020 $ — $ 3,745 $ 1,255 $ 18,273 $ 453 $ 23,726 Equity in income (loss) — ( 34 ) 583 1,005 — 1,554 Other (1) — — — — ( 75 ) ( 75 ) Balance at December 31, 2021 $ — $ 3,711 $ 1,838 $ 19,278 $ 378 $ 25,205 (1) Consists primarily of mark-to-market adjustment on an investment in marketable securities. (2) Consists of projectors distributed to the Company from DCIP as discussed below. (3) Consists primarily of the impairment of a cost method investment in the year ended December 31, 2020 (see Note 9 for discussion of impairments recorded) and mark-to-market adjustment on an investment in marketable securities.
Summary Financial Information	The tables below present summary financial information for NCM for its fiscal periods indicated: Year Ended Year Ended Year Ended December 26, 2019 December 31, 2020 December 30, 2021 Revenues $ 444,800 $ 89,887 $ 114,639 Operating income (loss) $ 155,700 $ ( 59,671 ) $ ( 68,576 ) Net income (loss) $ 98,800 $ ( 115,753 ) $ ( 134,562 ) As of As of December 31, 2020 December 30, 2021 Current assets $ 142,566 $ 114,620 Noncurrent assets $ 685,643 $ 658,438 Current liabilities $ 46,872 $ 66,806 Noncurrent liabilities $ 1,072,207 $ 1,114,712 Members' deficit $ ( 290,870 ) $ ( 408,460 )
Digital Cinema Implementation Partners
Summary Financial Information	Below is summary financial information for DCIP as of and for the periods indicated: Year ended December 31, 2019 2020 2021 Revenues $ 171,531 $ 30,561 $ 54,383 Operating income (loss) $ 99,812 $ ( 105,691 ) $ 43,062 Net income (loss) $ 95,820 $ ( 114,243 ) $ 45,323 As of December 31, 2020 December 31, 2021 Current assets $ 36,372 $ 22,947 Noncurrent assets $ 205 $ — Current liabilities $ 39,844 $ 11,631 Noncurrent liabilities $ 687 $ — Members' equity (deficit) $ ( 3,954 ) $ 11,316
Transactions with DCIP	Year Ended December 31, 2019 2020 2021 Equipment lease payments (1)(2) $ 4,399 $ 1,729 $ — Warranty reimbursements from DCIP (2) $ ( 11,800 ) $ ( 6,997 ) $ ( 798 ) Management services fees (2) $ 596 $ 208 $ 49 Cash distributions from DCIP (3) $ 23,696 $ 10,383 $ 13,139 Non-cash distributions from DCIP (4) $ — $ 12,915 $ — (1) Excludes lease termination payments of $ 695 and $ 3,895 made during the years ended December 31, 2020 and 2021, respectively. See discussion of MELA termination at Distribution of Digital Projectors above. (2) Amounts reflected in utilities and other costs on the consolidated statements of income (loss). (3) Recorded as a reduction in the Company's investment in DCIP for the years ended December 31, 2019 and 2020. Recorded in cash distributions from DCIP on the consolidated statements of income (loss) for the year ended December 31, 2021. See discussion at Distribution of Projectors from DCIP above. (4) Recorded as non-cash distributions from DCIP on the consolidated statements of income (loss). See discussion at Distribution of Projectors from DCIP above.

GOODWILL AND INTANGIBLE ASSET_2

GOODWILL AND INTANGIBLE ASSETS, NET (Tables)	12 Months Ended
	Dec. 31, 2021
Goodwill And Intangible Assets Disclosure [Abstract]
Summary of Goodwill	The Company’s goodwill was as follows: U.S. International Total Balance at December 31, 2019 (1) $ 1,182,853 $ 100,518 $ 1,283,371 Impairment (2) — ( 16,128 ) ( 16,128 ) Foreign currency translation adjustments — ( 13,403 ) ( 13,403 ) Balance at December 31, 2020 (3) $ 1,182,853 $ 70,987 $ 1,253,840 Foreign currency translation adjustments — ( 5,049 ) ( 5,049 ) Balance at December 31, 2021 (3) $ 1,182,853 $ 65,938 $ 1,248,791 (1) Balances are presented net of historical accumulated impairment losses of $ 214,031 for the U.S. operating segment and $ 27,622 for the international operating segment. (2) See Note 11 for discussion of impairment evaluations performed during the year ended December 31, 2020. (3) Balances are presented net of historical accumulated impairment losses of $ 214,031 for the U.S. operating segment and $ 43,750 for the international operating segment.
Intangible Assets	ntangible assets activity and balances consisted of the following for the periods indicated: Balance at January 1, 2020 Amortization Other (1) Balance at December 31, 2020 Intangible assets with finite lives: Gross carrying amount $ 84,953 $ — $ ( 2,521 ) $ 82,432 Accumulated amortization ( 63,870 ) ( 4,746 ) 200 ( 68,416 ) Total intangible assets with finite lives, net $ 21,083 $ ( 4,746 ) $ ( 2,321 ) $ 14,016 Intangible assets with indefinite lives: Tradename and other 300,686 — ( 507 ) 300,179 Total intangible assets, net $ 321,769 $ ( 4,746 ) $ ( 2,828 ) $ 314,195 Balance at January 1, 2021 Additions (2) Amortization Other (3) Balance at December 31, 2021 Intangible assets with finite lives: Gross carrying amount $ 82,432 $ — $ — $ ( 665 ) $ 81,767 Accumulated amortization ( 68,416 ) — ( 2,639 ) — ( 71,055 ) Total net intangible assets with finite lives $ 14,016 $ — $ ( 2,639 ) $ ( 665 ) $ 10,712 Intangible assets with indefinite lives: Tradename and other 300,179 146 — ( 194 ) 300,131 Total intangible assets, net $ 314,195 $ 146 $ ( 2,639 ) $ ( 859 ) $ 310,843 (1) Includes the write-off of fully amortized intangible assets, foreign currency translation adjustments and impairment recorded related to a previously acquired theatre leasehold interest in Brazil. See Note 11 for discussion of impairment evaluations performed during the year ended December 31, 2020. (2) Amount represents licenses acquired to sell alcohol beverage for certain theatres. (3) Includes foreign currency translation adjustments and impairment recorded related to a previously acquired theatre leasehold interest in Brazil. See Note 11 for discussion of impairment evaluations performed during the year ended December 31, 2021.
Estimated Aggregate Future Amortization Expense for Intangible Assets	Estimated aggregate future amortization expense for intangible assets is as follows: Year ended December 31, 2022 $ 2,468 Year ended December 31, 2023 2,416 Year ended December 31, 2024 2,416 Year ended December 31, 2025 1,898 Year ended December 31, 2026 1,514 Total $ 10,712

IMPAIRMENT OF LONG-LIVED AND _2

IMPAIRMENT OF LONG-LIVED AND OTHER ASSETS (Tables)	12 Months Ended
	Dec. 31, 2021
Impairment Or Disposal Of Tangible Assets Disclosure [Abstract]
Summary Of Evaluations Performed By Asset Classification	The following table is a summary of the evaluations performed for each quarter by asset classification. Asset Impairment Valuation Valuation Category Test Approach Multiple First and second quarters Goodwill Qualitative N/A N/A Tradename intangible assets Qualitative N/A N/A Other long-lived assets Qualitative N/A N/A Third quarter Goodwill Qualitative N/A N/A Tradename intangible assets Qualitative N/A N/A Other long-lived assets Quantitative Market 3.1 to 6 times Fourth quarter Goodwill Quantitative Market 3.7 to 7 times Tradename intangible assets Quantitative Income N/A Other long-lived assets Quantitative Market 3.7 to 6 times
Long-Lived Asset Impairment Charges	The Company’s impairment charges were as follows for the periods indicated: Year Ended December 31, 2019 2020 2021 U.S. segment Theatre properties $ 36,005 $ 12,398 $ 6,371 Theatre operating lease right-of-use assets 10,457 13,216 6,804 Investment in NCM (1) — 92,655 — Cost method investment — 2,500 — U.S. total 46,462 120,769 13,175 International segment Theatre properties 8,821 9,951 4,002 Theatre operating lease right-of-use assets 1,718 5,025 3,210 Goodwill — 16,128 — Intangible assets, net — 833 458 International total 10,539 31,937 7,670 Total impairment $ 57,001 $ 152,706 $ 20,845 (1) See Note 6 for discussion of investment in NCM.

ACCRUED OTHER CURRENT LIABILI_2

ACCRUED OTHER CURRENT LIABILITIES (Tables)	12 Months Ended
	Dec. 31, 2021
Accrued Liabilities And Other Liabilities [Abstract]
Summary of Accrued Other Current Liabilities	Accrued other current liabilities consisted of the following as of the periods presented: December 31, 2020 2021 Gift card liability (1) $ 43,448 $ 54,521 Discount vouchers (SuperSavers) liability (1) 38,882 34,836 Accrued lease payable (2) 48,366 31,903 Other 70,906 103,106 Total $ 201,602 $ 224,366 (1) See discussion at Revenue Recognition Policy in Note 5. See discussion at Lease Deferrals and Abatements in Note 4.

LONG-TERM DEBT (Tables)

LONG-TERM DEBT (Tables)	12 Months Ended
	Dec. 31, 2021
Components of Long-Term Debt	Long-term debt consisted of the following for the periods presented: December 31, 2020 2021 Cinemark USA, Inc. term loan due 2025 $ 639,731 $ 633,136 Cinemark USA, Inc. 8.750% senior secured notes due 2025 250,000 250,000 Cinemark USA, Inc. 5.875% senior notes due 2026 — 405,000 Cinemark USA, Inc. 5.250% senior notes due 2028 — 765,000 Cinemark USA, Inc. 5.125% senior notes due 2022 400,000 — Cinemark USA, Inc. 4.875% senior notes due 2023 755,000 — Other 23,169 30,200 Total long-term debt carrying value 2,067,900 2,083,336 Less: Current portion 18,056 24,254 Less: Debt debt issuance costs, net of accumulated amortization 24,888 30,390 Long-term debt, less current portion, net of unamortized debt issuance costs $ 2,024,956 $ 2,028,692
Maturities of Long-Term Debt, Excluding Unamortized Debt Issuance Costs	The Company’s long-term debt, excluding unamortized debt issuance costs, at December 31, 2021 matures as follows: 2022 $ 24,254 2023 12,285 2024 6,983 2025 863,538 2026 405,000 Thereafter 771,276 Total $ 2,083,336
Summary of Company's Interest Rate Swap Agreements Designated as Cash Flow Hedges	Below is a summary of the Company’s interest rate swap agreements designated as cash flow hedges as of December 31, 2021: Estimated Fair Value at Notional December 31, Amount Effective Date Pay Rate Receive Rate Expiration Date 2021 (1) $ 137,500 December 31, 2018 2.12 % 1-Month LIBOR December 31, 2024 $ 4,313 $ 175,000 December 31, 2018 2.12 % 1-Month LIBOR December 31, 2024 5,537 $ 137,500 December 31, 2018 2.19 % 1-Month LIBOR December 31, 2024 4,611 $ 150,000 March 31, 2020 0.57 % 1-Month LIBOR March 31, 2022 164 Total $ 14,625 (1) Approximately $ 7,884 is included in accrued other current liabilities and $ 6,741 is included in other long-term liabilities on the consolidated balance sheet as of December 31, 2021.
Subsidiaries [Member]
Summary of Loans	Below is a summary of loans outstanding as of December 31, 2021: Loan Balances as of Interest Rates as of Loan Description(s) December 31, 2021 December 31, 2021 Covenants Maturity Colombia loans $ 2,741 4.9% to 5.2% Negative and maintenance covenants June 2023 and Peru loans $ 4,879 1.0% to 4.8% Negative covenants June and December 2023 Brazil loans $ 18,376 4.0% to 8.7% Negative covenants November 2022, October 2023 and January 2029 Chile loans $ 4,204 3.5% Negative and maintenance covenants November 2023 Total $ 30,200

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	12 Months Ended
	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Summary of Liabilities Measured at Fair Value on a Recurring Basis	Below is a summary of liabilities measured at fair value on a recurring basis by the Company under FASB ASC Topic 820 as of the periods presented: As of Carrying Fair Value Description December 31, Value Level 1 Level 2 Level 3 Interest rate swap liabilities 2020 $ 33,847 $ — $ 33,847 $ — Interest rate swap liabilities 2021 $ 14,625 $ — $ 14,625 $ —

FOREIGN CURRENCY TRANSLATION (T

FOREIGN CURRENCY TRANSLATION (Tables)	12 Months Ended
	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Summary of Impact of Translating Financial Statements of Company's International Subsidiaries	Below is a summary of the impact of translating the financial statements of the Company’s international subsidiaries, whose functional currency is other than the US dollar, for the periods presented. Other Comprehensive Income (Loss) Exchange Rate as of December 31, Year Ended December 31, Country 2019 2020 2021 2019 2020 2021 Brazil 4.02 5.20 5.57 $ ( 8,140 ) $ ( 42,698 ) $ ( 4,696 ) Colombia 3,277.14 3,432.50 3,981.16 ( 362 ) ( 2,183 ) ( 140 ) Chile 736.86 714.14 852.02 ( 5,158 ) 1,228 ( 10,890 ) Peru 3.37 3.65 4.02 257 ( 3,403 ) ( 2,785 ) All other 650 ( 536 ) ( 326 ) $ ( 12,753 ) $ ( 47,592 ) $ ( 18,837 )

NONCONTROLLING INTERESTS IN S_2

NONCONTROLLING INTERESTS IN SUBSIDIARIES (Tables)	12 Months Ended
	Dec. 31, 2021
Noncontrolling Interest [Abstract]
Noncontrolling Interests in Subsidiaries	Noncontrolling interests in subsidiaries of the Company were as follows as of the periods presented: December 31, 2020 2021 Cinemark Partners II — 49.2 % interest $ 7,706 $ 7,989 Laredo Theatres – 25 % interest 1,681 2,018 Greeley Ltd. — 49 % interest 1,101 1,048 Other 508 509 Total $ 10,996 $ 11,564

CAPITAL STOCK (Tables)

CAPITAL STOCK (Tables)	12 Months Ended
	Dec. 31, 2021
Restricted Stock
Summary of Restricted Stock Award Activity	Below is a summary of restricted stock award activity recorded for the periods indicated. Year Ended December 31, 2019 2020 2021 Compensation expense recognized by the Company during the (1) $ 9,266 $ 14,555 $ 21,923 Additional compensation expense recognized by Cinemark $ 919 $ 918 $ 923 Fair value of restricted shares held by Company employees that $ 7,044 $ 16,493 $ 9,669 Fair value of restricted shares held by Cinemark Holdings, Inc.’s $ 980 $ 377 $ 1,329 Income tax benefit recognized upon vesting of restricted stock $ 1,271 $ 5,475 $ 769 Additional income tax benefit recognized upon vesting of $ 245 $ 145 $ 279 (1) The former CEO of the Company retired on December 31, 2021, and all of his outstanding unvested shares vested upon his retirement in accordance with his employment agreement. The Company recorded incremental compensation expense of $ 4,277 related to the accelerated vesting of these awards during the year ended December 31, 2021.
Cinemark Holdings, Inc.
Summary of Restricted Stock Activity	Below is a summary of restricted stock activity for Cinemark Holdings, Inc. for the years ended December 31, 2019, 2020 and 2021. Year Ended Year Ended Year Ended December 31, 2019 December 31, 2020 December 31, 2021 Shares of Weighted Shares of Weighted Shares of Weighted Outstanding at January 1 704,353 $ 38.68 783,823 $ 37.53 1,431,975 $ 21.11 Granted 315,899 $ 37.34 1,555,361 $ 17.68 1,241,742 $ 21.91 Vested ( 209,821 ) $ 41.10 ( 832,609 ) $ 29.30 ( 617,607 ) $ 20.92 Forfeited ( 26,608 ) $ 37.69 ( 74,600 ) $ 30.72 ( 61,714 ) $ 18.96 Outstanding at December 31 783,823 $ 37.53 1,431,975 $ 21.11 1,994,396 $ 21.73
Cinemark Holdings, Inc. | Restricted Stock Units (RSUs)
Summary of Restricted Stock Unit Award Activity	Below is a summary of activity for restricted stock unit awards for Cinemark Holdings, Inc. for the periods indicated: Year Ended December 31, 2019 2020 2021 Number of restricted stock unit awards that vested during the period 90,895 208,204 232,200 Fair value of restricted stock unit awards that vested during the period $ 3,658 $ 5,050 $ 4,095 Accumulated dividends paid upon vesting of restricted stock unit awards (1) $ 386 $ 942 $ 62 Compensation expense recognized during the period (2) $ 4,430 $ 3,931 $ 6,425 Income tax benefit related to stock unit awards $ 397 $ 788 $ 691 (1) Approximately $ 296 of dividends were payable to the former CEO on December 31, 2021 and were paid in January 2022. These dividends were included in other current liabilities on the consolidated balance sheet as of December 31, 2021. (2) The former CEO of the Company retired on December 31, 2021, and all of his outstanding unvested restricted stock units vested upon his retirement in accordance with his employment agreement. The Company recorded incremental compensation expense of $ 2,374 related to the accelerated vesting of these awards during the year ended December 31, 2021.

SUPPLEMENTAL CASH FLOW INFORM_2

SUPPLEMENTAL CASH FLOW INFORMATION (Tables)	12 Months Ended
	Dec. 31, 2021
Supplemental Cash Flow Elements [Abstract]
Supplemental Information to Consolidated Statements of Cash Flows	The following is provided as supplemental information to the consolidated statements of cash flows: Year Ended December 31, 2019 2020 2021 Cash paid for interest $ 93,907 $ 102,859 $ 87,797 Cash paid (refunds received) for income taxes, net $ 88,670 $ ( 116,916 ) $ ( 136,512 ) Cash deposited in restricted accounts (1) $ — $ 13,847 $ 11,920 Noncash operating activities: Interest expense - NCM (see Note 6) $ ( 28,624 ) $ ( 23,595 ) $ ( 23,612 ) Noncash investing activities: Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment (2) $ 22,013 $ ( 13,259 ) $ 20,100 Theatre properties acquired under finance leases $ 21,535 $ — $ 725 Theatre properties acquired as distribution from equity investee (see Note 7) $ — $ 102,719 $ — Investment in NCM – receipt of common units (see Note 6) $ 1,552 $ 3,620 $ 10,237 (1) Funds are held as collateral for letters of credit associated with certain of the Company’s international subsidiary loans. See further discussion in Note 11. (2) Additions to theatre properties and equipment included in accounts payable as of December 31, 2020 and 2021 were $ 28,250 and $ 8,150 , respectively.

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Income Before Income Taxes	The Company’s provision for federal and foreign income tax expense for continuing operations consisted of the following: Year Ended December 31, 2019 2020 2021 Income (loss) before income taxes: U.S. $ 238,108 $ ( 767,767 ) $ ( 362,537 ) Foreign 38,189 ( 143,157 ) ( 49,841 ) Total $ 276,297 $ ( 910,924 ) $ ( 412,378 )
Current and Deferred Income Taxes	Current and deferred income taxes were as follows: Year Ended December 31, 2019 2020 2021 Current: Federal $ 45,758 $ ( 264,944 ) $ 4,026 Foreign 24,022 397 794 State 12,583 289 1,008 Total current expense $ 82,363 $ ( 264,258 ) $ 5,828 Deferred: Federal $ ( 298 ) $ ( 50,924 ) $ ( 36,666 ) Foreign 5 13,266 409 State ( 1,550 ) ( 1,721 ) ( 1,851 ) Total deferred taxes $ ( 1,843 ) $ ( 39,379 ) $ ( 38,108 ) Income taxes $ 80,520 $ ( 303,637 ) $ ( 32,280 )
Reconciliation Between Income Tax Expense and Taxes Computed	A reconciliation between income tax expense and taxes computed by applying the applicable statutory federal income tax rate to income before income taxes is as follows: Year Ended December 31, 2019 2020 2021 Computed statutory tax expense $ 58,022 $ ( 191,295 ) $ ( 86,599 ) State and local income taxes, net of federal income tax impact 8,555 ( 1,153 ) ( 689 ) Changes in valuation allowance 2,532 46,731 54,306 Foreign tax rate differential 4,646 ( 6,633 ) ( 4,466 ) Foreign tax credits 4,143 — — Impacts related to COVID-19 pandemic (1) — ( 185,220 ) — Changes in uncertain tax positions 197 24,879 5,658 Other, net 2,425 9,054 ( 490 ) Income taxes $ 80,520 $ ( 303,637 ) $ ( 32,280 ) (1) The amount for the year ended December 31, 2020 includes benefits of a rate differential on earnings of $ 120,680 , tax losses with respect to investments in foreign subsidiaries and a write down of certain intercompany receivables associated with the Company’s foreign subsidiaries of $ 135,599 , offset by a tax charge for the remeasurement of deferred taxes and tax attributes of $ 49,866 and dislodged foreign tax credits not benefited of $ 21,193 .
Tax Effects of Significant Temporary Differences and Tax Loss and Tax Credit Carryforwards	The tax effects of significant temporary differences and tax loss and tax credit carryforwards comprising the net long-term deferred income tax liabilities as of the periods presented consisted of the following: December 31, 2020 2021 Deferred liabilities: Theatre properties and equipment $ 118,051 $ 100,547 Finance lease assets 24,202 19,564 Operating lease right-of-use assets 297,452 288,205 Intangible asset – other 41,297 45,587 Intangible asset – tradenames 72,268 71,877 Investment in partnerships 20,402 16,128 Total deferred liabilities 573,672 541,908 Deferred assets: Deferred revenue – NCM 83,998 84,084 Deferred revenue – Other 6,208 3,661 Prepaid rent 5,255 3,365 Gift Cards 9,265 8,354 Operating lease obligations 313,552 304,462 Finance lease obligations 31,284 25,611 Tax impact of items in accumulated other comprehensive income and additional paid-in-capital 9,916 4,391 Restricted stock 2,489 5,376 Accrued expenses 3,552 4,326 Other tax loss carryforwards 89,320 121,631 Other tax credit and attribute carryforwards 121,698 145,449 Other expenses, not currently deductible for tax purposes 10,780 14,277 Total deferred assets 687,317 724,987 Net deferred income tax (asset) liability before valuation allowance ( 113,645 ) ( 183,079 ) Valuation allowance against deferred assets – non-current 203,606 240,847 Net deferred income tax liability $ 89,961 $ 57,768 Net deferred tax (asset) liability – Foreign $ 7,280 $ 6,737 Net deferred tax liability – U.S. 82,681 51,031 Total $ 89,961 $ 57,768
Reconciliation of Total Amounts of Unrecognized Tax Benefits Excluding Interest and Penalties	The following is a reconciliation of the total amounts of unrecognized tax benefits excluding interest and penalties for the periods presented: Year Ended December 31, 2019 2020 2021 Balance at January 1, $ 10,561 $ 10,235 $ 46,528 Gross increases - tax positions in prior periods 1 32,417 5,790 Gross decreases - tax positions in prior periods — ( 88 ) ( 1,611 ) Gross increases - current period tax positions 202 4,010 3,465 Settlements ( 522 ) — ( 122 ) Foreign currency translation adjustments ( 7 ) ( 46 ) ( 11 ) Balance at December 31, $ 10,235 $ 46,528 $ 54,039

SEGMENTS (Tables)

SEGMENTS (Tables)	12 Months Ended
	Dec. 31, 2021
Segment Reporting [Abstract]
Selected Financial Information by Reportable Operating Segment	is a breakdown of select financial information by reportable operating segment for the periods presented: Year Ended December 31, 2019 2020 2021 Revenues U.S. $ 2,594,246 $ 559,184 $ 1,296,343 International 702,196 129,401 216,842 Eliminations ( 13,343 ) ( 2,275 ) ( 2,721 ) Total revenues $ 3,283,099 $ 686,310 $ 1,510,464 Adjusted EBITDA (1) U.S. $ 616,799 $ ( 225,663 ) $ 85,886 International 129,884 ( 49,899 ) ( 4,271 ) Total Adjusted EBITDA $ 746,683 $ ( 275,562 ) $ 81,615 Capital expenditures U.S. $ 230,561 $ 64,026 $ 78,305 International 73,066 19,904 17,237 Total capital expenditures $ 303,627 $ 83,930 $ 95,542 (1) Distributions from equity investees are reported entirely within the U.S. operating segment.
Reconciliation of Net Income (Loss) to Adjusted EBITDA	The following table sets forth a reconciliation of net income to Adjusted EBITDA for the periods presented: Year Ended December 31, 2019 2020 2021 Net income (loss) $ 195,777 $ ( 607,287 ) $ ( 380,098 ) Add (deduct): Income taxes 80,520 ( 303,637 ) ( 32,280 ) Interest expense (1) 99,941 115,651 125,569 Loss on extinguishment of debt — — 6,527 Other (income) expense (2) ( 22,422 ) 62,425 43,612 Distributions from DCIP (3) 23,696 10,383 — Other cash distributions from equity investees (4) 29,670 15,047 156 Non-cash distributions from DCIP (5) — ( 12,915 ) — Depreciation and amortization 261,155 259,776 265,363 Impairment of long-lived and other assets 57,001 152,706 20,845 (Gain) loss on disposal of assets and other 12,008 ( 8,923 ) 8,025 Restructuring charges — 20,369 ( 1,001 ) Non-cash rent expense ( 4,360 ) 2,357 ( 3,451 ) Share based awards compensation expense 13,697 18,486 28,348 Adjusted EBITDA $ 746,683 $ ( 275,562 ) $ 81,615 (1) Includes amortization of debt issuance costs. (2) Includes interest income, foreign currency exchange loss, interest expense – NCM and equity in income (loss) of affiliates and excludes distributions from NCM. (3) See discussion of cash distributions from DCIP, which were recorded as a reduction of the Company’s investment in DCIP for the years ended December 31, 2019 and 2020, in Note 7. These distributions are reported entirely within the U.S. operating segment. (4) Reflects cash distributions received from equity investees, other than those from DCIP noted above, that were recorded as a reduction of the respective investment balances (see Notes 6 and 7). These distributions are reported entirely within the U.S. operating segment. (5) Reflects non-cash distribution of projectors from DCIP (see Note 7). These distributions are reported entirely within the U.S. operating segment.
Selected Financial Information by Geographic Area	The following tables are a breakdown of select financial information by geographic area for the periods presented: Year Ended December 31, 2019 2020 2021 Revenues U.S. $ 2,594,246 $ 559,184 $ 1,296,343 Brazil 302,074 59,321 73,468 Other international countries 400,122 70,080 143,374 Eliminations ( 13,343 ) ( 2,275 ) ( 2,721 ) Total $ 3,283,099 $ 686,310 $ 1,510,464 As of December 31, 2020 2021 Theatre properties and equipment, net U.S. $ 1,392,780 $ 1,208,701 Brazil 72,080 56,750 Other international countries 150,202 117,395 Total $ 1,615,062 $ 1,382,846

VALUATION AND QUALIFYING ACCO_2

VALUATION AND QUALIFYING ACCOUNTS (Tables)	12 Months Ended
	Dec. 31, 2021
Valuation And Qualifying Accounts [Abstract]
Valuation Allowance for Deferred Tax Assets	The Company’s valuation allowance for deferred tax assets for the periods presented were as follows: Valuation Allowance for Deferred Taxes Balance at January 1, 2019 $ 54,725 Additions 7,611 Deductions ( 1,977 ) Balance at December 31, 2019 $ 60,359 Additions 144,239 Deductions ( 992 ) Balance at December 31, 2020 $ 203,606 Additions 52,516 Deductions ( 10,974 ) Currency translation ( 4,301 ) Balance at December 31, 2021 $ 240,847

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2021USD ($)Segment	Dec. 31, 2020USD ($)Segment	Dec. 31, 2019USD ($)Segment
Summary Of Significant Accounting Policies [Line Items]
Cash and cash equivalents	$ 25,767,000
General liability claim per occurrence, cap	500,000	$ 500,000	$ 500,000
Aggregate annual cap per policy year	0	0	0
Annual cap for self-insured workers compensation plan	5,000,000	5,000,000	5,000,000
Medical claim per occurrence, cap	250,000	250,000	$ 250,000
Insurance Reserves	$ 6,810,000	$ 9,034,000
Minimum Percentage for Tax position measure as largest amount of benefit	50.00%
Reportable operating segments | Segment	2	2	2
Cumulative inflation rate	100.00%
Cumulative inflation rate period	3 years
Owned Properties
Summary Of Significant Accounting Policies [Line Items]
Estimated useful life of owned properties	20 years
Minimum
Summary Of Significant Accounting Policies [Line Items]
Equity method investment, ownership percentage	20.00%
Maximum
Summary Of Significant Accounting Policies [Line Items]
Equity method investment, ownership percentage	50.00%
Cost method investment, ownership Percentage	20.00%
Pre-funding claims and covers claims per occurrence	$ 250,000	$ 250,000	$ 250,000

Estimated Useful Lives of Asset

Estimated Useful Lives of Assets (Detail)	12 Months Ended
	Dec. 31, 2021
Buildings On Owned Land
Property, Plant and Equipment [Line Items]
Estimated useful life of owned properties	40 years
Buildings On Leased Land
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	Lesser of lease term or useful life
Land and Buildings Under Finance Leases
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	Lease term	[1]
Theatre furniture and equipment | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful life of owned properties	3 years
Theatre furniture and equipment | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful life of owned properties	15 years
Leasehold Improvements
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	Lesser of lease term or useful life
[1]	Amortization of finance lease assets is included in depreciation and amortization expense on the consolidated statements of income. Accumulated amortization of finance lease assets as of December 31, 2020 and 2021 was $ 47,961 and $ 57,778 , respectively.

Estimated Useful Lives of Ass_2

Estimated Useful Lives of Assets (Parenthetical) (Detail) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment [Line Items]
Accumulated depreciation and amortization	$ 1,985,927	$ 1,788,041
Property Under Finance Lease
Property, Plant and Equipment [Line Items]
Accumulated depreciation and amortization	$ 57,778	$ 47,961

Intangible Assets and Amortizat

Intangible Assets and Amortization Method (Detail)	12 Months Ended
	Dec. 31, 2021
Finite Lived Intangible Assets [Line Items]
Goodwill	Indefinite-lived
Tradename	Indefinite-lived and definite-lived. Definite-lived tradename asset has a remaining useful life of approximately five years.
Trade Names
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	5 years
Other Intangible Assets
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Amortization Method	Straight-line method over the terms of the underlying agreement or the expected useful life of the intangible asset. The remaining useful lives of these intangible assets range from one to four years.
Other Intangible Assets | Minimum
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	1 year
Other Intangible Assets | Maximum
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	4 years

Impact of COVID-19 - Additional

Impact of COVID-19 - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Unusual Or Infrequent Item [Line Items]
Restructuring costs	$ (1,001)	$ 20,369	$ 0
Impact of COVID-19
Unusual Or Infrequent Item [Line Items]
Unpaid and accrued restructuring costs	$ 1,433

Impact of COVID-19 - Schedule o

Impact of COVID-19 - Schedule of Restructuring Plan and Obligations Remained Outstanding (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Unusual Or Infrequent Item [Line Items]
Restructuring charges recorded during the year ended December 31, 2020		$ (1,001)	$ 20,369	$ 0
2020 Restructuring Plan | U.S. Operating Segment
Unusual Or Infrequent Item [Line Items]
Restructuring charges recorded during the year ended December 31, 2020			16,609
Restructuring Reserve, Beginning Balance		6,580
Amounts paid		(4,280)	(9,252)
Noncash write-offs			(777)
Reserve adjustments	[1]	(981)
Restructuring Reserve, Ending Balance		1,319	6,580
2020 Restructuring Plan | U.S. Operating Segment | Employee-related Costs
Unusual Or Infrequent Item [Line Items]
Restructuring charges recorded during the year ended December 31, 2020			8,964
Restructuring Reserve, Beginning Balance		840
Amounts paid		(350)	(7,603)
Noncash write-offs			(521)
Reserve adjustments	[1]	(94)
Restructuring Reserve, Ending Balance		396	840
2020 Restructuring Plan | U.S. Operating Segment | Facility Closure Costs
Unusual Or Infrequent Item [Line Items]
Restructuring charges recorded during the year ended December 31, 2020			7,645
Restructuring Reserve, Beginning Balance		5,740
Amounts paid		(3,930)	(1,649)
Noncash write-offs			(256)
Reserve adjustments	[1]	(887)
Restructuring Reserve, Ending Balance		923	5,740
2020 Restructuring Plan | International Operating Segment
Unusual Or Infrequent Item [Line Items]
Restructuring charges recorded during the year ended December 31, 2020			3,760
Restructuring Reserve, Beginning Balance		161
Amounts paid		(27)	(1,404)
Noncash write-offs			(2,195)
Reserve adjustments	[1]	(20)
Restructuring Reserve, Ending Balance		114	161
2020 Restructuring Plan | International Operating Segment | Employee-related Costs
Unusual Or Infrequent Item [Line Items]
Restructuring charges recorded during the year ended December 31, 2020			814
Restructuring Reserve, Beginning Balance		0
Amounts paid		0	(814)
Noncash write-offs			0
Reserve adjustments	[1]	0
Restructuring Reserve, Ending Balance		0	0
2020 Restructuring Plan | International Operating Segment | Facility Closure Costs
Unusual Or Infrequent Item [Line Items]
Restructuring charges recorded during the year ended December 31, 2020			2,946
Restructuring Reserve, Beginning Balance		161
Amounts paid		(27)	(590)
Noncash write-offs			(2,195)
Reserve adjustments	[1]	(20)
Restructuring Reserve, Ending Balance		114	161
2020 Restructuring Plan | Consolidated
Unusual Or Infrequent Item [Line Items]
Restructuring charges recorded during the year ended December 31, 2020			20,369
Restructuring Reserve, Beginning Balance		6,741
Amounts paid		4,307	10,656
Noncash write-offs			(2,972)
Reserve adjustments	[1]	(1,001)
Restructuring Reserve, Ending Balance		1,433	6,741
2020 Restructuring Plan | Consolidated | Employee-related Costs
Unusual Or Infrequent Item [Line Items]
Restructuring charges recorded during the year ended December 31, 2020			9,778
Restructuring Reserve, Beginning Balance		840
Amounts paid		350	8,417
Noncash write-offs			(521)
Reserve adjustments	[1]	(94)
Restructuring Reserve, Ending Balance		396	840
2020 Restructuring Plan | Consolidated | Facility Closure Costs
Unusual Or Infrequent Item [Line Items]
Restructuring charges recorded during the year ended December 31, 2020			10,591
Restructuring Reserve, Beginning Balance		5,901
Amounts paid		3,957	2,239
Noncash write-offs			(2,451)
Reserve adjustments	[1]	(907)
Restructuring Reserve, Ending Balance		$ 1,037	$ 5,901
[1]	Amounts are primarily adjustments based on final facility lease payments for certain closed theatres as compared with original estimates recorded.

Lease Accounting - Additional I

Lease Accounting - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Lease [Line Items]
Total deferred payment		$ 66,178
Accrued Other Current Liabilities
Lease [Line Items]
Total deferred payment	$ 31,903	48,366
Other Long Term Liability
Lease [Line Items]
Total deferred payment		$ 17,812
Real Estate | Minimum
Lease [Line Items]
Noncancelable operating and finance leases, term	10 years
Real Estate | Maximum
Lease [Line Items]
Noncancelable operating and finance leases, term	25 years
Equipment | Minimum
Lease [Line Items]
Noncancelable operating leases, term	5 years
Equipment | Maximum
Lease [Line Items]
Noncancelable operating leases, term	6 years
Theatres
Lease [Line Items]
Noncancelable lease payments payable under operating lease, lease not yet commenced	$ 90,032

Schedule of Operating and Finan

Schedule of Operating and Finance Right-of-Use Assets and Lease Liabilities (Detail) - USD ($) $ in Thousands		Dec. 31, 2021	Dec. 31, 2020
Assets
Operating lease assets	[1]	$ 1,230,790	$ 1,278,191
Finance lease assets	[1]	$ 80,513	$ 99,195	[2]
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]		Property under capital and finance leases	Property under capital and finance leases
Total lease assets	[1]	$ 1,311,303	$ 1,377,386
Liabilities, Current
Operating	[1]	217,092	208,593
Current portion of finance lease obligations	[1]	14,605	16,407
Liabilities, Noncurrent
Operating	[1]	1,078,260	1,138,142
Finance lease obligations, less current portion	[1]	102,571	124,609
Total lease liabilities	[1]	$ 1,412,528	$ 1,487,751
[1]	The operating lease right-of-use assets and liabilities recorded on the Company’s consolidated balance sheets generally do not include renewal options that have not yet been exercised. The Company does not consider a lease renewal exercise as reasonably certain until immediately before the necessary notification is provided to the landlord after consideration of market conditions and performance of the theatre.
[2]	Finance lease assets are net of accumulated amortization of $ 47,961 and $ 57,778 as of December 31, 2020 and 2021, respectively.

Schedule of Operating and Fin_2

Schedule of Operating and Finance Right-of-Use Assets and Lease Liabilities (Parenthetical) (Detail) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Leases [Abstract]
Finance lease assets, accumulated amortization	$ 57,778	$ 47,961

Schedule of Aggregate Lease Cos

Schedule of Aggregate Lease Costs by Lease Classification (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Operating lease costs
Total operating lease costs		$ 283,310	$ 278,380	$ 355,394
Finance lease costs
Total finance lease costs		18,550	21,676	22,520
Depreciation and Amortization
Finance lease costs
Depreciation of leased assets		12,634	14,662	14,734
Interest Expense
Finance lease costs
Interest on lease liabilities		5,916	7,014	7,786
Equipment | Utilities and Other
Operating lease costs
Total operating lease costs	[1]	2,342	3,324	9,172
Real Estate | Facility Lease Expense
Operating lease costs
Total operating lease costs	[2],[3]	$ 280,968	$ 275,056	$ 346,222
[1]	Includes approximately $ 4,700 $ ( 465 ) and $ 1,842 of short-term lease payments for the years ended December 31, 2019,. 2020 and 2021, respectively.
[2]	Approximately $ 1,614 , $ 1,445 and $ 1,304 of lease payments are included in general and administrative expenses primarily related to office leases for the years ended December 31, 2019, 2020 and 2021, respectively.
[3]	Includes approximately $ 68,799 , $ 7,058 and $ 11,791 of variable lease payments based on a change in index, such as CPI or inflation, variable payments based on revenues or attendance and variable common area maintenance costs for the years ended December 31, 2019, 2020 and 2021, respectively. The amount for the year ended December 31, 2020 was impacted by rent abatements on leases that were not recalculated in accordance with the FASB guidance discussed above, which resulted in variable rent credits in the amount of the rent abatements.

Schedule of Aggregate Lease C_2

Schedule of Aggregate Lease Costs by Lease Classification (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Lease Cost [Line Items]
Lease payments	$ 269,677	$ 271,787	$ 281,895
Equipment | Utilities and Other
Lease Cost [Line Items]
Short term lease payments	1,842	465	4,700
Real Estate | Facility Lease Expense
Lease Cost [Line Items]
Variable lease payments	11,791	7,058	68,799
Lease payments	$ 1,304	$ 1,445	$ 1,614

Schedule of Maturity of Lease L

Schedule of Maturity of Lease Liabilities by Lease Classification (Detail) $ in Thousands	Dec. 31, 2021USD ($)
Leases [Abstract]
Operating Leases, 2022	$ 274,005	[1]
Operating Leases, 2023	252,772
Operating Leases, 2024	220,455
Operating Leases, 2025	193,375
Operating Leases, 2026	156,573
Operating Leases, After 2026	447,815
Operating Leases, Total lease payments	1,544,995
Operating Leases, Less: Interest	249,643
Operating Leases, Present value of lease liabilities	1,295,352
Finance Leases, 2022	19,820	[1]
Finance Leases, 2023	19,131
Finance Leases, 2024	18,050
Finance Leases, 2025	16,453
Finance Leases, 2026	11,984
Finance Leases, After 2026	58,694
Finance Leases, Total lease payments	144,132
Finance Leases, Less: Interest	26,956
Finance Leases, Present value of lease liabilities	117,176
Total Leases, 2022	293,825	[1]
Total Leases, 2023	271,903
Total Leases, 2024	238,505
Total Leases, 2025	209,828
Total Leases, 2026	168,557
Total Leases, After 2026	506,509
Total Leases, Total lease payments	1,689,127
Total Leases, Less: Interest	276,599
Total Leases, Present value of lease liabilities	$ 1,412,528
[1]	Amounts do not include rent payments deferred under amendments as discussed at Lease Deferrals and Abatements above.

Schedule of Weighted-Average Re

Schedule of Weighted-Average Remaining Lease Term and Discount Rate (Detail)	Dec. 31, 2021
Equipment
Lease [Line Items]
Weighted-average remaining lease term - Operating leases	2 years 10 months 24 days	[1]
Weighted-average remaining lease term - Finance leases	3 years 4 months 24 days	[1]
Weighted-average discount rate - Operating leases	3.80%	[2]
Weighted-average discount rate - Finance leases	4.70%	[2]
Real Estate
Lease [Line Items]
Weighted-average remaining lease term - Operating leases	7 years 3 months 18 days	[1]
Weighted-average remaining lease term - Finance leases	8 years 10 months 24 days	[1]
Weighted-average discount rate - Operating leases	4.90%	[2]
Weighted-average discount rate - Finance leases	4.90%	[2]
[1]	The lease assets and liabilities recorded on the Company’s consolidated balance sheets generally do not include renewal options that have not yet been executed. The Company does not consider a lease renewal exercise as reasonably certain until immediately before the necessary notification is provided to the landlord after consideration of market conditions and performance of the theatre.
[2]	The discount rate for each lease represents the incremental borrowing rate at which the Company would borrow, on a collateralized basis, over a similar term and at an amount equal to the lease payments in a similar economic environment.

Schedule of Minimum Cash Lease

Schedule of Minimum Cash Lease Payments (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Cash paid for amounts included in the measurement of lease liabilities
Cash outflows for operating leases	$ 269,677	$ 271,787	$ 281,895
Cash outflows for finance leases - operating activities	5,910	6,985	7,576
Cash outflows for finance leases - financing activities	14,689	15,432	14,600
Non-cash amount of leased assets obtained in exchange for:
Operating lease liabilities	180,055	$ 132,717	114,113
Finance lease liabilities	$ 725		$ 21,535

Revenue Recognition - Additiona

Revenue Recognition - Additional Information (Detail) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Revenue From Contract With Customer [Abstract]
Receivables related to contracts with customers	$ 23,453	$ 6,232
Assets related to costs to obtain or fulfill contract with customers	$ 0	$ 0

Revenue Recognition - Summary o

Revenue Recognition - Summary of Revenues Disaggregated Based on Major Type of Good or Service and by Reportable Operating Segment (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disaggregation of Revenue [Line Items]
Total revenues		$ 1,510,464	$ 686,310	$ 3,283,099
U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[1]	1,293,622	556,909	2,580,903
International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		216,842	129,401	702,196
Admissions Revenues
Disaggregation of Revenue [Line Items]
Total revenues		780,040	356,508	1,805,321
Admissions Revenues | U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[1]	671,750	291,636	1,431,790
Admissions Revenues | International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		108,290	64,872	373,531
Concession Revenues
Disaggregation of Revenue [Line Items]
Total revenues		561,652	231,046	1,161,083
Concession Revenues | U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[1]	482,750	189,561	936,241
Concession Revenues | International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		78,902	41,485	224,842
Screen Advertising, Screen Rental and Promotional Revenues
Disaggregation of Revenue [Line Items]
Total revenues		84,084	62,531	164,727
Screen Advertising, Screen Rental and Promotional Revenues | U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[1]	66,192	46,199	128,839
Screen Advertising, Screen Rental and Promotional Revenues | International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		17,892	16,332	35,888
Other Revenues
Disaggregation of Revenue [Line Items]
Total revenues		84,688	36,225	151,968
Other Revenues | U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[1]	72,930	29,513	84,033
Other Revenues | International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		$ 11,758	$ 6,712	$ 67,935
[1]	U.S. segment revenues exclude intercompany transactions with the international operating segment. See Note 19 for additional information on intercompany eliminations.

Revenue Recognition - Summary_2

Revenue Recognition - Summary of Revenues Disaggregated Based on Timing of Revenue Recognition (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disaggregation of Revenue [Line Items]
Total revenues		$ 1,510,464	$ 686,310	$ 3,283,099
U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[1]	1,293,622	556,909	2,580,903
International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		216,842	129,401	702,196
Goods and Services Transferred at a Point in Time
Disaggregation of Revenue [Line Items]
Total revenues		1,394,864	607,335	3,110,501
Goods and Services Transferred at a Point in Time | U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[2]	1,201,206	497,338	2,488,716
Goods and Services Transferred at a Point in Time | International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		193,658	109,997	621,785
Goods and Services Transferred Over Time
Disaggregation of Revenue [Line Items]
Total revenues		115,600	78,975	172,598
Goods and Services Transferred Over Time | U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[2]	92,416	59,571	92,187
Goods and Services Transferred Over Time | International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		$ 23,184	$ 19,404	$ 80,411
[1]	U.S. segment revenues exclude intercompany transactions with the international operating segment. See Note 19 for additional information on intercompany eliminations.
[2]	U.S. segment revenues exclude intercompany transactions with the international operating segment. See Note 19 for additional information on intercompany eliminations.

Revenue Recognition - Changes i

Revenue Recognition - Changes in Deferred Revenues (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
NCM Screen Advertising Advances
Change in Contract with Customer Liability [Line Items]
Beginning Balance	[1]	$ 344,255	$ 348,354
Amounts recognized as accounts receivable	[1]	0	0
Cash received from customers in advance	[1]	0	0
Common units received from NCM (see Note 8)		(10,237)	(3,620)	$ (1,552)
Interest accrued related to significant financing component	[1]	23,612	23,595
Revenue recognized during period	[1]	(32,078)	(31,314)
Foreign currency translation adjustments	[1]	0	0
Ending Balance	[1]	346,026	344,255	348,354
NCM Screen Advertising Advances | NCM
Change in Contract with Customer Liability [Line Items]
Common units received from NCM (see Note 8)	[1]	10,237	3,620
Other Deferred Revenues
Change in Contract with Customer Liability [Line Items]
Beginning Balance	[2]	138,830	138,426
Amounts recognized as accounts receivable	[2]	2,170	2,915
Cash received from customers in advance	[2]	132,179	56,772
Revenue recognized during period	[2]	(111,228)	(57,625)
Foreign currency translation adjustments	[2]	(1,693)	(1,658)
Ending Balance	[2]	$ 160,258	$ 138,830	$ 138,426
[1]	See Significant Financing Component in Note 6 for discussion of NCM screen advertising advances and maturity of balances as of December 31, 2021.
[2]	Includes liabilities associated with outstanding gift cards and discount ticket vouchers, points or rebates outstanding under the Company’s loyalty and membership programs and revenues not yet recognized for screen advertising and other promotional activities. Amount is classified as accounts payable and accrued expenses or other long-term liabilities on the consolidated balance sheets.

Revenue Recognition - Aggregate

Revenue Recognition - Aggregate Amount of Transaction Price Allocated To Performance Obligation That Are Unsatisfied And Expected To Be Recognized (Detail) - Other Deferred Revenues $ in Thousands	Dec. 31, 2021USD ($)
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	$ 160,258
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2023-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	$ 138,945
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	$ 21,313
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year

Revenue Recognition - Aggrega_2

Revenue Recognition - Aggregate Amount of Transaction Price Allocated To Performance Obligation That Are Unsatisfied And Expected To Be Recognized (Detail 1) $ in Thousands	Dec. 31, 2021USD ($)
Other Deferred Revenues [Member]
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue Remaining Performance Obligation	$ 160,258

Summary of Activity with NCM In

Summary of Activity with NCM Included in Company's Consolidated Financial Statements (Detail) - USD ($)		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020		Dec. 31, 2019	Dec. 31, 2018
Schedule Of Equity Method Investments [Line Items]
Equity		$ 554,846,000	$ 784,994,000		$ 1,474,207,000	$ 1,429,636,000
Equity in earnings		(25,045,000)	(38,745,000)		41,870,000
NCM
Schedule Of Equity Method Investments [Line Items]
Beginning Balance		151,962,000
Beginning Balance		(344,255,000)
Ending Balance		135,444,000	151,962,000
Ending Balance		(346,026,000)	(344,255,000)
Investment In NCM
Schedule Of Equity Method Investments [Line Items]
Beginning Balance		151,962,000	265,792,000		275,592,000
Receipt of common units due to annual common unit adjustment		10,237,000	3,620,000		1,552,000
Revenues earned under ESA	[1]	0	0		0
Interest accrued related to significant financing component		0	0		0
Receipt of excess cash distributions			(12,022,000)		(23,452,000)
Receipt under tax receivable agreement		(156,000)	(2,146,000)		(2,492,000)
Equity in earnings		(26,599,000)	(10,627,000)		14,592,000
Impairment of investment in NCM		0	(92,655,000)	[2]
Amortization of screen advertising advances		0	0		0
Ending Balance		135,444,000	151,962,000		265,792,000
NCM Screen Advertising Advances
Schedule Of Equity Method Investments [Line Items]
Beginning Balance		(344,255,000)	(348,354,000)		(350,242,000)
Receipt of common units due to annual common unit adjustment		(10,237,000)	(3,620,000)		(1,552,000)
Revenues earned under ESA	[1]	0	0		0
Interest accrued related to significant financing component		(23,612,000)	(23,595,000)		(28,624,000)
Receipt of excess cash distributions			0		0
Receipt under tax receivable agreement		0	0		0
Equity in earnings		0	0		0
Impairment of investment in NCM	[2]		0
Amortization of screen advertising advances		32,078,000	31,314,000		32,064,000
Ending Balance		(346,026,000)	(344,255,000)		(348,354,000)
NCM Screen Advertising Advances | NCM
Schedule Of Equity Method Investments [Line Items]
Receipt of common units due to annual common unit adjustment	[3]	10,237,000	3,620,000
Distributions from NCM
Schedule Of Equity Method Investments [Line Items]
Beginning Balance		(6,975,000)	(12,873,000)
Receipt of common units due to annual common unit adjustment		0	0		0
Revenues earned under ESA	[1]	0	0		0
Interest accrued related to significant financing component		0	0		0
Receipt of excess cash distributions			(5,914,000)		(11,631,000)
Receipt under tax receivable agreement		(77,000)	(1,061,000)		(1,242,000)
Equity in earnings		0	0		0
Impairment of investment in NCM	[2]		0
Amortization of screen advertising advances		0	0		0
Ending Balance		(77,000)	(6,975,000)		(12,873,000)
Equity in Earnings
Schedule Of Equity Method Investments [Line Items]
Beginning Balance		10,627,000	(14,592,000)
Receipt of common units due to annual common unit adjustment		0	0		0
Revenues earned under ESA	[1]	0	0		0
Interest accrued related to significant financing component		0	0		0
Receipt of excess cash distributions			0		0
Receipt under tax receivable agreement		0	0		0
Equity in earnings		26,599,000	10,627,000		(14,592,000)
Impairment of investment in NCM	[2]		0
Amortization of screen advertising advances		0	0		0
Ending Balance		26,599,000	10,627,000		(14,592,000)
Other Revenues
Schedule Of Equity Method Investments [Line Items]
Total Revenues		(36,003,000)	(45,846,000)
Receipt of common units due to annual common unit adjustment		0	0		0
Revenues earned under ESA	[1]	(12,001,000)	(4,689,000)		(13,782,000)
Interest accrued related to significant financing component		0	0		0
Receipt of excess cash distributions			0		0
Receipt under tax receivable agreement		0	0		0
Equity in earnings		0	0		0
Impairment of investment in NCM	[2]		0
Amortization of screen advertising advances		(32,078,000)	(31,314,000)		(32,064,000)
Ending Balance		(44,079,000)	(36,003,000)		(45,846,000)
Interest Expense - NCM
Schedule Of Equity Method Investments [Line Items]
Beginning Balance		23,595,000	28,624,000
Receipt of common units due to annual common unit adjustment		0	0		0
Revenues earned under ESA	[1]	0	0		0
Interest accrued related to significant financing component		23,612,000	23,595,000		28,624,000
Receipt of excess cash distributions			0		0
Receipt under tax receivable agreement		0	0		0
Equity in earnings		0	0		0
Impairment of investment in NCM	[2]		0
Amortization of screen advertising advances		0	0		0
Ending Balance		23,612,000	23,595,000		28,624,000
Cash Received
Schedule Of Equity Method Investments [Line Items]
Total Cash Received		25,832,000	52,599,000
Receipt of common units due to annual common unit adjustment		0	0		0
Revenues earned under ESA	[1]	12,001,000	4,689,000		13,782,000
Interest accrued related to significant financing component		0	0		0
Receipt of excess cash distributions			17,936,000		35,083,000
Receipt under tax receivable agreement		233,000	3,207,000		3,734,000
Equity in earnings		0	0		0
Impairment of investment in NCM	[2]		0
Amortization of screen advertising advances		0	0		0
Total Cash Received		$ 12,234,000	$ 25,832,000		$ 52,599,000
[1]	Amounts include the per patron and per digital screen theatre access fees due to the Company, net of amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire. The amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire were approximately $ 11,478 , $ 2,605 and $ 4,952 for the years ended December 31, 2019, 2020 and 2021, respectively.
[2]	Recorded in impairment of long-lived and other assets on the consolidated income statement for the year ended December 31, 2020. See further discussion at Fair Value of Investment in NCM below. (3) (3) Excess cash distributions from NCM decreased beginning in the second quarter of 2020 primarily as a result of the impact of the COVID-19 discussed at Note 3. Excess cash distributions will be restricted through December 2023 in accordance with the credit agreement amendment NCM recently entered into with its lenders.
[3]	See Significant Financing Component in Note 6 for discussion of NCM screen advertising advances and maturity of balances as of December 31, 2021.

Summary of Activity with NCM _2

Summary of Activity with NCM Included in Company's Consolidated Financial Statements (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Schedule Of Equity Method Investments [Line Items]
Company's beverage concessionaire advertising costs	$ 4,952	$ 2,605	$ 11,478
Accounts receivable	68,835	25,257
NCM
Schedule Of Equity Method Investments [Line Items]
Accounts receivable	$ 4,498	$ 636

Investment in National CineMe_3

Investment in National CineMedia LLC - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020		Dec. 31, 2019
Schedule Of Equity Method Investments [Line Items]
Number of additional common units of NCM received under common unit adjustment agreement	2,311,482
Value of common units received from NCM	$ 10,237
Interest in common units of NCM owned by Company		26.00%
Number of common units of NCM owned by Company		43,161,550
Minimum
Schedule Of Equity Method Investments [Line Items]
Percentage of incremental borrowing rates		4.40%
Maximum
Schedule Of Equity Method Investments [Line Items]
Percentage of incremental borrowing rates		8.30%
Investment In NCM
Schedule Of Equity Method Investments [Line Items]
Investment in NCM		$ 121,284
NCMI common stock price		$ 2.81
Impairment of investment in NCM		$ 0	$ (92,655)	[1]
NCM
Schedule Of Equity Method Investments [Line Items]
Remaining performance obligations		$ 174,000
Deferred revenue amortization year and month		2041-02
Value of common units received from NCM		$ 10,237	3,620		$ 1,552
Company's carrying value		$ 135,444
Deferred revenue or NCM screen advertising advances extended term		2041-02
NCM | Theatre Properties and Equipment
Schedule Of Equity Method Investments [Line Items]
Payment for installation of certain equipment used for digital advertising		$ 8	$ 9		$ 61
[1]	Recorded in impairment of long-lived and other assets on the consolidated income statement for the year ended December 31, 2020. See further discussion at Fair Value of Investment in NCM below. (3) (3) Excess cash distributions from NCM decreased beginning in the second quarter of 2020 primarily as a result of the impact of the COVID-19 discussed at Note 3. Excess cash distributions will be restricted through December 2023 in accordance with the credit agreement amendment NCM recently entered into with its lenders.

Summary of Common Units Receive

Summary of Common Units Received Under Adjustment Agreement (Detail) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Schedule Of Equity Method Investments [Line Items]
Number of Common Units Received	2,311,482
Value of common units received from NCM	$ 10,237
Annual Common Unit Adjustment
Schedule Of Equity Method Investments [Line Items]
Date Common Units Received		Apr. 14, 2021	Mar. 31, 2020	Mar. 31, 2019
Number of Common Units Received		2,311,482	1,112,368	219,056
Value of common units received from NCM		$ 10,237	$ 3,620	$ 1,552

Summary of Recognition of Reven

Summary of Recognition of Revenue Related to Deferred Revenue (Detail) - N C M Screen Advertising Advances [Member] $ in Thousands	Dec. 31, 2021USD ($)
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue remaining performance obligation, amount	$ 346,026	[1]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2023-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue remaining performance obligation, amount	$ 9,119	[1]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue remaining performance obligation, amount	$ 9,749	[1]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2025-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue remaining performance obligation, amount	$ 10,424	[1]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2026-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue remaining performance obligation, amount	$ 11,147	[1]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2027-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue remaining performance obligation, amount	$ 11,922	[1]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2028-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue remaining performance obligation, amount	$ 293,665	[1]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
[1]	Amounts are net of the estimated interest to be accrued for the periods presented.

Summary of Recognition of Rev_2

Summary of Recognition of Revenue Related to Deferred Revenue (Detail1) $ in Thousands	Dec. 31, 2021USD ($)
NCM Screen Advertising Advances
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue remaining performance obligation, amount	$ 346,026	[1]
[1]	Amounts are net of the estimated interest to be accrued for the periods presented.

Summary Financial Information f

Summary Financial Information for National CineMedia (Detail) - NCM - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 26, 2019
Schedule Of Equity Method Investments [Line Items]
Revenues	$ 114,639	$ 89,887	$ 444,800
Operating income (loss)	(68,576)	(59,671)	155,700
Net income (loss)	(134,562)	(115,753)	$ 98,800
Current assets	114,620	142,566
Noncurrent assets	658,438	685,643
Current liabilities	66,806	46,872
Noncurrent liabilities	1,114,712	1,072,207
Members' deficit	$ (408,460)	$ (290,870)

Summary of Activity for Each of

Summary of Activity for Each of Company's Other Investments (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2021		Dec. 31, 2020		Dec. 31, 2019
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance		$ 23,726
Equity in income (loss) of affiliates		(25,045)		$ (38,745)		$ 41,870
Cash distributions received		(156)		(25,430)		(53,366)
Investments, ending balance		25,205		23,726
Digital Cinema Implementation Partners
Schedule Of Equity Method Investments [Line Items]
Cash distributions received	[1]	0		(10,383)		(23,696)
Other				12,915
Other Affiliates
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance		23,726		155,285		156,766
Cash contributions				50
Equity in income (loss) of affiliates		1,554		(28,118)		27,278
Equity in comprehensive loss						(141)
Cash distributions received				(11,261)		(27,422)
Non-cash distribution received	[2]			(89,804)
Other		(75)	[3]	(2,426)	[4]	(1,196)	[3]
Investments, ending balance		25,205		23,726		155,285
Other Affiliates | Digital Cinema Implementation Partners
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance				124,696		125,252
Cash contributions				50
Equity in income (loss) of affiliates				(24,559)		23,281
Equity in comprehensive loss						(141)
Cash distributions received				(10,383)		(23,696)
Non-cash distribution received	[2]			(89,804)
Investments, ending balance						124,696
Other Affiliates | AC JV, LLC
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance		3,745		5,022		5,266
Equity in income (loss) of affiliates		(34)		(1,277)		3,276
Cash distributions received						(3,520)
Investments, ending balance		3,711		3,745		5,022
Other Affiliates | Digital Cinema Distribution Coalition
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance		1,255		3,169		2,255
Equity in income (loss) of affiliates		583		(1,036)		1,120
Cash distributions received				(878)		(206)
Investments, ending balance		1,838		1,255		3,169
Other Affiliates | FE Concepts
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance		18,273		19,519		19,918
Equity in income (loss) of affiliates		1,005		(1,246)		(399)
Investments, ending balance		19,278		18,273		19,519
Other Affiliates | Other Investments
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance		453		2,879		4,075
Other		(75)	[3]	(2,426)	[4]	(1,196)	[3]
Investments, ending balance		$ 378		$ 453		$ 2,879
[1]	See discussion of cash distributions from DCIP, which were recorded as a reduction of the Company’s investment in DCIP for the years ended December 31, 2019 and 2020, in Note 7. These distributions are reported entirely within the U.S. operating segment.
[2]	Consists of projectors distributed to the Company from DCIP as discussed below.
[3]	Consists primarily of mark-to-market adjustment on an investment in marketable securities.
[4]	Consists primarily of the impairment of a cost method investment in the year ended December 31, 2020 (see Note 9 for discussion of impairments recorded) and mark-to-market adjustment on an investment in marketable securities.

Other Investments - Additional

Other Investments - Additional Information (Detail) $ in Thousands	Apr. 30, 2018USD ($)	Dec. 31, 2021USD ($)Studio	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Maximum
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest		50.00%
Minimum
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest		20.00%
Digital Cinema Implementation Partners
Schedule Of Equity Method Investments [Line Items]
Number of major motion picture studio, long-term digital cinema deployment agreements | Studio		6
Description of digital cinema deployment agreements		The DCDAs end on the earlier to occur of (i) the tenth anniversary of the "mean deployment date" for all digital projection systems scheduled to be deployed over a period of up to five years, or (ii) the date DCIP achieves "cost recoupment", each as defined in the DCDAs.
Percentage of voting interest		33.00%
Economic interest in Digital Cinema Implementation Partners		24.30%
Operating lease right of use asset write off			$ 7,468
Operating lease right of use liabilities write off			14,102
Gain on sale of asset			6,634
Lease termination liability			4,169
Fair value of projectors			102,719
Reduction in investment in DCIP			89,804
Other			12,915
Digital Cinema Implementation Partners | Maximum
Schedule Of Equity Method Investments [Line Items]
Deployment period of digital cinema deployment agreements		5 years
AC JV, LLC | Film rentals and advertising
Schedule Of Equity Method Investments [Line Items]
Event fees		$ 6,161	3,740	$ 15,376
Digital Cinema Distribution Coalition
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest		14.60%
Payments for content delivery services		$ 574	428	896
CNMK Texas Properties, LLC
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest	50.00%
Cash contributions	$ 20,000
CNMK Texas Properties, LLC | AWSR Investments, LLC
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest	50.00%
Cash contributions	$ 20,000
Management fee revenues		$ 62	$ 34	$ 64

OTHER INVESTMENTS - Summary Fin

OTHER INVESTMENTS - Summary Financial Information for DCIP (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2021		Dec. 31, 2020		Dec. 31, 2019
Schedule Of Equity Method Investments [Line Items]
Cash distributions from DCIP		$ 156		$ 25,430		$ 53,366
Non-cash distribution from DCIP		0		12,915		0	[1]
Digital Cinema Implementation Partners [Member]
Schedule Of Equity Method Investments [Line Items]
Equipment lease payments	[2],[3]	0		1,729		4,399
Warranty reimbursements from DCIP	[2]	(798)		(6,997)		(11,800)
Management services fees	[2]	49		208		596
Cash distributions from DCIP	[4]	0		10,383		23,696
Cash distributions from DCIP	[5]	13,139		10,383		23,696
Non-cash distribution from DCIP	[6]	0	[1]	12,915	[1]	0
Other Affiliates
Schedule Of Equity Method Investments [Line Items]
Cash distributions from DCIP				11,261		27,422
Other Affiliates | Digital Cinema Implementation Partners [Member]
Schedule Of Equity Method Investments [Line Items]
Revenues		54,383		30,561		171,531
Operating income (loss)		43,062		(105,691)		99,812
Net income (loss)		45,323		(114,243)		95,820
Current assets		22,947		36,372
Noncurrent assets		0		205
Current liabilities		11,631		39,844
Noncurrent liabilities		0		687
Members' equity		$ 11,316		(3,954)
Cash distributions from DCIP				$ 10,383		$ 23,696
[1]	Reflects non-cash distribution of projectors from DCIP (see Note 7). These distributions are reported entirely within the U.S. operating segment.
[2]	Amounts reflected in utilities and other costs on the consolidated statements of income (loss).
[3]	Excludes lease termination payments of $ 695 and $ 3,895 made during the years ended December 31, 2020 and 2021, respectively. See discussion of MELA termination at Distribution of Digital Projectors above.
[4]	See discussion of cash distributions from DCIP, which were recorded as a reduction of the Company’s investment in DCIP for the years ended December 31, 2019 and 2020, in Note 7. These distributions are reported entirely within the U.S. operating segment.
[5]	Recorded as a reduction in the Company's investment in DCIP for the years ended December 31, 2019 and 2020. Recorded in cash distributions from DCIP on the consolidated statements of income (loss) for the year ended December 31, 2021. See discussion at Distribution of Projectors from DCIP above.
[6]	Recorded as non-cash distributions from DCIP on the consolidated statements of income (loss). See discussion at Distribution of Projectors from DCIP above.

OTHER INVESTMENTS - Transaction

OTHER INVESTMENTS - Transactions with DCIP (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Schedule Of Equity Method Investments [Line Items]
Lease Termination Payment	$ 3,895	$ 695

Summary of Goodwill and Intangi

Summary of Goodwill and Intangible assets, net (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2021		Dec. 31, 2020		Dec. 31, 2019
Goodwill [Line Items]
Beginning Balance		$ 1,253,840	[1]	$ 1,283,371	[2]
Impairment	[3]			(16,128)
Foreign currency translation adjustments		(5,049)		(13,403)
Ending Balance		1,248,791	[1]	1,253,840	[1]	$ 1,283,371	[2]
U.S. Operating Segment
Goodwill [Line Items]
Beginning Balance		1,182,853	[1]	1,182,853	[2]
Ending Balance		1,182,853	[1]	1,182,853	[1]	1,182,853	[2]
International Operating Segment
Goodwill [Line Items]
Beginning Balance		70,987	[1]	100,518	[2]
Impairment		0		(16,128)	[3]	0
Foreign currency translation adjustments		(5,049)		(13,403)
Ending Balance		$ 65,938	[1]	$ 70,987	[1]	$ 100,518	[2]
[1]	Balances are presented net of historical accumulated impairment losses of $ 214,031 for the U.S. operating segment and $ 43,750 for the international operating segment.
[2]	Balances are presented net of historical accumulated impairment losses of $ 214,031 for the U.S. operating segment and $ 27,622 for the international operating segment.
[3]	See Note 11 for discussion of impairment evaluations performed during the year ended December 31, 2020.

Summary of Goodwill and Intan_2

Summary of Goodwill and Intangible assets, net (Parenthetical) (Detail) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
U.S. Operating Segment
Goodwill [Line Items]
Accumulated impairment losses	$ 214,031	$ 214,031
International Operating Segment
Goodwill [Line Items]
Accumulated impairment losses	$ 43,750		$ 27,622

Goodwill and Intangible assets

Goodwill and Intangible assets - Net (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2021		Dec. 31, 2020
Intangible Assets [Line Items]
Intangible assets with finite lives, Beginning balance		$ 82,432		$ 84,953
Intangible assets with finite lives, additions	[1]	146
Other, Gross carrying amount		(665)	[2]	(2,521)	[3]
Intangible assets with finite lives, Ending balance		81,767		82,432
Intangible assets with finite lives, Accumulated amortization, Beginning balance		(68,416)		(63,870)
Accumulated amortization		(2,639)		(4,746)
Other Accumulated Amortization of Intangible Assets	[3]			200
Intangible assets with finite lives, Accumulated amortization, Ending balance		(71,055)		(68,416)
Net intangible assets with finite lives, Beginning balance		14,016		21,083
Other, Finite lived intangible assets		(665)	[2]	(2,321)	[3]
Net intangible assets with finite lives, Ending balance		10,712		14,016
Indefinite-lived Intangible Assets, Tradename and Other, Beginning Balance		300,179		300,686
Indefinite lived intangible assets, additions	[1]	146
Other, Tradename and other		(194)	[2]	(507)	[3]
Indefinite-lived Intangible Assets, Tradename, Ending Balance		300,131		300,179
Total intangible assets - net, Beginning balance		314,195		321,769
Other, Total intangible assets - net		859	[2]	(2,828)	[3]
Total intangible assets - net, Ending balance		$ 310,843		$ 314,195
[1]	Amount represents licenses acquired to sell alcohol beverage for certain theatres.
[2]	Includes foreign currency translation adjustments and impairment recorded related to a previously acquired theatre leasehold interest in Brazil. See Note 11 for discussion of impairment evaluations performed during the year ended December 31, 2021.
[3]	Includes the write-off of fully amortized intangible assets, foreign currency translation adjustments and impairment recorded related to a previously acquired theatre leasehold interest in Brazil. See Note 11 for discussion of impairment evaluations performed during the year ended December 31, 2020.

Estimated Aggregate Future Amor

Estimated Aggregate Future Amortization Expense for Intangible Assets (Detail) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Finite Lived Intangible Assets Net [Abstract]
For the year ended December 31, 2022	$ 2,468
For the year ended December 31, 2023	2,416
For the year ended December 31, 2024	2,416
For the year ended December 31, 2025	1,898
For the year ended December 31, 2026	1,514
Thereafter
Total	$ 10,712	$ 14,016	$ 21,083

Summary of Evaluations Performe

Summary of Evaluations Performed by Asset Classification (Detail) - Quantitative - Valuation, Market Approach	3 Months Ended
	Dec. 31, 2021	Sep. 30, 2021
Goodwill | Minimum
Impaired Long Lived Assets Held And Used [Line Items]
Valuation multiple	3.7
Goodwill | Maximum
Impaired Long Lived Assets Held And Used [Line Items]
Valuation multiple	7
Other Long-Lived Assets | Minimum
Impaired Long Lived Assets Held And Used [Line Items]
Valuation multiple	3.7	3.1
Other Long-Lived Assets | Maximum
Impaired Long Lived Assets Held And Used [Line Items]
Valuation multiple	6	6

Long-Lived Asset Impairment Cha

Long-Lived Asset Impairment Charges (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020		Dec. 31, 2019
Impaired Long Lived Assets Held And Used [Line Items]
Goodwill	[1]		$ 16,128
Impairment of long-lived and other assets		$ 20,845	152,706		$ 57,001
Investment In NCM
Impaired Long Lived Assets Held And Used [Line Items]
Investment in NCM		121,284
U.S. Operating Segment
Impaired Long Lived Assets Held And Used [Line Items]
Theatre properties		6,371	12,398		36,005
Theatre operating lease right-of-use assets		6,804	13,216		10,457
Cost method investment		0	2,500		0
Impairment of long-lived and other assets		13,175	120,769		46,462
U.S. Operating Segment | Investment In NCM
Impaired Long Lived Assets Held And Used [Line Items]
Investment in NCM	[2]	0	92,655		0
International Operating Segment
Impaired Long Lived Assets Held And Used [Line Items]
Theatre properties		4,002	9,951		8,821
Theatre operating lease right-of-use assets		3,210	5,025		1,718
Goodwill		0	16,128	[1]	0
Intangible assets		458	833		0
Impairment of long-lived and other assets		$ 7,670	$ 31,937		$ 10,539
[1]	See Note 11 for discussion of impairment evaluations performed during the year ended December 31, 2020.
[2]	See Note 6 for discussion of investment in NCM.

Accrued other current liabili_3

Accrued other current liabilities (Detail) - USD ($) $ in Thousands		Dec. 31, 2021	Dec. 31, 2020
Accrued Liabilities And Other Liabilities [Abstract]
Gift card liability	[1]	$ 54,521	$ 43,448
SuperSaver liability	[1]	34,836	38,882
Accrued lease payable	[2]	31,903	48,366
Other		103,106	70,906
Total		$ 224,366	$ 201,602
[1]	See discussion at Revenue Recognition Policy in Note 5.
[2]	See discussion at Lease Deferrals and Abatements in Note 4.

Long Term Debt (Detail)

Long Term Debt (Detail) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
Cinemark USA, Inc. term loan due 2025	$ 633,136	$ 639,731
Other	30,200	23,169
Total	2,083,336	2,067,900
Less current portion	24,254	18,056
Less: Debt debt issuance costs, net of accumulated amortization	30,390	24,888
Long-term debt, less current portion	2,028,692	2,024,956
8.750% senior secured notes due 2025
Debt Instrument [Line Items]
Senior notes	250,000	250,000
5.875% senior notes due 2026
Debt Instrument [Line Items]
Senior notes	405,000	0
5.250% senior notes due 2028
Debt Instrument [Line Items]
Senior notes	765,000	0
5.125% senior notes due 2022
Debt Instrument [Line Items]
Senior notes	0	400,000
4.875% senior notes due 2023
Debt Instrument [Line Items]
Senior notes	$ 0	$ 755,000

Long Term Debt - Additional Inf

Long Term Debt - Additional Information (Detail) $ in Thousands	Jun. 15, 2021USD ($)	May 21, 2021USD ($)	Mar. 16, 2021USD ($)	Apr. 20, 2020USD ($)	Mar. 31, 2020USD ($)Agreement	Dec. 31, 2021USD ($)	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Aug. 21, 2020	Apr. 17, 2020
Debt Instrument [Line Items]
Loss on extinguishment of debt						$ 6,527	$ 0	$ 0
Debt issue cost paid						30,390	24,888
Amount outstanding under the term loan						$ 633,136	639,731
Percentage voting stock of foreign subsidiaries						65.00%
Multiple consolidated interest expense under sub condition two of condition two under dividend restriction						0.0175
Interest rate										8.75%
Aggregate principal amount of add-on to Senior Notes	Prior to July 15, 2024, Cinemark USA, Inc. may redeem all or any part of the 5.25% Senior Notes at its option at 100% of the principal amount plus a make-whole premium plus accrued and unpaid interest on the 5.25% Senior Notes to the date of redemption. On or after July 15, 2024, Cinemark USA, Inc. may redeem the 5.25% Senior Notes in whole or in part at redemption prices specified in the indenture. In addition, prior to July 15, 2024, Cinemark USA, Inc. may redeem up to 40% of the aggregate principal amount of the 5.25% Senior Notes from the net proceeds of certain equity offerings at the redemption price set forth in the indenture, so long as at least 60% of the principal amount of the 5.25% Senior Notes remains outstanding immediately after each such redemption.
Debt Instrument Amount Tendered At Expiration			$ 333,990
Cash Deposit To Support Bank Letters Of Credit						$ 25,767
Aggregate principal amount of add-on to Senior Notes						30,200
Fair value of long-term debt						2,057,957	1,978,322
Designated as Hedging Instrument | Cash Flow Hedging | Interest Rate Swap Agreements
Debt Instrument [Line Items]
Loss accumulated on swaps prior to the amendments					$ 29,359
Unrealized gain (loss) on interest rate cash flow hedges, pretax, accumulated other comprehensive income (loss)						4,495	3,371
Subsidiaries [Member]
Debt Instrument [Line Items]
Aggregate principal amount of add-on to Senior Notes						35,797	$ 35,797
Subsidiaries [Member] | Colombia
Debt Instrument [Line Items]
Aggregate principal amount of add-on to Senior Notes						$ 2,741
Number of interest rate swap agreements | Agreement					3
Minimum
Debt Instrument [Line Items]
Senior secured leverage ratio required						1.00%
Maximum
Debt Instrument [Line Items]
Senior secured leverage ratio required						1.10%
Amended Senior Secured Credit Facility
Debt Instrument [Line Items]
Amended senior secured credit facility, dividend that could have distributed						$ 2,700,000
Amended Senior Secured Credit Facility | Maximum
Debt Instrument [Line Items]
Senior secured leverage ratio required						4.25%
5.25% Senior Notes
Debt Instrument [Line Items]
Aggregate principal amount of add-on to Senior Notes	$ 765,000
Debt issue cost paid	$ 10,684
Interest rate	5.25%
Debt instrument, maturity date	Jul. 15, 2028
Price to repurchase the senior subordinated notes as a percentage of the aggregate principal amount outstanding plus accrued and unpaid interest in case of change of control	101.00%
5.875% senior notes
Debt Instrument [Line Items]
Aggregate principal amount of add-on to Senior Notes			405,000
Debt issue cost paid			$ 6,021
Interest rate			5.875%
Debt instrument, maturity date			Mar. 15, 2026
Price to repurchase the senior subordinated notes as a percentage of the aggregate principal amount outstanding plus accrued and unpaid interest in case of change of control			101.00%
Senior Secured Notes Due 2025
Debt Instrument [Line Items]
Interest rate	8.75%
Convertible Senior Notes Due 2025
Debt Instrument [Line Items]
Interest rate	4.50%
8.750% senior notes
Debt Instrument [Line Items]
Aggregate principal amount of add-on to Senior Notes				$ 250,000
Interest rate				8.75%
Debt instrument, maturity date				May 1, 2025
Price to repurchase the senior subordinated notes as a percentage of the aggregate principal amount outstanding plus accrued and unpaid interest in case of change of control				101.00%
Aggregate principal amount of add-on to Senior Notes				Prior to May 1, 2022, Cinemark USA, Inc. may redeem all or any part of the 8.750% Secured Notes at its option at 100% of the principal amount plus a make-whole premium plus accrued and unpaid interest on the 8.750% Secured Notes to the date of redemption. On or after May 1, 2022, Cinemark USA, Inc. may redeem the 8.750% Secured Notes in whole or in part at redemption prices specified in the indenture. In addition, prior to May 1, 2022, Cinemark USA, Inc. may redeem up to 40% of the aggregate principal amount of the 8.750% Secured Notes from the net proceeds of certain equity offerings at the redemption price set forth in the indenture, so long as at least 60% of the principal amount of the 8.750% Secured Notes remains outstanding immediately after each such redemption.
Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed				40.00%
5.125% senior note
Debt Instrument [Line Items]
Loss on extinguishment of debt						$ (2,603)
Interest rate			5.125%
Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed			100.00%
Debt Instrument Redemption Amount			$ 66,010
Debt Instrument, Redemption Period, End Date			Apr. 15, 2021
Write off deferred debt issuance cost						1,168
Tender and legal fees						1,435
4.875% senior notes
Debt Instrument [Line Items]
Aggregate principal amount of add-on to Senior Notes	$ 755,000	$ 755,000
Loss on extinguishment of debt						(3,919)
Interest rate	4.875%	4.875%
Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed		100.00%
Debt related fees						618
Write off deferred debt issuance cost						$ 3,301
Covenant Compliance
Debt Instrument [Line Items]
Price to repurchase the senior subordinated notes as a percentage of the aggregate principal amount outstanding plus accrued and unpaid interest in case of change of control						101.00%
Senior notes indenture, amount that could have distributed						$ 3,000,000
Covenant Compliance | Minimum
Debt Instrument [Line Items]
Debt covenants, required minimum coverage ratio						1.00%
Actual coverage ratio						1.00%
Covenant Compliance | Maximum
Debt Instrument [Line Items]
Debt covenants, required minimum coverage ratio						2.00%
Actual coverage ratio						0.60%
Term Loan Credit facility | Senior Secured Credit Facility
Debt Instrument [Line Items]
Aggregate principal amount of add-on to Senior Notes						$ 700,000
Quarterly principal payments due						$ 1,649
Last quarterly payment date						Dec. 31, 2024
Final principal payment						$ 613,351
Final principal payment due date						Mar. 29, 2025
Term Loan Credit facility | Amended Senior Secured Credit Facility
Debt Instrument [Line Items]
Percentage of variable margin rate added to Eurodollar rate						1.75%
Debt instrument description of interest						a Eurodollar-based rate for a period of 1, 2, 3, 6, 9 or 12 months plus a margin of 1.75% per annum.
Amount outstanding under the term loan						$ 633,136
Average interest rate on outstanding borrowings						3.40%
Term Loan Credit facility | Amended Senior Secured Credit Facility | One Month Eurodollar Rate
Debt Instrument [Line Items]
Percentage of variable margin rate added to Eurodollar rate						0.75%
Revolving Credit Line | Senior Secured Credit Facility
Debt Instrument [Line Items]
Aggregate principal amount of add-on to Senior Notes						$ 100,000
Revolving Credit Line | Amended Senior Secured Credit Facility
Debt Instrument [Line Items]
Percentage of Variable rate added to federal funds effective rate						0.50%
Percentage of variable margin rate added to one-month Eurodollar rate						1.00%
Debt instrument description of interest						a Eurodollar-based rate for a period of 1, 2, 3, 6, 9 or 12 months plus a margin that ranges from 1.50% to 2.25% per annum.
Percentage Of Applicable Margin Under The Line of Credit						2.25%
Amount outstanding under the revolving credit line						$ 0
Revolving Credit Line | Amended Senior Secured Credit Facility | Minimum
Debt Instrument [Line Items]
Percentage of variable margin rate added to Eurodollar rate						1.50%
Revolving Credit Line | Amended Senior Secured Credit Facility | Maximum
Debt Instrument [Line Items]
Percentage of variable margin rate added to Eurodollar rate						2.25%
Revolving Credit Line | Amended Senior Secured Credit Facility | One Month Eurodollar Rate | Maximum
Debt Instrument [Line Items]
Percentage of variable margin rate added to Eurodollar rate						1.25%
Revolving Credit Line | 5.25% Senior Notes
Debt Instrument [Line Items]
Debt issue cost paid	$ 500
Interest rate	5.25%
Revolving Credit Line | 5.25% Senior Notes | Minimum
Debt Instrument [Line Items]
Line of credit, maturity date	Nov. 28, 2022
Revolving Credit Line | 5.25% Senior Notes | Maximum
Debt Instrument [Line Items]
Line of credit, maturity date	Nov. 28, 2024
Convertible Senior Notes
Debt Instrument [Line Items]
Interest rate									4.50%

Long Term Debt - Summary of Loa

Long Term Debt - Summary of Loans (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Loan Balances	$ 30,200
Subsidiaries [Member]
Loan Balances	$ 35,797	$ 35,797
Subsidiaries [Member] | Colombia
Loan Description	Colombia loans
Loan Balances	$ 2,741
Interest Rates	4.9% to 5.2%
Covenants	Negative and maintenance covenants
Maturity	June 2023 and September 2025
Subsidiaries [Member] | Peru
Loan Description	Peru loans
Loan Balances	$ 4,879
Interest Rates	1.0% to 4.8%
Covenants	Negative covenants
Maturity	June and December 2023
Subsidiaries [Member] | Brazil
Loan Description	Brazil loans
Loan Balances	$ 18,376
Interest Rates	4.0% to 8.7%
Covenants	Negative covenants
Maturity	November 2022, October 2023 and January 2029
Subsidiaries [Member] | Chile
Loan Description	Chile loans
Loan Balances	$ 4,204
Interest Rates	3.5%
Covenants	Negative and maintenance covenants
Maturity	November 2023

Maturities of Long-Term Debt, E

Maturities of Long-Term Debt, Excluding Unamortized Debt Issuance Costs (Detail) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Debt Disclosure [Abstract]
2021	$ 24,254
2022	12,285
2023	6,983
2024	863,538
2025	405,000
Thereafter	771,276
Total	$ 2,083,336	$ 2,067,900

Long Term Debt - Summary of Com

Long Term Debt - Summary of Company's Interest Rate Swap Agreements Designated as Cash Flow Hedges (Detail) - Cash Flow Hedging - Designated as Hedging Instrument $ in Thousands	12 Months Ended
	Dec. 31, 2021USD ($)
Debt Instrument [Line Items]
Estimated Fair Value	$ 14,625	[1]
Interest Rate Swap Agreement 1
Debt Instrument [Line Items]
Notional Amount	$ 137,500
Effective Date	Dec. 31, 2018
Pay Rate	2.12%
Receive Rate	1-Month LIBOR
Expiration Date	Dec. 31, 2024
Estimated Fair Value	$ 4,313	[1]
Interest Rate Swap Agreement 2
Debt Instrument [Line Items]
Notional Amount	$ 175,000
Effective Date	Dec. 31, 2018
Pay Rate	2.12%
Receive Rate	1-Month LIBOR
Expiration Date	Dec. 31, 2024
Estimated Fair Value	$ 5,537	[1]
Interest Rate Swap Agreement 3
Debt Instrument [Line Items]
Notional Amount	$ 137,500
Effective Date	Dec. 31, 2018
Pay Rate	2.19%
Receive Rate	1-Month LIBOR
Expiration Date	Dec. 31, 2024
Estimated Fair Value	$ 4,611	[1]
Interest Rate Swap Agreement 4
Debt Instrument [Line Items]
Notional Amount	$ 150,000
Effective Date	Mar. 31, 2020
Pay Rate	0.57%
Receive Rate	1-Month LIBOR
Expiration Date	Mar. 31, 2022
Estimated Fair Value	$ 164	[1]
[1]	Approximately $ 7,884 is included in accrued other current liabilities and $ 6,741 is included in other long-term liabilities on the consolidated balance sheet as of December 31, 2021.

Long Term Debt Activity - Summa

Long Term Debt Activity - Summary of Company's Interest Rate Swap Agreements Designated as Cash Flow Hedges (Parenthetical) (Detail) $ in Thousands	Dec. 31, 2021USD ($)
Accrued Other Current Liabilities
Debt Instrument [Line Items]
Estimated Fair Value	$ 7,884
Other Long-term Liabilities
Debt Instrument [Line Items]
Estimated Fair Value	$ 6,741

Summary of Liabilities Measured

Summary of Liabilities Measured at Fair Value on Recurring Basis (Detail) - Fair Value Measurements, Recurring - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Interest rate swap liabilities	$ 14,625	$ 33,847
Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Interest rate swap liabilities	$ 14,625	$ 33,847

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Fair Value Disclosures [Abstract]
Fair value of assets transfers in or out, level 1 to level 2	$ 0	$ 0	$ 0
Fair value of assets transfers in or out, level 2 to level 1	0	0	0
Fair value, asset transfers into Level 3	0	0	0
Fair value, asset transfers out of Level 3	$ 0	$ 0	$ 0

Foreign Currency Translation -

Foreign Currency Translation - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Foreign Currency Translation [Line Items]
Accumulated other comprehensive income (loss)	$ 397,051	$ 398,653
Cumulative foreign currency adjustments	$ (394,481)	(375,644)
Cumulative inflation rate	100.00%
Cumulative inflation period	3 years
Foreign currency exchange gain loss	$ (1,271)	(4,865)	$ (3,394)
Argentina
Foreign Currency Translation [Line Items]
Foreign currency exchange gain loss	$ 195	$ 1,243

Summary of Impact of Translatin

Summary of Impact of Translating Financial Statements of Company's International Subsidiaries (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2021USD ($)Rate	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Foreign Currency Translation [Line Items]
Other Comprehensive Income (Loss)	$ (18,837)	$ (47,592)	$ (12,753)
Brazil
Foreign Currency Translation [Line Items]
Exchange Rate	557.00%	5.20	4.02
Other Comprehensive Income (Loss)	$ (4,696)	$ (42,698)	$ (8,140)
Colombia
Foreign Currency Translation [Line Items]
Exchange Rate	398116.00%	3,432.50	3,277.14
Other Comprehensive Income (Loss)	$ (140)	$ (2,183)	$ (362)
Chile
Foreign Currency Translation [Line Items]
Exchange Rate	85202.00%	714.14	736.86
Other Comprehensive Income (Loss)	$ (10,890)	$ (1,228)	$ (5,158)
Peru
Foreign Currency Translation [Line Items]
Exchange Rate	402.00%	3.65	3.37
Other Comprehensive Income (Loss)	$ (2,785)	$ 3,403	$ (257)
Other foreign countries
Foreign Currency Translation [Line Items]
Other Comprehensive Income (Loss)	$ (326)	$ 536	$ (650)

Summary of Impact of Translat_2

Summary of Impact of Translating Financial Statements of Company's International Subsidiaries (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Foreign Currency Translation [Line Items]
Foreign currency exchange gain (loss)	$ (1,271)	$ (4,865)	$ (3,394)

Non-controlling Interest in Sub

Non-controlling Interest in Subsidiaries (Detail) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Noncontrolling Interest [Line Items]
Noncontrolling interests	$ 11,564	$ 10,996
Cinemark Partners II
Noncontrolling Interest [Line Items]
Noncontrolling interests	7,989	7,706
Laredo Theatre
Noncontrolling Interest [Line Items]
Noncontrolling interests	2,018	1,681
Greeley Ltd
Noncontrolling Interest [Line Items]
Noncontrolling interests	1,048	1,101
Other
Noncontrolling Interest [Line Items]
Noncontrolling interests	$ 509	$ 508

Non-controlling Interest in S_2

Non-controlling Interest in Subsidiaries (Parenthetical) (Detail)	Dec. 31, 2021
Cinemark Partners II
Noncontrolling Interest [Line Items]
Ownership share	49.20%
Laredo Theatre
Noncontrolling Interest [Line Items]
Ownership share	25.00%
Greeley Ltd
Noncontrolling Interest [Line Items]
Ownership share	49.00%

Noncontrolling Interests in S_3

Noncontrolling Interests in Subsidiaries - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Noncontrolling Interest [Abstract]
Changes in ownership interest in subsidiaries	$ 0	$ 0	$ 0

Capital Stock - Additional Info

Capital Stock - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Stockholders Equity Note [Line Items]
Preferred stock, shares	1,000,000
Preferred stock, par value	$ 1
Preferred stock, issued	0
Preferred stock, outstanding	0
Restricted Stock
Stockholders Equity Note [Line Items]
Incremental stock-based compensation expense arising from the modification	$ 4,277
Unrecognized compensation expense	23,234
Remaining Compensation Expense recognition period (in years)		2 years
Restricted Stock | Cinemark USA, Inc.
Stockholders Equity Note [Line Items]
Unrecognized compensation expense	$ 22,568
Restricted Stock | Cinemark Holdings, Inc.
Stockholders Equity Note [Line Items]
Shares of Restricted Stock, Granted	1,241,742	1,555,361	315,899
Market value of common stock on the dates of grant	$ 21.91	$ 17.68	$ 37.34
Restricted stock grants vested	617,607	832,609	209,821
Incremental stock-based compensation expense arising from the modification	$ 2,374
Unrecognized compensation expense	$ 648
Restricted Stock | Directors
Stockholders Equity Note [Line Items]
Award vesting period for restricted stock granted	1 year
Restricted Stock | Minimum
Stockholders Equity Note [Line Items]
Forfeiture rate for restricted stock awards	0.00%
Restricted Stock | Minimum | Cinemark Holdings, Inc.
Stockholders Equity Note [Line Items]
Market value of common stock on the dates of grant	$ 16.09
Restricted Stock | Minimum | Employees
Stockholders Equity Note [Line Items]
Award vesting period for restricted stock granted	1 year
Restricted Stock | Maximum
Stockholders Equity Note [Line Items]
Forfeiture rate for restricted stock awards	10.00%
Restricted Stock | Maximum | Cinemark Holdings, Inc.
Stockholders Equity Note [Line Items]
Market value of common stock on the dates of grant	$ 24.48
Restricted Stock | Maximum | Employees
Stockholders Equity Note [Line Items]
Award vesting period for restricted stock granted	4 years
Restricted Stock Units (RSUs)
Stockholders Equity Note [Line Items]
Market value of common stock on the dates of grant		$ 32.12	$ 36.77
Unrecognized compensation expense	$ 3,616
Share-based compensation arrangement by share-based payment award, description	The financial performance factors are based on an implied equity value concept that determines an internal rate of return (“IRR”) for a two year measurement period, as defined in the award agreement, based on a formula utilizing a multiple of Adjusted EBITDA subject to certain specified adjustments (as defined in the restricted stock unit award agreement)
Share-based compensation arrangement by share-based payment award, vesting condition	All payouts of restricted stock units that vest will be subject to an additional service requirement and will be paid in the form of common stock if the participant continues to provide services through the fourth anniversary of the grant date
Number of hypothetical shares of common stock at maximum IRR level	344,071
Restricted Stock Units (RSUs) | Cinemark Holdings, Inc.
Stockholders Equity Note [Line Items]
Restricted stock grants vested	232,200	208,204	90,895
Number of hypothetical shares of common stock		436,681	306,651
Restricted Stock Units (RSUs) | Minimum
Stockholders Equity Note [Line Items]
Expected forfeiture rate	0.00%
Restricted Stock Units (RSUs) | Maximum
Stockholders Equity Note [Line Items]
Expected forfeiture rate	5.00%
Class A common stock
Stockholders Equity Note [Line Items]
Common stock, shares outstanding	1,500	1,500
Class B common stock
Stockholders Equity Note [Line Items]
Common stock, shares outstanding	182,648	182,648

Summary of Restricted Stock Act

Summary of Restricted Stock Activity (Detail) - Restricted Stock - Cinemark Holdings, Inc. - $ / shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Shares of Restricted Stock
Shares of Restricted Stock, Beginning balance	1,431,975	783,823	704,353
Shares of Restricted Stock, Granted	1,241,742	1,555,361	315,899
Shares of Restricted Stock, Vested	(617,607)	(832,609)	(209,821)
Shares of Restricted Stock, Forfeited	(61,714)	(74,600)	(26,608)
Shares of Restricted Stock, Ending balance	1,994,396	1,431,975	783,823
Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value Outstanding, Beginning	$ 21.11	$ 37.53	$ 38.68
Weighted Average Grant Date Fair Value, Granted	21.91	17.68	37.34
Weighted Average Grant Date Fair Value, Vested	20.92	29.30	41.10
Weighted Average Grant Date Fair Value, Forfeited	18.96	30.72	37.69
Weighted Average Grant Date Fair Value Outstanding, Ending	$ 21.73	$ 21.11	$ 37.53

Summary of Restricted Stock Awa

Summary of Restricted Stock Award Activity (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2021		Dec. 31, 2020		Dec. 31, 2019
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense recognized during the period	[1]	$ (21,923)		$ 14,555		$ 9,266
Restricted Stock | Employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of restricted shares that vested during the period		9,669		16,493		7,044
Income tax benefit recognized upon vesting of share based awards		$ (769)		$ 5,475		$ 1,271
Restricted Stock | Cinemark Holdings, Inc.
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock grants vested		617,607		832,609		209,821
Compensation expense recognized during the period		$ 923		$ 918		$ 919
Restricted Stock | Cinemark Holdings, Inc. | Directors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of restricted shares that vested during the period		1,329		377		980
Income tax benefit recognized upon vesting of share based awards		$ 279		$ 145		$ 245
Restricted Stock Units (RSUs) | Cinemark Holdings, Inc.
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock grants vested		232,200		208,204		90,895
Fair value of restricted shares that vested during the period		$ 4,095		$ 5,050		$ 3,658
Distribution to parent and sole stockholder	[2]	62		942		386
Income tax benefit recognized upon vesting of share based awards		691		3,931	[3]	4,430	[3]
Compensation expense recognized during the period		$ 6,425	[3]	$ 788		$ 397
[1]	The former CEO of the Company retired on December 31, 2021, and all of his outstanding unvested shares vested upon his retirement in accordance with his employment agreement. The Company recorded incremental compensation expense of $ 4,277 related to the accelerated vesting of these awards during the year ended December 31, 2021.
[2]	Approximately $ 296 of dividends were payable to the former CEO on December 31, 2021 and were paid in January 2022. These dividends were included in other current liabilities on the consolidated balance sheet as of December 31, 2021.
[3]	The former CEO of the Company retired on December 31, 2021, and all of his outstanding unvested restricted stock units vested upon his retirement in accordance with his employment agreement. The Company recorded incremental compensation expense of $ 2,374 related to the accelerated vesting of these awards during the year ended December 31, 2021.

Summary of Restricted Stock A_2

Summary of Restricted Stock Award Activity (Detail) (Parenthetical) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Cinemark Holdings Inc [Member] | Chief Executive Officer [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Dividends Payable		$ 296
Restricted Stock [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Compensation expense recognized during the period	[1]	(21,923)	$ 14,555	$ 9,266
Incremental compensation expense		4,277
Restricted Stock [Member] | Cinemark Holdings Inc [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Compensation expense recognized during the period		923	$ 918	$ 919
Incremental compensation expense		$ 2,374
[1]	The former CEO of the Company retired on December 31, 2021, and all of his outstanding unvested shares vested upon his retirement in accordance with his employment agreement. The Company recorded incremental compensation expense of $ 4,277 related to the accelerated vesting of these awards during the year ended December 31, 2021.

Summary of Potential Number of

Summary of Potential Number of Units that Could Vest Under Restricted Stock Unit Awards (Parenthetical) (Detail) - $ / shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Restricted Stock Units (RSUs)
Schedule Of Restricted Stock Unit [Line Items]
Weighted Average Grant Date Fair Value, Granted	$ 32.12	$ 36.77

Supplemental Information to Con

Supplemental Information to Consolidated Statements of Cash Flows (Detail) - USD ($) $ in Thousands		Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Schedule Of Cash Flow Supplemental [Line Items]
Cash paid for interest			$ 87,797	$ 102,859	$ 93,907
Cash paid (refunds received) for income taxes, net			(136,512)	(116,916)	88,670
Cash balance classified as restricted	[1]		11,920	13,847
Noncash investing activities:
Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment	[2]		20,100	(13,259)	22,013
Theatre properties acquired under finance leases			725		21,535
Theatre properties acquired as distribution from equity investee (see Note 7)				102,719
Investment in NCM - receipt of common units (see Note 6)		$ 10,237
NCM
Noncash operating activities:
Interest expense - NCM (see Note 6)			(23,612)	(23,595)	(28,624)
Noncash investing activities:
Investment in NCM - receipt of common units (see Note 6)			$ 10,237	$ 3,620	$ 1,552
[1]	Funds are held as collateral for letters of credit associated with certain of the Company’s international subsidiary loans. See further discussion in Note 11.
[2]	Additions to theatre properties and equipment included in accounts payable as of December 31, 2020 and 2021 were $ 28,250 and $ 8,150 , respectively.

Supplemental Information to C_2

Supplemental Information to Consolidated Statements of Cash Flows (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Supplemental Cash Flow Elements [Abstract]
Additions to theatre properties and equipment included in accounts payable	$ 8,150	$ 28,250

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Taxes [Line Items]
Income tax benefits due to NOL carryback provision	$ (32,280)	$ (303,637)	$ 80,520
Accumulated undistributed earnings and profits	94,107
One-time transition tax accumulated undistributed earnings and profits	168,307
Gross unrecognized tax benefits, including interest and penalties	60,601	51,643
Unrecognized tax benefit that if recognized would impact effective tax rate	60,601	51,643
Accrued for interest and penalties	6,561	5,114
Other Noncurrent Assets
Income Taxes [Line Items]
Valuation allowance against deferred assets – non-current	$ 240,847	$ 203,606
Foreign
Income Taxes [Line Items]
Tax credit carryforwards expiring year	A majority of our foreign tax credit carryforwards expire in 2023, 2026 and 2027, with the remainder expiring in 2028.
CARES Act
Income Taxes [Line Items]
Income tax benefits due to NOL carryback provision	$ 185,220

Income Before Income Taxes (Det

Income Before Income Taxes (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Income (loss) before income taxes, U.S.	$ (362,537)	$ (767,767)	$ 238,108
Income (loss) before income taxes, Foreign	(49,841)	(143,157)	38,189
Income (loss) before income taxes	$ (412,378)	$ (910,924)	$ 276,297

Current and Deferred Income Tax

Current and Deferred Income Taxes (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Current:
Federal	$ 4,026	$ (264,944)	$ 45,758
Foreign	794	397	24,022
State	1,008	289	12,583
Total current expense	5,828	(264,258)	82,363
Deferred:
Federal	(36,666)	(50,924)	(298)
Foreign	409	13,266	5
State	(1,851)	(1,721)	(1,550)
Total deferred taxes	(38,108)	(39,379)	(1,843)
Income taxes	$ (32,280)	$ (303,637)	$ 80,520

Reconciliation Between Income T

Reconciliation Between Income Tax Expenses (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Computed statutory tax expense		$ (86,599)	$ (191,295)	$ 58,022
State and local income taxes, net of federal income tax impact		(689)	(1,153)	8,555
Changes in valuation allowance		54,306	46,731	2,532
Foreign tax rate differential		(4,466)	(6,633)	4,646
Foreign tax credits		0	0	4,143
Impacts related to COVID-19 pandemic	[1]		(185,220)	0
Changes in uncertain tax positions		5,658	24,879	197
Other, net		(490)	9,054	2,425
Income taxes		$ (32,280)	$ (303,637)	$ 80,520
[1]	The amount for the year ended December 31, 2020 includes benefits of a rate differential on earnings of $ 120,680 , tax losses with respect to investments in foreign subsidiaries and a write down of certain intercompany receivables associated with the Company’s foreign subsidiaries of $ 135,599 , offset by a tax charge for the remeasurement of deferred taxes and tax attributes of $ 49,866 and dislodged foreign tax credits not benefited of $ 21,193 .

Reconciliation Between Income_2

Reconciliation Between Income Tax Expenses (Parenthetical) (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2020USD ($)
Income Tax Disclosure [Abstract]
Benefit of rate differential on earnings	$ 120,680
Tax charge for remeasurement of deferred taxes and tax attributes	49,866
Tax losses with investment in foreign subsidiaries and write down of intercompany receivables of foreign subsidiaries	135,599
Tax credit, foreign	$ 21,193

Net Long-Term Deferred Income T

Net Long-Term Deferred Income Tax Liabilities (Detail) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Schedule Of Deferred Income Tax Assets And Liabilities [Line Items]
Theatre properties and equipment	$ 100,547	$ 118,051
Finance lease assets	19,564	24,202
Operating lease right-of-use assets	288,205	297,452
Intangible asset — other	45,587	41,297
Intangible asset — tradenames	71,877	72,268
Investment in partnerships	16,128	20,402
Total deferred liabilities	541,908	573,672
Deferred revenue - NCM	84,084	83,998
Deferred revenue - Other	3,661	6,208
Prepaid rent	3,365	5,255
Gift Cards	8,354	9,265
Operating lease obligations	304,462	313,552
Finance lease obligations	25,611	31,284
Tax impact of items in accumulated other comprehensive income and additional paid-in-capital	4,391	9,916
Restricted stock	5,376	2,489
Accrued expenses	4,326	3,552
Other tax loss carryforwards	121,631	89,320
Other tax credit and attribute carryforwards	145,449	121,698
Other expenses, not currently deductible for tax purposes	14,277	10,780
Total deferred assets	724,987	687,317
Net deferred income tax (asset) liability before valuation allowance	(183,079)	(113,645)
Net deferred income tax liability	57,768	89,961
Other Noncurrent Assets
Schedule Of Deferred Income Tax Assets And Liabilities [Line Items]
Valuation allowance against deferred assets – non-current	240,847	203,606
Foreign
Schedule Of Deferred Income Tax Assets And Liabilities [Line Items]
Net deferred income tax liability	6,737	7,280
U.S.
Schedule Of Deferred Income Tax Assets And Liabilities [Line Items]
Net deferred income tax liability	$ 51,031	$ 82,681

Reconciliation of Total Amounts

Reconciliation of Total Amounts of Unrecognized Tax Benefits Excluding Interest and Penalties (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Beginning Balance	$ 46,528	$ 10,235	$ 10,561
Gross increases - tax positions in prior periods	5,790	32,417	1
Gross decreases - tax positions in prior periods	(1,611)	(88)	0
Gross increases - current period tax positions	3,465	4,010	202
Settlements	(122)	0	(522)
Foreign currency translation adjustments	(11)	(46)	(7)
Ending Balance	$ 54,039	$ 46,528	$ 10,235

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Commitments And Contingencies Disclosure [Line Items]
Employer matching contribution payments	$ 2,123	$ 1,562
Liability recorded for employer contribution payments	$ 3,728
Messrs. Mitchell, Gamble, Fernandes and Cavalier
Commitments And Contingencies Disclosure [Line Items]
Employment agreements term extension	1 year

Selected Financial Information

Selected Financial Information by Reportable Operating Segment (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Segment Reporting Information [Line Items]
Revenues		$ 1,510,464	$ 686,310	$ 3,283,099
Adjusted EBITDA	[1]	81,615	(275,562)	746,683
Capital expenditures		95,542	83,930	303,627
U.S. Operating Segment
Segment Reporting Information [Line Items]
Revenues	[2]	1,293,622	556,909	2,580,903
International Operating Segment
Segment Reporting Information [Line Items]
Revenues		216,842	129,401	702,196
Operating Segments | U.S. Operating Segment
Segment Reporting Information [Line Items]
Revenues		1,296,343	559,184	2,594,246
Adjusted EBITDA	[1]	85,886	(225,663)	616,799
Capital expenditures		78,305	64,026	230,561
Operating Segments | International Operating Segment
Segment Reporting Information [Line Items]
Revenues		216,842	129,401	702,196
Adjusted EBITDA	[1]	(4,271)	(49,899)	129,884
Capital expenditures		17,237	19,904	73,066
Eliminations
Segment Reporting Information [Line Items]
Revenues		$ (2,721)	$ (2,275)	$ (13,343)
[1]	Distributions from equity investees are reported entirely within the U.S. operating segment.
[2]	U.S. segment revenues exclude intercompany transactions with the international operating segment. See Note 19 for additional information on intercompany eliminations.

Reconciliation of Net Income (L

Reconciliation of Net Income (Loss) to Adjusted EBITDA (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2021		Dec. 31, 2020		Dec. 31, 2019
Segment Reporting Information [Line Items]
Net income (loss)		$ (380,098)		$ (607,287)		$ 195,777
Add (deduct):
Income taxes		(32,280)		(303,637)		80,520
Interest expense	[1]	125,569		115,651		99,941
Loss on extinguishment of debt		(6,527)		0		0
Other (income) expense	[2]	43,612		62,425		(22,422)
Equity Method Investment Dividends Or Distributions		156		25,430		53,366
Non-cash distributions from DCIP		0		(12,915)		0	[3]
Depreciation and amortization		265,363		259,776		261,155
Impairment of long-lived and other assets		20,845		152,706		57,001
(Gain) loss on disposal of assets and other		8,025		(8,923)		12,008
Restructuring costs		(1,001)		20,369		0
Non-cash rent expense		(3,451)		2,357		(4,360)
Share based awards compensation expense		28,348		18,486		13,697
Adjusted EBITDA	[4]	81,615		(275,562)		746,683
Digital Cinema Implementation Partners
Add (deduct):
Equity Method Investment Dividends Or Distributions	[5]	0		10,383		23,696
Non-cash distributions from DCIP	[6]	0	[3]	(12,915)	[3]	0
Equity Investees
Add (deduct):
Equity Method Investment Dividends Or Distributions	[7]	$ 156		$ 15,047		$ 29,670
[1]	Includes amortization of debt issuance costs.
[2]	Includes interest income, foreign currency exchange loss, interest expense – NCM and equity in income (loss) of affiliates and excludes distributions from NCM.
[3]	Reflects non-cash distribution of projectors from DCIP (see Note 7). These distributions are reported entirely within the U.S. operating segment.
[4]	Distributions from equity investees are reported entirely within the U.S. operating segment.
[5]	See discussion of cash distributions from DCIP, which were recorded as a reduction of the Company’s investment in DCIP for the years ended December 31, 2019 and 2020, in Note 7. These distributions are reported entirely within the U.S. operating segment.
[6]	Recorded as non-cash distributions from DCIP on the consolidated statements of income (loss). See discussion at Distribution of Projectors from DCIP above.
[7]	Reflects cash distributions received from equity investees, other than those from DCIP noted above, that were recorded as a reduction of the respective investment balances (see Notes 6 and 7). These distributions are reported entirely within the U.S. operating segment.

Selected Financial Informatio_2

Selected Financial Information by Geographic Area (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$ 1,510,464	$ 686,310	$ 3,283,099
Theatre properties and equipment, net	1,382,846	1,615,062
Reportable Geographical Components | U.S.
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	1,296,343	559,184	2,594,246
Theatre properties and equipment, net	1,208,701	1,392,780
Reportable Geographical Components | Brazil
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	73,468	59,321	302,074
Theatre properties and equipment, net	56,750	72,080
Reportable Geographical Components | Other international countries
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	143,374	70,080	400,122
Theatre properties and equipment, net	117,395	150,202
Eliminations
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$ (2,721)	$ (2,275)	$ (13,343)

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2021USD ($)Theatre	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Related Party Transaction [Line Items]
Consulting Services	$ 122
Dividends paid to parent	0	$ (42,000)	$ (158,450)
Accounts receivable from parent	46,651	36,775
Contributions received from parent	120,000
FE Concepts LLC
Related Party Transaction [Line Items]
Management Fee Revenues	$ 62	34	64
Percentage of voting interest	50.00%
Laredo Theatres, Ltd
Related Party Transaction [Line Items]
Company's interest in Laredo	75.00%
Lone Star Theatre's interest in Laredo	25.00%
Ownership interest held by David Roberts	100.00%
Percentage of common stock held by Chairman of the Board of Directors	9.00%
Percentage of management fees based on theatre revenues	5.00%
Maximum amount of theater revenue used to calculate management fees	$ 50,000
Percentage of management fees based on theatre revenues in excess	3.00%
Minimum amount of theater revenue used to calculate management fees	$ 50,000
Management Fee Revenues	399	146	694
Copper Beech Capital LLC
Related Party Transaction [Line Items]
Amount paid for the use of aircraft	$ 23	12	114
Syufy Enterprises, LP
Related Party Transaction [Line Items]
Number of theatres leased | Theatre	13
Total rent paid to Syufy	$ 23,317	23,810	25,678
Amount billed for digital support provided to Syufy	55	0	30
Cinemark Holdings Inc [Member]
Related Party Transaction [Line Items]
Dividends paid to parent	0	(42,000)	$ (158,450)
Accounts receivable from parent	46,651	$ 36,775
Contributions received from parent	$ 120,000

Valuation Allowance of Deferred

Valuation Allowance of Deferred Tax Assets (Detail) - Valuation Allowance of Deferred Tax Assets - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Valuation and Qualifying Accounts Disclosure [Line Items]
Beginning Balance	$ 203,606	$ 60,359	$ 54,725
Additions	52,516	144,239	7,611
Deductions	(10,974)	(992)	(1,977)
Currency translation	(4,301)
Ending Balance	$ 240,847	$ 203,606	$ 60,359

Summary Financial Information o

Summary Financial Information of Subsidiary Guarantors - Additional Information (Detail)	Apr. 17, 2020
Condensed Consolidating Financial Information [Line Items]
Interest rate	8.75%

Summary of Balance Sheet Inform

Summary of Balance Sheet Information (Detail) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Condensed Financial Statements, Captions [Line Items]
Current assets	$ 656,454	$ 528,495
Current liabilities	760,598	598,782
Long-term liabilities	3,697,188	3,814,894
Stockholder's equity	$ 554,846	$ 784,994	$ 1,474,207	$ 1,429,636

Summary Income Statement Inform

Summary Income Statement Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Condensed Financial Statements, Captions [Line Items]
Revenues	$ 1,510,464	$ 686,310	$ 3,283,099
Operating loss	(249,886)	(752,738)	340,943
Net income (loss)	$ (380,098)	$ (607,287)	$ 195,777

Supplemental Schedules - Conden

Supplemental Schedules - Condensed Consolidating Balance Sheet (Detail) - USD ($) $ in Thousands		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Current assets
Cash and cash equivalents		$ 442,677	$ 260,538
Other current assets		213,777
Total current assets		656,454
Theatre properties and equipment, net		1,382,846	1,615,062
Operating lease right-of-use assets, net	[1]	1,230,790	1,278,191
Other assets		1,742,542	1,776,922
Total assets		5,012,632	5,198,670
Current liabilities
Current portion of long-term debt		24,254	18,056
Current portion of operating lease obligations	[1]	217,092	208,593
Current portion of finance lease obligations	[1]	14,605	16,407
Accounts payable and accrued expenses		504,647
Total current liabilities		760,598	598,782
Long-term liabilities
Long-term debt, less current portion		2,028,692	2,024,956
Operating lease obligations, less current portion	[1]	1,078,260	1,138,142
Capital and finance lease obligations, less current portion	[1]	102,571	124,609
Other long-term liabilities and deferrals		487,665
Total long-term liabilities		3,697,188	3,814,894
Commitments and contingencies
Equity		554,846	784,994	$ 1,474,207	$ 1,429,636
Total liabilities and equity		5,012,632	$ 5,198,670
Restricted Subsidiaries
Current assets
Cash and cash equivalents		342,603
Other current assets		338,664
Total current assets		681,267
Theatre properties and equipment, net		1,382,846
Operating lease right-of-use assets, net		1,230,790
Other assets		1,794,697
Total assets		5,089,600
Current liabilities
Current portion of long-term debt		24,254
Current portion of operating lease obligations		217,092
Current portion of finance lease obligations		14,605
Accounts payable and accrued expenses		510,366
Total current liabilities		766,317
Long-term liabilities
Long-term debt, less current portion		2,293,215
Operating lease obligations, less current portion		1,078,260
Capital and finance lease obligations, less current portion		102,571
Other long-term liabilities and deferrals		475,666
Total long-term liabilities		3,949,712
Commitments and contingencies
Equity		373,571
Total liabilities and equity		5,089,600
Unrestricted Subsidiaries
Current assets
Cash and cash equivalents		100,074
Other current assets		(119,168)
Total current assets		(19,094)
Other assets		319,387
Total assets		300,293
Long-term liabilities
Other long-term liabilities and deferrals		11,999
Total long-term liabilities		11,999
Commitments and contingencies
Equity		288,294
Total liabilities and equity		300,293
Eliminations
Current assets
Other current assets		(5,719)
Total current assets		(5,719)
Other assets		(371,542)
Total assets		(377,261)
Current liabilities
Accounts payable and accrued expenses		(5,719)
Total current liabilities		(5,719)
Long-term liabilities
Long-term debt, less current portion		(264,523)
Total long-term liabilities		(264,523)
Commitments and contingencies
Equity		(107,019)
Total liabilities and equity		$ (377,261)
[1]	The operating lease right-of-use assets and liabilities recorded on the Company’s consolidated balance sheets generally do not include renewal options that have not yet been exercised. The Company does not consider a lease renewal exercise as reasonably certain until immediately before the necessary notification is provided to the landlord after consideration of market conditions and performance of the theatre.

Supplemental Schedules - Cond_2

Supplemental Schedules - Condensed Consolidating Statement of Income (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Condensed Financial Statements, Captions [Line Items]
Revenues	$ 1,510,464	$ 686,310	$ 3,283,099
Cost of operations
Theatre operating costs	1,308,628
General and administrative expenses	158,490	125,363	170,828
Depreciation and amortization	265,363	259,776	261,155
Impairment of long-lived assets	20,845	152,706	57,001
Restructuring costs	(1,001)	20,369	0
Loss on sale of assets and other	8,025	(8,923)	12,008
Total cost of operations	1,760,350	1,439,048	2,942,156
Operating income (loss)	(249,886)	(752,738)	340,943
Other income (expense)	(162,492)	(158,186)	(64,646)
Income (loss) before income taxes	(412,378)	(910,924)	276,297
Income taxes	(32,280)	(303,637)	80,520
Net income (loss)	(380,098)	(607,287)	195,777
Less: Net income attributable to noncontrolling interests	568	(1,120)	2,462
Net income (loss) attributable to Cinemark USA, Inc.	(380,666)	$ (606,167)	$ 193,315
Restricted Subsidiaries
Condensed Financial Statements, Captions [Line Items]
Revenues	1,510,464
Cost of operations
Theatre operating costs	1,308,628
General and administrative expenses	158,472
Depreciation and amortization	265,363
Impairment of long-lived assets	20,845
Restructuring costs	(1,001)
Loss on sale of assets and other	8,025
Total cost of operations	1,760,332
Operating income (loss)	(249,868)
Other income (expense)	(169,057)
Income (loss) before income taxes	(418,925)
Income taxes	(33,758)
Net income (loss)	(385,167)
Less: Net income attributable to noncontrolling interests	568
Net income (loss) attributable to Cinemark USA, Inc.	(385,735)
Unrestricted
Cost of operations
General and administrative expenses	18
Total cost of operations	18
Operating income (loss)	(18)
Other income (expense)	6,565
Income (loss) before income taxes	6,547
Income taxes	1,478
Net income (loss)	5,069
Net income (loss) attributable to Cinemark USA, Inc.	5,069
Eliminations
Cost of operations
Net income (loss) attributable to Cinemark USA, Inc.	$ 0

Supplemental Schedules - Cond_3

Supplemental Schedules - Condensed Consolidating of Comprehensive Loss (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Net loss	$ (380,098)	$ (607,287)	$ 195,777
Other comprehensive income (loss), net of tax
Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes of $(3278), net of settlements	15,944	(14,320)	(8,210)
Foreign currency translation adjustments	(18,837)	(47,592)	(12,753)
Total other comprehensive loss, net of tax	(2,893)	(61,912)	(21,105)
Total comprehensive loss, net of tax	(382,991)	(669,199)	174,672
Comprehensive (income) loss attributable to noncontrolling interests	(568)	1,120	(2,462)
Comprehensive income attributable to Cinemark USA, Inc.	(383,559)	$ (668,079)	$ 172,210
Restricted Subsidiaries
Net loss	(385,167)
Other comprehensive income (loss), net of tax
Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes of $(3278), net of settlements	15,944
Foreign currency translation adjustments	(18,837)
Total other comprehensive loss, net of tax	(2,893)
Total comprehensive loss, net of tax	(388,060)
Comprehensive (income) loss attributable to noncontrolling interests	(568)
Comprehensive income attributable to Cinemark USA, Inc.	(388,628)
Unrestricted Subsidiaries
Net loss	5,069
Other comprehensive income (loss), net of tax
Total comprehensive loss, net of tax	5,069
Comprehensive income attributable to Cinemark USA, Inc.	5,069
Eliminations
Other comprehensive income (loss), net of tax
Comprehensive income attributable to Cinemark USA, Inc.	$ 0

Supplemental Schedules - Cond_4

Supplemental Schedules - Condensed Consolidating of Comprehensive Loss (Parenthetical) (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2021USD ($)
Condensed Financial Information Of Parent Company Only Disclosure [Abstract]
Unrealized gain due to fair value adjustments on interest rate swap agreements, taxes	$ (3,278)

Supplemental Schedules - Cond_5

Supplemental Schedules - Condensed Consolidating Statement of Cash Flows (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Operating activities
Net loss	$ (380,098)	$ (607,287)	$ 195,777
Adjustments to reconcile net loss to cash used for operating activities	315,728
Changes in assets and liabilities	(240,727)
Net cash provided by (used for) operating activities	176,357	(334,903)	561,072
Investing activities
Additions to theatre properties and equipment and other	(95,542)	(83,930)	(303,627)
Proceeds from sale of theatre properties and equipment and other	6,246	614	3,155
Net cash used for investing activities	(89,296)	(83,366)	(310,642)
Financing activities
Contributions from parent	120,000
Dividends paid to parent	0	(42,000)	(158,450)
Proceeds from issuance of senior notes	1,170,000	250,000	0
Proceeds from other borrowings	13,475	22,322	0
Redemptions of senior notes	(1,155,000)
Repayments of long-term debt	(10,284)	(6,691)	(7,984)
Payment of debt issuance costs	(17,272)	(7,859)	0
Payments on finance leases	(14,689)
Other	(6,160)
Net cash provided by (used for) financing activities	100,070	194,511	(185,675)
Effect of exchange rate changes on cash and cash equivalents	(4,992)	(3,919)	(2,756)
Increase (decrease) in cash and cash equivalents	182,139	(227,677)	61,999
Cash and cash equivalents:
Beginning of period	260,538	488,215	426,216
End of period	442,677	260,538	$ 488,215
Restricted Subsidiaries
Operating activities
Net loss	(385,167)
Adjustments to reconcile net loss to cash used for operating activities	306,069
Changes in assets and liabilities	242,356
Net cash provided by (used for) operating activities	163,258
Investing activities
Additions to theatre properties and equipment and other	(95,542)
Proceeds from sale of theatre properties and equipment and other	6,246
Net cash used for investing activities	(89,296)
Financing activities
Contributions from parent	120,000
Borrowings from parent/subsidiary	7,785
Proceeds from issuance of senior notes	1,170,000
Proceeds from other borrowings	13,475
Redemptions of senior notes	(1,155,000)
Repayments of long-term debt	(10,284)
Payment of debt issuance costs	(17,272)
Payments on finance leases	(14,689)
Other	(6,160)
Net cash provided by (used for) financing activities	107,855
Effect of exchange rate changes on cash and cash equivalents	(4,992)
Increase (decrease) in cash and cash equivalents	176,825
Cash and cash equivalents:
Beginning of period	165,778
End of period	342,603	165,778
Unrestricted Subsidiaries
Operating activities
Net loss	5,069
Adjustments to reconcile net loss to cash used for operating activities	9,659
Changes in assets and liabilities	(1,629)
Net cash provided by (used for) operating activities	13,099
Investing activities
Investments and loans to affiliates	(7,785)
Net cash used for investing activities	7,785
Financing activities
Increase (decrease) in cash and cash equivalents	5,314
Cash and cash equivalents:
Beginning of period	94,760
End of period	100,074	$ 94,760
Eliminations
Investing activities
Investments and loans to affiliates	(7,785)
Net cash used for investing activities	7,785
Financing activities
Borrowings from parent/subsidiary	7,785
Net cash provided by (used for) financing activities	$ (7,785)